# IMPORTS:
import streamlit as st
import pandas as pd
from transformers import AutoTokenizer, AutoModel
import torch
from sklearn.metrics.pairwise import cosine_similarity

# GLOBAL VARIABLES:

# FUNCTIONS:
@st.cache()
def get_sentences_dataset():
    data = [
        [2019, "We found that venetoclax and voreloxin synergistically induced apoptosis in multiple AML cell lines."],
        [2010, "Anthracyclines like daunorubicin (daunorubicin) are important drugs in the treatment of AML (AML)."],
        [2012, "The use of mitoxantrone is limited by severe cardiotoxicity and the risk of treatment related acute leukemia."],
        [2004, "Recent resurgence in the use of arsenictrioxide is related to its high efficacy in AML (APL)."],
        [2019, "Corticosteroids, especially dexamethasone, play a critical role in chemotherapy for pediatric hematological malignancies."],
        [2018, "Cyclophosphamide is a chemotherapy drug for the treatment of cancer."],
        [2001, "In conclusion, primary chemotherapy based on high dose MTX and cytarabine is highly efficient in PCNSL."],
        [2019, "Adding pioglitazone to cytarabine and daunorubicin increased the remission rate in AML patients compared to control subjects."],
        [2008, "Despite the significant anti-tumor activities, cyclophosphamide (CP) also shows cytotoxicity to normal cells."],
        [1993, "Idarubicin plus continuous-infusion high-dose cytarabine as treatment for patients with AML or myelodysplastic syndrome."],
        [2014, "Furthermore, we identified that arsenictrioxide exerts its anti-tumor activity partly through regulation of miR-125b."],
        [2019, "Notably, chemotherapy plus midostaurin improved survival compared with chemotherapy alone."],
        [1985, "A phase II trial of prolonged IV infusions of vincristine was conducted in 21 patients with refractory acute leukemia."],
        [1981, "vincristine (vincristine), cyclophosphamide (CP), and carmustine have antineoplastic activity in acute lymphocytic leukemia."],
        [1990, "Treatment of refractory acute lymphoblastic leukemia in adults with high dose cytarabine and mitoxantrone (HAM)."],
        [1995, "Pharmacokinetics and anti-tumor activity of vincristine encapsulated in sterically stabilized liposomes."],
        [2017, "Furthermore, we explored the in vivo activity of quinacrine in combination with the widely used AML agent cytarabine."],
        [2015, "Finally, Msi2 silencing in AML cells also enhanced their chemosensitivity to daunorubicin."],
        [2022, "A total of 170 adult AML patients were treated with first-line azacitidine (azacitidine) or decitabine (DEC) +/- VEN."],
        [2021, "Mechanistic effects of arsenictrioxide on AML and other types of leukemias."],
        [2007, "A case of successful intrapleural chemotherapy with Cisplatin plus cytarabine for intractable malignant pleural effusion."],
        [2017, "He has received chemotherapy with FLAG (Fludarabine, cytarabine."],
        [1999, "Metabolism and excretion of the new antitumor drug N4-octadecyl-cytarabine (NOAC) was investigated in mice."],
        [1994, "Comparison of the intracellular pharmacokinetics of daunorubicin and idarubicin in patients with acute leukemia."],
        [2009, "We describe a child with acute lymphoblastic leukemia who developed vincristine-induced bilateral vocal cord paralysis."],
        [2020, "The patient was treated with a chemotherapy regimen based on idarubicin and cytarabine arabinoside."],
        [1998, "The present study indicates that epirubicin and idarubicin in a combined chemotherapy regimen, have similar activities."],
        [2017, "Together with anthracyclines, cytarabine forms the backbone of AML treatment for children and adults."],
        [2011, "It is well recognized that arsenictrioxide (arsenictrioxide) is an efficacious agent for the treatment of AML (APL)."],
        [2009, "Step 1 consisted of consolidation chemotherapy using cytarabine 2000 mg/m(2) i.v."],
        [1987, "A total of 17 pediatric patients with pretreated acute lymphoblastic leukemia were included in a phase II study of idarubicin."],
        [2008, "Asparaginase may influence dexamethasone pharmacokinetics in acute lymphoblastic leukemia."],
        [2006, "Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia."],
        [1996, "Cyclophosphamide alone (60 mg/kg/day on each of 2 successive days) was used as conditioning chemotherapy in all patients."],
        [1983, "Pretreatment with these drugs increased the acute toxicity of cyclophosphamide (300 or 450 mg/kg, i.p."],
        [2009, "K-RAS mutations - AML - Cytarabine."],
        [2013, "Fludarabine, cytarabine, and attenuated-dose idarubicin (m-FLAI) combination therapy for elderly AML patients."],
        [2008, "Rituximab combination with chemotherapy is highly suggested but only for patients enrolled into approved clinical trials."],
        [2019, "The use of dexamethasone in acute lymphoblastic leukemia therapy contributes to short- and long-term toxicities."],
        [2022, "Bendamustine, along with rituximab, were the most commonly prescribed chemotherapy regimens during the treatments."],
        [1999, "mitoxantrone and cyclophosphamide combination chemotherapy for the treatment of various canine malignancies."],
        [2016, "Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type AML models."],
        [2010, "arsenictrioxide (arsenictrioxide) is a widely used drug for AML (APL)."],
        [2021, "Platelet Microparticles Protect AML Cells against Daunorubicin-Induced Apoptosis."],
        [2014, "Eight cycles of adjuvant chemotherapy of lomustine, vincristinesulfate and platinol were given to all patients after RT."],
        [2011, "Cyclophosphamide is a cytotoxic chemotherapy drug that causes severe damages to hematopoietic and gastrointestinal systems."],
        [1983, "Ten patients with refractory acute leukemia were treated with high-dose cytarabine (cytarabine) infusions."],
        [2014, "Clinicians must always keep in mind that acute hyponatremic encephalopathy can be induced by low-dose cyclophosphamide."],
        [1992, "Unscheduled DNA synthesis induced by the antitumor drug vincristine in germ cells of male mice."],
        [2018, "Population Pharmacokinetics of Volasertib Administered in Patients with AML as a Single Agent or in Combination with Cytarabine."],
        [2004, "Intrapleural chemotherapy with cisplatin and cytarabine in the management of malignant pleural effusion."],
        [1991, "Synthesis and antitumor properties of activated cyclophosphamide analogues."],
        [2016, "Treatment of hemorrhagic acute disseminated encephalomyelitis with cyclophosphamide."],
        [1985, "Synthesis and comparison of antitumor activity of cytarabine conjugates of corticosteroids and selected lipophilic ethanol."],
        [2016, "Pre-treatment with DAC restores cellular sensitivity in cytarabine-resistant AML cells."],
        [1998, "Initial chemotherapy was with Cisplatinum, cyclophosphamidemonohydrate, and doxorubicin."],
        [2012, "Postoperative chemotherapy consisted of actinomycind, vincristine and epirubicin/doxorubicin for 27 weeks."],
        [2012, "rituximab) plus chemotherapy compared to chemotherapy alone."],
        [1995, "The effect of haemopoietic growth factors on the cell cycle of AML progenitors and their sensitivity to cytarabine in vitro."],
        [2001, "The anthracycline daunorubicin is widely used in the treatment of acute nonlymphocytic leukemia."],
        [2003, "This study was performed to investigate the effects of dexamethasone on AML (AML) cells."],
        [2017, "Synergistic antileukemic interactions between AZ20 and cytarabine were confirmed in primary AML patient samples."],
        [2015, "The addition of rituximab (RTX) to standard chemotherapy has improved the treatment of B-cell malignancies."],
        [1968, "daunorubicin in acute leukemia in adults."],
        [2014, "Retinoic acid synergizes arsenictrioxide-mediated cytotoxicity by precluding Nrf2 activity in AML cells."],
        [2004, "Rituximab in a patient with acute renal failure due to B-cell lymphomatous infiltration of the kidneys."],
        [1984, "Eight courses of chemotherapy with vincristine (2 mg/M2, i.v.)"],
        [2016, "No review has yet been published on the dose-related toxicity and efficacy of gemtuzumab-ozogamicin in pediatric AML patients."],
        [1990, "mitoxantrone and high-dose cytarabine for the treatment of refractory acute lymphocytic leukemia."],
        [2014, "A total of 51 patients with AML (AML) induction failure were given elacytarabine-idarubicin as a second induction course."],
        [1985, "Treatment of AML with a daunorubicin cytarabine thioguanine regimen without maintenance therapy."],
        [2022, "Impact of Venetoclax and azacitidine in Treatment-Naïve Patients with AML and IDH1/2 Mutations."],
        [2013, "A C-type lectin receptor pathway is responsible for the pathogenesis of acute cyclophosphamide-induced cystitis in mice."],
        [2021, "Patients with DLBCL treated with combination chemotherapy plus rituximab were included."],
        [2012, "Antileukemia effect of sirolimus alone or in combination with daunorubicin on Ph+ acute lymphoblastic leukemia cell line."],
        [2002, "arsenictrioxide (arsenictrioxide) is a novel agent to treat AML (APL)."],
        [2020, "Slower degradation rate of cytarabine in blood samples from AML by comparison with control samples."],
        [2007, "Human DNA mismatch repair (MMR) is involved in the response to certain chemotherapy drugs, including thioguanine (6-TG)."],
        [2017, "PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary AML via miR-181b-1 upregulation."],
        [2006, "Salvage chemotherapy with cyclophosphamide for recurrent temozolomide-refractory anaplastic astrocytoma."],
        [2015, "Adjuvant mitoxantrone chemotherapy may be an option for feline mammary tumors."],
        [2003, "Taken together, high-dose chemotherapy can be safely given following treatment with CHOP+rituximab."],
        [2013, "Effects of azacitidine on matrix metalloproteinase-9 in AML and myelodysplasia."],
        [2021, "Midostaurin is an FMS-like dl-tyrosine kinase 3 receptor (FLT3) inhibitor that provides renewed hope for treating AML (AML)."],
        [1981, "All patients entering remission were placed on weekly maintenance chemotherapy consisting of cytarabine and thioguanine."],
        [2013, "Low-dose cyclophosphamide-induced acute hepatotoxicity."],
        [1999, "A 5 year old boy developed severe weakness after receiving vincristine for treatment of acute lymphoblastic leukemia."],
        [2018, "Most patients with chronic lymphocytic leukemia relapse after initial therapy combining chemotherapy with rituximab."],
        [2013, "azacitidine is a hypomethylating agent with recognized efficacy in high risk myelodysplasia and AML in the elderly."],
        [2021, "JAK-STAT inhibitor as a potential therapeutic opportunity in AML patients resistant to cytarabine and epigenetic therapy."],
        [2009, "The Prognostic Impact of K-RAS Mutations in Adult AML Patients Treated with High Dose Cytarabine."],
        [2004, "The anthracycline antitumor agents doxorubicin and daunorubicin reduce the activity of Candida albicans phospholipase B."],
        [2020, "Venetoclax combined with 5 + 2 induction chemotherapy was safe and tolerable in fit older patients with AML."],
        [2000, "All patients with relapsed or persistent AML had been pretreated with IDA and cytarabine."],
        [2018, "Midostaurin has been shown to improve outcomes in FLT3-mutated AML in the frontline setting."],
        [2022, "Gilteritinib is approved for the treatment of relapsed/refractory (R/R) AML (AML) with an FLT3-mutation (FLT3mut+ )."],
        [2002, "She was treated with conventional chemotherapy (idarubicin plus cytarabine) and reached complete remission of leukemia."],
        [2001, "Arsenic oxide (arsenictrioxide) has recently been reported to induce remission in a high percentage of patients with AML (APL)."],
        [2013, "Rituximab-containing chemotherapy was associated with an improved survival rate in MCL patients."],
        [2022, "Resistance to cytarabine is a key problem in the treatment of AML (AML)."],
        [2011, "Enhanced enzymatic stability and antitumor activity of daunorubicin-GnRH-III bioconjugates modified in position 4."],
        [2006, "MEK1 inhibition sensitizes primary AML to arsenictrioxide-induced apoptosis."],
        [2021, "Our study examines if dexamethasone coadministration with RT inhibits the RT-induced antitumor T cell response in mouse."],
        [2020, "arsenictrioxide), we revived an oral formulation of pure arsenictrioxide in 1998 for the treatment of AML (APL)."],
        [2005, "Gemcitabine (dFdCyd) is an analog of cytarabine with anti-tumor activity in several human cancers."],
        [2004, "Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatment of acute Kawasaki disease."],
        [2013, "Antiemetic regimen 1 containing granisetron 0, 04 mg/kg plus dexamethasone 0, 2 mg/kg were given in 45 chemotherapy cycles."],
        [2021, "The standard treatment for pediatric AML currently consists in a combination of cytarabine (cytarabine) and antracycline."],
        [2011, "Continuous and high-dose cytarabine combined chemotherapy with reduced intensity would be effective in DS children with AML."],
        [2016, "A Phase I trial of venetoclax in CLL showed remarkable antitumor activity and stable patient platelet counts."],
        [1992, "Autologous bone marrow transplantation for AML using 4-hydroperoxycyclophosphamide and etoposide purged bone marrow."],
        [2015, "Few data are available on SH occurring after chemotherapy and/or Rituximab (R)."],
        [2021, "Delaying dexamethasone during the first chemotherapy cycle reduces the number of early deaths without extending survival."],
        [2010, "Reduced dose-limiting toxicity of intraperitoneal mitoxantrone chemotherapy using cardiolipin-based anionic liposomes."],
        [2007, "However, little is known about usefulness of rituximab on central nervous system involvement mimicking acute ischemic stroke."],
        [2006, "Two cases of AML complicated by torsade de pointes during arsenictrioxide therapy."],
        [2018, "Enhanced Response of AML Cells to Low-dose Cytarabine by 1,25-dihydroxyvitamin D3."],
        [2004, "The impressive activity of arsenictrioxide in AML (APL) has renewed the interest in this old compound."],
        [2022, "Characterisation of infections in patients with AML receiving venetoclax and a hypomethylating agent."],
        [1995, "Low-dose cytarabine in patients with AML not eligible for standard chemotherapy."],
        [2018, "To compare the efficacy of pulse cyclophosphamide with pulse dexamethasone in acute macular serpiginous choroiditis (SC)."],
        [2009, "arsenictrioxide (As(2)O(3)) has been established to be an effective agent for treating acute promyleocytic leukemia."],
        [2016, "arsenictrioxide (arsenictrioxide) is an efficient drug for the treatment of the patients with AML (APL)."],
        [2022, "Twenty-two patients received systemic chemotherapy with carboplatin, vincristine and etoposide."],
        [1986, "A series of 46 patients with acute leukemia were treated with amsacrine (m-AMSA) and cytarabine (cytarabine)."],
        [2013, "The patient was diagnosed with multiple myeloma and received chemotherapy with thalidomide, cyclophosphamide and dexamethasone."],
        [2022, "Cytarabine (CYT) is involved in the AML treatment regimen."],
        [1978, "Synthesis and antitumor evaluation of 4-ethoxycarbonyl cyclophosphamide analogs."],
        [2015, "The efficacy and pharmacodynamics of MLN4924/cytarabine were assessed in an AML xenograft model."],
        [1992, "High-dose cytarabine intensification for acute nonlymphocytic leukemia in patients over 56 years of age."],
        [1991, "Phase II trial of mitoxantrone in acute lymphocytic leukemia of childhood."],
        [2011, "Outcome of therapy-related AML with or without arsenictrioxide as a component of frontline therapy."],
        [2010, "High dose dexamethasone therapy shows better responses in acute immune thrombocytopenia than in chronic immune thrombocytopenia."],
        [2022, "However, resistance eventually develops, decreasing the efficacy of cytarabine in AML patients."],
        [2021, "Non-cytarabine-based induction chemotherapy was more commonly administered in older patients (76% vs 32%, p = 0.0012)."],
        [1985, "infusion, potentially avoiding acute toxicities associated with bolus administration of azacitidine."],
        [2013, "Cytarabine arabinoside (cytarabine) is the key agent for treating AML (AML)."],
        [2006, "A phase II trial of arsenictrioxide for relapsed and refractory acute lymphoblastic leukemia."],
        [2009, "The mainstay of AML chemotherapy is the nucleoside analog cytarabine (cytarabine)."],
        [2003, "High-dose daunorubicin as liposomal compound (daunorubicin) in elderly patients with acute lymphoblastic leukemia."],
        [2006, "The children received vincristine during the maintenance phase of their outpatient chemotherapy treatments."],
        [2013, "MicroRNA-125b (miR-125b), miR-99a and miR-100 are overexpressed in vincristine-resistant acute lymphoblastic leukemia (ALL)."],
        [2006, "Cytarabine (cytarabine) is commonly used for the treatment of acute leukemia."],
        [2008, "Notably, the combination of everolimus with cyclophosphamide resulted in synergistic anti-tumor activity (T/C 9%, p<0.01)."],
        [2013, "Arsenic speciation in saliva of AML patients undergoing arsenictrioxide treatment."],
        [2021, "NOXA-mediated degradation of MCL1 and BCL2L1 causes apoptosis of daunorubicin-treated human AML cells."],
        [1994, "Modulation of intracellular metabolism of cytarabine in AML by granulocyte-macrophage colony-stimulating factor."],
        [2012, "Fludarabine and cytarabine in patients with relapsed AML refractory to initial salvage therapy."],
        [2003, "Three hours following acute dexamethasone treatment (0.05 mg/kg, p.o."],
        [2020, "Patients received chemotherapy consisting of cyclophosphamide, etoposide, cisplatin, and vincristine."],
        [2006, "arsenictrioxide (arsenictrioxide) is a novel agent for acute promylocytic leukemia (APL)."],
        [2002, "Licensure of gemtuzumab-ozogamicin for the treatment of selected patients 60 years of age or older with AML in first relapse."],
        [1988, "mitoxantrone in relapsed or refractory acute nonlymphocytic leukemia."],
        [1989, "Treatment of relapsed AML with idarubicin and intermediate-dose cytarabine."],
        [1990, "mitoxantrone, etoposide and cytarabine in the treatment of acute nonlymphocytic leukemia."],
        [2019, "Synergistic anti-tumor effects of arsenictrioxide and blue LED irradiation on human osteosarcoma."],
        [2021, "In cytarabine-adapted AML cells, increased SAMHD1 and reduced DCK levels contributed to cytarabine and CNDAC resistance."],
        [2020, "The alkylating agent cyclophosphamide is used in chemotherapy regimens for various type of cancer."],
        [1991, "High-dose cytarabine and etoposide in refractory or relapsing acute leukemia."],
        [2021, "vincristine (vincristine) is an integral part of chemotherapy regimens in the US and in developing countries."],
        [2013, "arsenictrioxide has been successfully used as a therapeutic in the treatment of AML (APL)."],
        [2010, "Third-line chemotherapy was vincristine/dactinomycin/cyclophosphamide (VAC) or vincristine/ iphosphamide/cisplatin (VIP)."],
        [2007, "arsenictrioxide (As(2)O(3)) is highly efficacious for AML (APL)."],
        [2009, "Intravenous dexamethasone vs methylprednisolone pulse therapy in the treatment of acute endothelial graft rejection."],
        [2017, "High-dose cytarabine is recommended for re-induction chemotherapy in patients less than 60 years of age with AML."],
        [1992, "Effector molecules from antitumor macrophages induced with picibanil and cyclophosphamide."],
        [2007, "All-trans retinoic acid in association with low dose cytarabine in the treatment of acute myeoid leukemia in elderly patients."],
        [2009, "Patients diagnosed with AML are often treated with a combination of daunorubicin and cytarabine (cytarabine)."],
        [2008, "Adults with de novo AML received daunorubicin and cytarabine induction therapy."],
        [2021, "In addition, co-incubation with PMPs protected THP-1 and primary AML cells against daunorubicin-induced cell death."],
        [2007, "Addition of rituximab to chemotherapy for FL has been shown to improve survival."],
        [2021, "Lomustine, methotrexate and cytarabine chemotherapy as a rescue treatment for feline lymphoma."],
        [2021, "Mechanistically, synergistic anti-tumor effect of cytarabine/)Brusatol in AML cells is mediated by attenuating Nrf2 expression."],
        [1992, "Idarubicin is currently approved for use with other agents in the management of acute nonlymphocytic leukemia in adults."],
        [2021, "Neutropenia is an adverse effect of vincristine when used in multidrug chemotherapy protocols."],
        [2015, "To evaluate safety and efficacy of intravenous pulse cyclophosphamide (CyP) in acute macular serpiginous choroiditis (SC)."],
        [2018, "Cyclophosphamide (CTX) is a widely used antitumor drug that can suppress the immune system."],
        [2022, "Surface-modified vacuole-based daunorubicin delivery system for AML (AML) and their selective therapeutics."],
        [2019, "He was resistant to anti-tumor necrosis factor (TNF)-α antibody and azacitidine."],
        [2019, "azacitidine therapy was utilised in ten eligible patients, while four received induction chemotherapy for AML."],
        [2017, "Before the introduction of anthracyclines and cytarabine in the 1960s, AML (AML) was considered a fatal disease."],
        [1996, "Her treatment consisted of tumor bed irradiation (4,000 cGy) and chemotherapy with actinomycind, vincristine, and doxorubicin."],
        [2005, "After fifth surgery, chemotherapy with cisplatin, doxorubicin and vincristine was started."],
        [2020, "arsenictrioxide (arsenictrioxide) an evident effect in the treatment of AML and other malignant tumors in recent years."],
        [1991, "cyclosporine was continued during induction chemotherapy with daunorubicin, cytarabine, and thioguanine (DAT)."],
        [1992, "In first trial, fluorouracil, mitomycin C, and cytarabine for chemotherapy and OK 432 for immunotherapy were used."],
        [2003, "Intraperitoneal chemotherapy with mitoxantrone in malignant ascites."],
        [2021, "Single-center experience with venetoclax combinations in patients with newly diagnosed and relapsed AML evolving from MPNs."],
        [2014, "Induction chemotherapy for AML with cytarabine, etoposide, and mitoxantrone was initiated."],
        [2021, "However, the role of autophagy in the antitumor effect of arsenictrioxide has not yet been elucidated."],
        [2021, "Daunorubicin is used clinically in the treatment of myeloma, acute lymphatic and myelocytic leukemia."],
        [2003, "vincristine (vincristine) is an effective drug against acute lymphoblastic leukemia (ALL), many solid tumors, but not AML."],
        [2014, "Twenty-three adults with relapsed/refractory AML received azacitidine 75 mg/m(2) daily on days 1-7."],
        [2013, "MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia."],
        [2009, "Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo AML."],
        [1992, "Similar inhibition was observed for daunorubicin, a structurally related anthracycline antitumor drug."],
        [2011, "Effect of dexamethasone on brain oedema following acute ischemic stroke."],
        [1989, "Daunorubicin, an anthracycline antitumor antibiotic, can be complexed in egg white apo-riboflavin binding protein."],
        [2022, "However, we found that two AML patients with FLT3-ITD mutation did not respond to venetoclax plus azacitidine (VEN+AZA)."],
        [2007, "arsenictrioxide (arsenictrioxide) is highly efficacious in AML (APL)."],
        [2020, "Daunorubicin is a chemotherapy medication used to treat cancer, specifically for AML."],
        [2017, "Autophagy is an important event for low-dose cytarabine treatment in AML cells."],
        [1983, "The membrane transport of cytarabine (cytarabine) has been studied in blasts freshly isolated from a variety of acute leukemias."],
        [1995, "Adjuvant chemotherapy with procarbazine, lomustine, and vincristine (PCV) was given up to 1 year or until tumor progression."],
        [2020, "Vincristine is a core chemotherapeutic drug administered to pediatric acute lymphoblastic leukemia patients."],
        [1998, "Patients with relapsed AML received 2- or 4-h infusions of 0.5 g/m2/h cytarabine."],
        [2015, "arsenictrioxide (arsenictrioxide) is one of the most effective therapeutic agents used for patients with AML (APL)."],
        [1994, "After debulking surgery, chemotherapy (vincristine, 6alpha-methylprednisone, and cyclophosphamide) was initiated."],
        [2008, "Intensive chemotherapy combined thiotepa, busulfan, and cyclophosphamide."],
        [1977, "N-Acetyldaunorubicinol appears to be a new compound which is yet to be tested for antitumor activity."],
        [2003, "Synergistic effect of vincristine with tacrolimus or sirolimus in prevention of acute heart allograft rejection in the rat."],
        [2021, "Patients who have received prior HMAs for antecedent MDS rarely benefit from vyxeos or other cytotoxic chemotherapy regimens."],
        [1987, "azacitidinecytidine, a drug used in the treatment of acute leukemias and beta-thalassemia, was administered i.p."],
        [1990, "vincristinesulfate as single-agent chemotherapy in a dog and a cat with malignant neoplasms."],
        [2015, "The combination of midostaurin and AZA is an effective and safe regimen in patients with AML and high-risk MDS."],
        [1979, "The addition of C. parvum to chemotherapy with cyclophosphamide plus dtic-dome is not recommended."],
        [2017, "Idarubicin (IDR), cytarabine (cytarabine), and tamibarotene (Am80) are effective for treatment of AML (AML)."],
        [2012, "Allogeneic stem cell transplantation for advanced AML in the ATRA and arsenictrioxide era."],
        [2016, "Targeting Notch-1 positive acute leukemia cells by novel fucose-bound liposomes carrying daunorubicin."],
        [1986, "Small-dose cytarabine in the treatment of elderly patients with acute leukemia and refractory anemia with excess of blast."],
        [2018, "Clofarabine and cytarabine (Clo + Ara-C) combinations have efficacy in treatment of AML (AML)."],
        [2018, "arsenictrioxide (As₂O₃), a traditional remedy in Chinese medicine, has been used in AML (APL) research and clinical treatment."],
        [2011, "The prognostic impact of K-RAS mutations in adult AML patients treated with high-dose cytarabine."],
        [2017, "Cytarabine is a kind of chemotherapy medication."],
        [2017, "We describe 17 children and adolescents with relapsed/refractory AML who received clofarabine, cyclophosphamide, and etoposide."],
        [1987, "Combined chemotherapy consisting of cis-platinum, doxorubicin and cyclophosphamidemonohydrate was administered for 5 months."],
        [2014, "Options include low-dose cytarabine, other non-intensive chemotherapy regimens, or tailored supportive care."],
        [2012, "Pharmacologic inhibition of WEE1 in AML cell lines and primary cells is synergistic with cytarabine."],
        [1988, "Intensive chemotherapy with high doses of carmustine, etoposide, cytarabine."],
        [2018, "We diagnosed rituximab-induced acute thrombocytopenia (RIAT), and her platelet counts spontaneously recovered."],
        [2009, "Effective treatment of AML with all-trans-retinoic acid, arsenictrioxide, and gemtuzumab-ozogamicin."],
        [1997, "High antileukemic activity of sequential high dose cytarabine and mitoxantrone in patients with refractory acute leukemias."],
        [2006, "arsenictrioxide is now considered the standard agent in treatment of refractory cases of AML (APL)."],
        [2021, "The standard chemotherapy for AML (AML) is usually composed of anthracyclines and cytarabine."],
        [2005, "The standard drug treatment is a corticosteroid and chemotherapy with mitoxantrone."],
        [2021, "A Relapsing Meningeal AML FLT3-ITD+ Responding to Gilteritinib."],
        [2006, "In contrast, high-dose cyclophosphamide exhibited similar anti-tumor effects in both mice."],
        [2017, "Ikaros 6 protects acute lymphoblastic leukemia cells against daunorubicin-induced apoptosis by activating the Akt-FoxO1 pathway."],
        [2014, "In the past decade, the therapeutic potential of arsenictrioxide (arsenictrioxide) in the treatment of AML (APL) was recognized."],
        [1985, "mitoxantrone in the treatment of relapsed and refractory acute leukemia."],
        [2019, "Both lenalidomide (LEN) and azacitidine (azacitidine) possess significant antitumor activity effect in AML."],
        [2002, "We conclude that ATRA in combination with Ida and cytarabine can be administered safely to high-risk AML patients."],
        [1995, "Clonogenic data from fresh AML LDMCs not pretreated with growth factors demonstrated a heterogenous response to cytarabine."],
        [2017, "The FDA has approved the small-molecule inhibitor midostaurin in combination with chemotherapy to treat AML."],
        [2020, "FHL1-targeted intervention enhances the sensitivity of AML cells to cytarabine."],
        [2016, "Predicting the neurobehavioral side effects of dexamethasone in pediatric acute lymphoblastic leukemia."],
        [2022, "Effect of Chemotherapy Cytarabine and AML on the Development of Spermatogenesis at the Adult Age of Immature Treated Mice."],
        [2017, "Previously, we observed that adipocytes protect acute lymphoblastic leukemia (ALL) cells from the anthracycline, daunorubicin."],
        [1983, "Treatment of AML with low-dose cytarabine."],
        [1989, "In 3 patients with ANLL, chemotherapy including high or conventional doses of cytarabine had been ineffective."],
        [1978, "flurocitabine seems to be as active as cytarabine in acute leukemias and is probably active too in malignant lymphomas."],
        [1996, "Haemopoietic growth factors, the cell cycle of AML progenitors and sensitivity to cytarabine."],
        [2016, "The impact of dexamethasone and 6alpha-methylprednisone on sleep in children with acute lymphoblastic leukemia."],
        [2012, "Early relapses and/or patients refractory to upfront rituximab-based chemotherapy have a poor response rate and prognosis."],
        [2013, "zidovudine hinders arsenictrioxide-induced apoptosis in AML cells by induction of p21 and attenuation of G2/M arrest."],
        [2011, "CD34+ AML cells are 10-15-fold more resistant to daunorubicin (daunorubicin) than CD34- AML cells."],
        [2020, "Isavuconazole Therapy of Disseminated and Encephalic Saprochaete Capitata Infection in an AML Patient Treated with Midostaurin."],
        [1982, "Cellular and plasma kinetics of daunorubicin given by two methods of administration in a patient with acute leukemia."],
        [2018, "Simultaneous chemotherapy with vincristine was given to 20 patients and sequential chemotherapy to 15 patients."],
        [1991, "All patients were given chemotherapy consisting of procarbazine, vincristine, and lomustine (CCNU) (PVC)."],
        [1999, "Synthesis and antitumor activity of 5'-demethyl-5'-trifluoromethyl-daunorubicin and -doxorubicin."],
        [1985, "A phase II study of mitoxantrone in acute leukemia."],
        [2013, "Treatment protocols consisted of all-trans retinoic acid (ATRA) and chemotherapy with or without the arsenictrioxide therapy."],
        [2001, "Successful treatment of hepatosplenic candidiasis in an elderly patient with AML using liposomaldaunorubicin and fluconazole."],
        [2012, "A 69-year-old woman was treated with oral CTD (cyclophosphamide/thalidomide/dexamethasone) chemotherapy for multiple myeloma."],
        [2007, "dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia."],
        [1980, "Modified procarbazine, lomustine, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors."],
        [2022, "Oral azacitidine prolongs survival of patients with AML in remission independently of measurable residual disease status."],
        [2017, "Mechanisms responsible for the synergistic antileukemic interactions between ATR inhibition and cytarabine in AML cells."],
        [1987, "Low-dose cytarabine (LD-Ara C) treatment in dysmyelopoietic syndromes (DMPS) and AML (AML)."],
        [2020, "Cladribine, cytarabine, and idarubicin in relapsed AML is feasible and induces good response rates."],
        [2011, "QTc prolongation is associated with arsenictrioxide (arsenictrioxide) treatment of AML (APL)."],
        [2021, "Cytarabine is a nucleoside analog used in chemotherapy regimens for the treatment of multiple hematologic malignancies."],
        [1996, "GM-CSF administered during induction treatment of AML with a DNR/cytarabine combination did not provide any clinical benefit."],
        [1977, "cyclophosphamidemonohydrate, or cytarabine chemotherapy demonstrated CNS leukemia in addition to systemic disease at death."],
        [1981, "Oral thioguanine (6-TG) is an S-phase antimetabolite with significant activity against acute leukemia."],
        [2021, "We discovered that venetoclax directly activated T cells to increase their cytotoxicity against AML (AML) in vitro and in vivo."],
        [2002, "The influence of intracellular idarubicin and daunorubicin levels on drug cytotoxicity in childhood acute leukemia."],
        [1984, "Anthracycline antitumor antibiotics, such as doxorubicin and daunorubicin, are potent genotoxic agents and carcinogens."],
        [2019, "Venetoclax is approved for older untreated AML (AML) patients."],
        [2016, "EZH2 mediates arsenictrioxide-induced apoptosis in AML cell lines through the Wnt signaling pathway."],
        [2006, "HRQOL implications of treatment with dexamethasone for children with acute lymphoblastic leukemia (ALL)."],
        [2006, "Effect of gemtuzumab-ozogamicin on AML blast cells in vitro, as a single agent and combined with other cytotoxic cells."],
        [1989, "VM-26-vincristine-cisplatin combination chemotherapy in the treatment of primary advanced and recurrent endometrial carcinoma."],
        [2016, "STAT5 gene polymorphisms are associated with the response of AML patients to cytarabine-based chemotherapy."],
        [1974, "The use of a combination of daunorubicin and cytarabine in the treatment of AML in a district general hospital is described."],
        [2017, "Vincristine toxicity with co-administration of fluconazole during induction therapy for pediatric acute lymphoblastic leukemia."],
        [2016, "Patients received FA5-BUCY, i.e., 5-day salvage chemotherapy (Fludarabine/Ara-C) and conditioning (Busulfan/Cyclophosphamide)."],
        [2009, "Effect of laromustine (VNP40101M) on AML blast cells in vitro as a single agent and combined with cytarabine and daunorubicin."],
        [2014, "Therefore, it is warranted to explore the underlying mechanism of arsenictrioxide-mediated anti-tumor activity in glioma."],
        [2019, "Ivosidenib is an approved drug for relapsed or refractory IDH1 mutant AML patients."],
        [2022, "Nephroprotective effect of magnesium isoglycyrrhizinate against arsenictrioxide-induced acute kidney damage in mice."],
        [2013, "These included chemotherapy (fludarabine and cyclophosphamide) with or without 2 Gy irradiation, and 5.5 Gy irradiation alone."],
        [1989, "23 adult patients with refractory or relapsed AML (AML) received salvage chemotherapy with mitoxantrone and etoposide."],
        [2015, "arsenictrioxide (As2 O3 ) is commonly used to treat AML and solid tumors."],
        [1986, "Fourteen patients with acute nonlymphocytic leukemia were treated with low-dose arabinofuranosylcytosine (low-dose cytarabine)."],
        [1983, "Vindesine, 6alpha-methylprednisone, and daunorubicin in acute lymphoblastic leukemia in relapse."],
        [2013, "AKT signaling as a novel factor associated with in vitro resistance of human AML to gemtuzumab-ozogamicin."],
        [2005, "Doxycycline potentiates antitumor effect of cyclophosphamide in mice."],
        [2002, "In a pilot study 28 patients with untreated MCL received standard chemotherapy followed by sHDT with rituximab in vivo purging."],
        [2015, "The patient was given induction chemotherapy (3 + 7 regimen) with daunorubicin and cytarabine."],
        [2013, "arsenictrioxide (arsenictrioxide) induces disease remission in AML (APL) patients, but not in non-APL AML (AML) patients."],
        [2019, "dexamethasone inhibits mucin secretion considering the primary option for treating acute asthma exacerbation."],
        [1994, "High-dose chemotherapy consisted of cyclophosphamidemonohydrate, thiotepa +/- carmustine."],
        [2010, "arsenictrioxide (arsenictrioxide) is an effective therapeutic agent for AML (APL) and other hematopoietic malignancies."],
        [2007, "Synergistic interaction between dexamethasone and tramadol in a murine model of acute visceral pain."],
        [2017, "Ptosis is a rare side effect of vincristine chemotherapy in patients treated for cancer."],
        [2021, "Risk factor analysis for taxane-associated acute pain syndrome under the dexamethasone prophylaxis."],
        [2020, "TRIM31 promotes AML progression and sensitivity to daunorubicin through the Wnt/β-catenin signaling."],
        [2018, "Arsenic speciation in hair and nails of AML (APL) patients undergoing arsenictrioxide treatment."],
        [2020, "Encapsulation of daunorubicin into Saccharomyces cerevisiae-derived lysosome as drug delivery vehicles for AML (AML) treatment."],
        [2010, "The immune response and the therapeutic effect of metronomic chemotherapy with cyclophosphamide."],
        [2003, "Degradation of vincristine by myeloperoxidase and hypochlorous acid in children with acute lymphoblastic leukemia."],
        [2008, "dexamethasone affects inflammation but not trypsinogen activation in experimental acute pancreatitis."],
        [2007, "Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura."],
        [1983, "A patient with refractory AML was treated with high-dose cytarabine (3.0 g/m2 every 12 hours)."],
        [2015, "Cytarabine arabinoside (cytarabine) is the most important agent for treating AML (AML)."],
        [2005, "UKT-04 trial of continuous metronomic low-dose chemotherapy with methotrexate and cyclophosphamide for recurrent glioblastoma."],
        [2017, "We showed that BMSCs secrete soluble factors that protect AML cells from cytarabine induced cytotoxicity."],
        [2019, "Elevated VMP1 expression in AML amplifies autophagy and is protective against venetoclax-induced apoptosis."],
        [2019, "Preclinical studies suggested that glasdegib could sensitize AML cells to chemotherapy."],
        [2018, "Venetoclax (venetoclax) targets BCL-2 and has shown promising efficacy in AML but over-expression of MCL-1 can cause resistance."],
        [2001, "Treatment of AML cells with cytarabine and imatinibmesylate showed synergistic effect at low concentrations."],
        [2021, "HDAC8 promotes daunorubicin resistance of human AML cells via regulation of IL-6 and IL-8."],
        [2006, "Different mechanisms for anti-tumor effects of low- and high-dose cyclophosphamide."],
        [2013, "Daunorubicin has historically been considered the anthracycline of choice at many cancer centers for the treatment of AML (AML)."],
        [2001, "arsenictrioxide (arsenictrioxide) effectively induces clinical remission via apoptosis in relapsed AML (APL)."],
        [2011, "With the introduction of all-trans retinoic acid (ATRA) and arsenictrioxide, AML (APL) has become a highly curable malignancy."],
        [2015, "The microtubule-depolymerizing agent vincristine is widely used in the treatment of acute leukemia."],
        [2015, "Musashi-2 Silencing Exerts Potent Activity against AML and Enhances Chemosensitivity to Daunorubicin."],
        [1991, "A new combination chemotherapy including mitoxantrone 10 mg/m2 i.v."],
        [2017, "The cytostatic deoxycytidine analog cytarabine (cytarabine) is the most active agent available against AML (AML)."],
        [1996, "To evaluate single-agent liposomaldaunorubicin chemotherapy in the management of early HIV-related Kaposi's sarcoma (KS)."],
        [2007, "The use of rituximab in acute refractory TTP appears to be safe, with no excess infectious complications."],
        [2004, "All patients received high dose chemotherapy with thiotepa, mitoxantrone and carboplatin (TMJ)."],
        [2000, "Cyclophosphamide and thioTEPA are frequently used simultaneously in high-dose chemotherapy regimens."],
        [2021, "vincristine (vincristine) is a widely used chemotherapy drug that induced peripheral painful neuropathy."],
        [2022, "Long-term remission of extramedullary cutaneous relapse of AML (leukemia cutis) treated with decitabine-venetoclax."],
        [2016, "The effect of race on the CYP3A-mediated metabolism of vincristine in pediatric patients with acute lymphoblastic leukemia."],
        [2019, "arsenictrioxide (arsenictrioxide) has been used clinically for the treatment of AML and some solid tumors."],
        [2012, "Resistance to gemtuzumab-ozogamicin (gemtuzumab-ozogamicin) hampers the effective treatment of refractory AML (AML)."],
        [2020, "Cytarabine stability is higher in AML than in CTRL samples."],
        [2018, "The patient was started on chemotherapy with rituximab, cyclophosphamide, vincristine, and 6alpha-methylprednisone."],
        [1997, "Thirty-seven received chemotherapy with cyclophosphamide 1.5 g/m2 daily x 4 and melphalan 25 to 60 mg/m2 daily x 3."],
        [1987, "15 patients with AML (AML) were treated with low-dose cytarabine (LD cytarabine)."],
        [2002, "Potential mechanisms of resistance to cytarabine in AML patients."],
        [1990, "Development and characterization of a cyclophosphamide-resistant subline of AML in the Lewis x Brown Norway hybrid rat."],
        [2014, "Chemoradiotherapy comprised 56 Gy of irradiation over 43 days and two courses chemotherapy with cisplatin and vincristine."],
        [2018, "Moreover, the anti-tumor effects of the RPANs against the HL60 cell line were comparable to those of arsenictrioxide solution."],
        [2018, "Chloroquine exerts antitumor effects on NB4 AML cells and functions synergistically with arsenictrioxide."],
        [2008, "Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus."],
        [2011, "Brain perfusion in adult patients with AML before and after cytarabine."],
        [2021, "Vitamin C (Vit C) is reported to enhance the antineoplastic action of azacitidine-CdR on AML cells."],
        [1977, "A 65-year-old white male with AML received whole brain irradiation (2550 rads) and intrathecal cytarabine for CNS prophylaxis."],
        [2018, "Downregulation of ROS1 enhances the therapeutic efficacy of arsenictrioxide in AML cell lines."],
        [2018, "Patients received CAR-BCMA T cells after a conditioning chemotherapy regimen of cyclophosphamide and fludarabine."],
        [2008, "The patient was started on a novel bladder chemotherapy regimen using a combination of mitoxantrone and paclitaxel."],
        [2012, "CDA RNA expression as well as cytarabine IC₅₀ showed wide variation in AML samples and normal controls."],
        [2018, "vincristine (vincristine) resistance can lead to cancer chemotherapy failure."],
        [2005, "forfenimex enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma."],
        [2019, "A randomized controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for acute viral conjunctivitis."],
        [1999, "One cycle of chemotherapy consisted of mitoxantrone, fluorouracil, folinic acid, and cisplatinum."],
        [2011, "All patients received induction chemotherapy combining an anthracycline with cytarabine."],
        [1996, "Clinical and laboratory studies of 2'-chloro-2'-deoxyadenosine +/- cytarabine for relapsed or refractory AML in adults."],
        [2008, "Low dose interleukin-2 following intensification therapy with high dose cytarabine for AML in first complete remission."],
        [2016, "Synergistic anti-leukemic interactions between venetoclax and panobinostat in AML ex vivo."],
        [2022, "The addition of rituximab to intensive chemotherapy is feasible even in a developing country."],
        [1998, "Restraint stress reduces the antitumor efficacy of cyclophosphamide in tumor-bearing mice."],
        [2021, "We conducted a phase I, dose-escalation study combining ADI-PEG20 and low-dose cytarabine (LDC) in AML patients."],
        [1983, "Pharmacokinetics of N4-behenoyl-cytarabine in patients with acute leukemia."],
        [2021, "Thirty-five patients received 419 doses of intravenous chemotherapy at home (cytarabine, vincristine, vinblastine)."],
        [2016, "Parenteral arsenictrioxide (arsenictrioxide) has been firmly established as a standard therapy for AML (APL)."],
        [2006, "Molecular response in two children with relapsed AML treated with a combination of gemtuzumab-ozogamicin and cytarabine."],
        [1995, "Exposure to repeated chemotherapy or cytarabine were independent risk-factors for streptococcal bacteraemia."],
        [2021, "Enhanced cytarabine-induced killing in OGG1-deficient AML cells."],
        [2022, "Durable remission of AML in an elderly patient following a limited course of azacitidine and venetoclax."],
        [2022, "For patients in group R4, rituximab was added to the chemotherapy backbone for patients in R3 (A-RBB-RAA-RBB-RAA-BB)."],
        [2015, "Upregulation of microRNA-126-5p is associated with drug resistance to cytarabine and poor prognosis in AML patients."],
        [2004, "The patient received procarbazine, lomustine, vincristine chemotherapy and radiotherapy after the second surgery."],
        [2022, "Netupitant/palonosetron (NEPA) is administered with dexamethasone (DEXA) for CINV prevention in several chemotherapy regimens."],
        [2005, "arsenictrioxide (As(2)O(3)) is effective against AML and has potential as a novel treatment against malignant solid tumors."],
        [2020, "c-Myc Inhibition Using 10058-F4 Increased the Sensitivity of AML Cells to arsenictrioxide Via Blunting PI3K/NF-κB Axis."],
        [1990, "Adjuvant chemotherapy with fluorouracil, vincristine and lomustine for patients with Dukes' C colorectal cancer."],
        [2009, "In conclusion, taurine can enhance the function of the leucocyte after chemotherapy of cyclophosphamide."],
        [2014, "Rituximab-vincristine chemotherapy-induced acute anterior wall myocardial infarction with cardiogenic shock."],
        [2021, "A total of eight cycles of arsenictrioxide-combined chemotherapy were applied throughout the entire scheme."],
        [2017, "Identification of potential predictive markers of dexamethasone resistance in childhood acute lymphoblastic leukemia."],
        [2021, "The patient underwent chemotherapy with CHOP, mini-CHOP regimens, and venetoclax, as well as treatment for CNS involvement."],
        [2013, "cytarabine (cytarabine or cytarabine) has been one of the cornerstones of treatment of AML since its approval in 1969."],
        [2018, "The study included 33 children with AML (0.7-19.7 years) treated with thioguanine (6-TG) according to the AML-BFM 2004 Protocol."],
        [2005, "Locoregional mitoxantrone chemotherapy was locally delivered as a single dose of 4 mg every 20 days."],
        [2021, "In addition, compound 31 combined with idarubicin synergistically inhibited the proliferation of AML cells."],
        [1973, "By using cultured, transformed fibroblastic cells, antitumor agents including cytarabine."],
        [2002, "arsenictrioxide is highly effective in the treatment of AML (APL)."],
        [2019, "The combination of cytarabine and an anthracycline has been the standard of care for the induction of remission in AML (AML)."],
        [2022, "PON2 blockade overcomes dexamethasone resistance in acute lymphoblastic leukemia."],
        [2004, "Furthermore, irofulven and mitoxantrone in combination exhibit enhanced antitumor activity against PC-3 and DU-145 xenografts."],
        [2018, "Methotrexate (MTX) is commonly administered with cytarabine (cytarabine, cytarabine) during intrathecal chemotherapy for ALL."],
        [2021, "Addition of dexamethasone to manage acute phase responses following initial zoledronic acid infusion."],
        [2022, "Efficiency of a dexamethasone nanosuspension as an intratympanic injection for acute hearing loss."],
        [1991, "The pharmacokinetics of thioguanine were studied in 10 patients with AML treated with 25-100 mg/m(2) orally."],
        [2005, "Intrinsically activated Ras seems to increase sensitivity of the AML blast to high-dose cytarabine therapy."],
        [1988, "Clinical use of intermediate to high dose of N4-behenoyl-cytarabine in children with acute leukemia."],
        [2018, "Heteronemin, a marine natural product, sensitizes AML cells towards cytarabine chemotherapy by regulating farnesylation of Ras."],
        [2021, "For decades two chemotherapeutic agents, cytarabine and daunorubicin, remained the backbone of AML therapy protocols."],
        [2002, "Spectroelectrochemical study of the interaction between antitumor drug daunorubicin and DNA in the presence of antioxidants."],
        [2016, "The addition of rituximab to FC chemotherapy results in a gain of 1.1 quality-adjusted life-years."],
        [2009, "Allo-SCT conditioning for myelodysplastic syndrome and AML with clofarabine, cytarabine and ATG."],
        [2001, "To determine the safety and efficacy of arsenictrioxide (arsenictrioxide) in patients with relapsed AML (APL)."],
        [2022, "The addition of rituximab to chemotherapy has substantially improved outcomes for patients with B-cell malignancies."],
        [1987, "However, improved survival was noted when chemotherapy in the form of cyclophosphamidemonohydrate was used to supplement XTC."],
        [2017, "Midostaurin for the treatment of adult patients with newly diagnosed AML that is FLT3 mutation-positive."],
        [2016, "Mobilization chemotherapy with cyclophosphamide 1 x 2 g/m(2) and 2 x 2 g/m(2) is equally effective in those patients."],
        [2018, "Inhibition of XPO1 enhances cell death induced by venetoclax in AML via Mcl-1."],
        [2022, "Validation of CRISPR targeting for proliferation and cytarabine resistance control genes in the AML cell line MOLM-13."],
        [2015, "Our results demonstrate that AML cells adhered to stroma exhibited significantly reduced sensitivity to arsenictrioxide."],
        [2012, "Subsequently, a second-line chemotherapy was started using the GVP regimen (gemcitabine, vincristine, cisplatin)."],
        [2003, "Cardiovascular and endocrine responses to acute hypoxaemia during and following dexamethasone infusion in the ovine fetus."],
        [2016, "Clofarabine Plus Low-Dose Cytarabine Is as Effective as and Less Toxic Than Intensive Chemotherapy in Elderly AML Patients."],
        [2012, "A 74-year-old Japanese man with myelodysplastic syndrome (MDS) received chemotherapy with azacitidine."],
        [2015, "Inhibition of ERK5 enhances cytarabine-induced apoptosis in AML cells."],
        [2015, "cytarabine and anti-CD47 antibody combination therapy eliminates AML THP-1 cells in vivo and in vitro."],
        [2008, "A combined chemotherapy regimen comprising fludarabine, cytarabine."],
        [2016, "Inhibition of CHK1 enhances cell death induced by the Bcl-2-selective inhibitor venetoclax in AML cells."],
        [1990, "Cytotoxicity and DNA damage caused by idarubicin and its metabolite 4-demethoxy-13-hydroxydaunorubicin in human AML cells."],
        [2008, "Fatal peri-operative acute tumour lysis syndrome precipitated by dexamethasone."],
        [2015, "mitoxantrone is a conventional agent for relapsed or refractory acute lymphoblastic leukemia (ALL)."],
        [2011, "Treatment of AML with single-agent arsenictrioxide."],
        [1995, "Successful treatment of retinoic acid syndrome with high-dose dexamethasone pulse therapy in a child with AML treated with ATRA."],
        [2013, "venetoclax, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets."],
        [2001, "Consolidative chemotherapy included two cycles of vincristine, methotrexate, etoposide, doxorubicin and cyclophosphamide."],
        [2005, "The combined 2-CdA and cytarabine chemotherapy regimen had activity in patients with HES."],
        [2015, "Adjuvant chemotherapy with mitoxantrone for cats with mammary carcinomas treated with radical mastectomy."],
        [2014, "Induction chemotherapy consisted of idarubicin (IDA) plus fludarabine and cytarabine (cytarabine) as a 24-hour CI."],
        [2018, "Bone marrow and/or blood samples from 90 AML patients treated with cytarabine and daunorubicin were included."],
        [1981, "Intermittent continuous iv infusion of high-dose cyclophosphamide for remission induction in acute lymphocytic leukemia."],
        [2005, "The tumors did not respond to combination chemotherapy with dtic-dome, nimustine, vincristine, and interferon-beta."],
        [2015, "All patients received cytarabine-based standard induction chemotherapy regimens, and the treatment response was evaluated."],
        [1998, "Both cycles included intrathecal chemotherapy (cytarabine or methotrexate)."],
        [1990, "mitoxantrone is a substituted anthraquinone with considerable activity against human acute leukemia."],
        [2013, "Combination with cyclophosphamide further induces ICD, depletes Treg, and thus potentiates antitumor immunity."],
        [2008, "Six animals per group were injected with dexamethasone 1 h prior to the induction of acute pancreatitis."],
        [2016, "These results highly suggest that the pharmacogenetic analyses of cytarabine influx may be decisive in AML patients."],
        [1975, "The specific cytotoxic effects of daunorubicin conjugated to antitumor antibodies."],
        [2000, "Cyclophosphamide enhances anti-tumor effect of wild-type p53-specific CTL."],
        [2012, "Incidence of therapy-related acute leukemia in mitoxantrone-treated multiple sclerosis patients in Germany."],
        [1997, "Molecular remission in PML/RAR alpha-positive AML by combined all-trans retinoic acid and idarubicin (AIDA) therapy."],
        [2015, "We re-evaluate the anti-tumor effect of dexamethasone according to the molecular heterogeneity of MM."],
        [2004, "cytarabine) is the most important antimetabolite chemotherapeutic drug used for acute leukemia."],
        [2022, "Current Status of vyxeos Therapy in AML and Myelodysplastic Syndrome."],
        [1975, "Vincristine chemotherapy on a low-dose basis was associated chiefly with increased survival only."],
        [2001, "Cytarabine is a well established component of the treatment of acute leukemias and has its principal action on dividing cells."],
        [2021, "All-trans retinoic acid (ATRA) and pre-upfront arsenictrioxide (arsenictrioxide) have revolutionized the therapy of AML (APL)."],
        [1986, "Treatment of acute leukemia with amsacrine in combination with cytarabine."],
        [1993, "The antitumor activity of mitoxantrone was unaltered by dexrazoxanehydrochloride in human tumor cells and in P-388-bearing mice."],
        [2022, "Molecular profile of FLT3-mutated relapsed/refractory patients with AML in the phase 3 ADMIRAL study of gilteritinib."],
        [2020, "Treatment with SINE compounds and venetoclax combined led to a reduction in tumor growth in both AML and DLBCL xenografts."],
        [2012, "arsenictrioxide, believed to be a carcinogen and a teratogen, has found its niche in the treatment of AML (APL)."],
        [1979, "Binding of anti-tumor immunoglobulins and their daunorubicin conjugates to the tumor and its metastase."],
        [2006, "Clinical resistance to the kinase inhibitor midostaurin in AML by mutation of Asn-676 in the FLT3 dl-tyrosine kinase domain."],
        [1982, "One of the serious toxicities of cyclophosphamide chemotherapy is urotoxicity."],
        [2010, "The protection of the myocardium by amifostine against mitoxantrone-induced acute cardiotoxicity in rats."],
        [2022, "The beneficial effect of statins on the anti-lymphoma activity of the rituximab-based chemotherapy regimen is controversial."],
        [2006, "Enhanced antitumor activity of P450 prodrug-based gene therapy using the low Km cyclophosphamide 4-hydroxylase P450 2B11."],
        [2010, "Preclinical data indicate that there is substantial antitumor activity and synergy between calcitriol and dexamethasone."],
        [2012, "arsenictrioxide (As(2)O(3)) is known to degrade PML protein and has been used for the treatment of patients with acute PML."],
        [1990, "Patient with advanced adenocarcinoma of the pancreas and no prior chemotherapy were treated on a Phase II trial of mitoxantrone."],
        [2012, "In combination therapy with cyclophosphamide, RL2 had an additive antitumor effect for ascites-producing tumors."],
        [2006, "Triapine and cytarabine is an active combination in patients with acute leukemia or myelodysplastic syndrome."],
        [2004, "The pyrimidine nucleoside analog, cytarabine (cytarabine), is an effective therapeutic agent for acute leukemia."],
        [2004, "cytarabine also induced CD80 or CD86 expression in 14 of 21 primary cultured human AML samples."],
        [2020, "Cyclophosphamide plus fludarabine conditioning chemotherapy was administered before CAR T cells."],
        [1999, "Anthracyclines such as daunorubicin (daunorubicin) are typically used to treat AML and can induce drug resistance."],
        [2022, "Gilteritinib is approved for relapsed/refractory FLT3+ AML but its efficacy in extramedullary relapse is still undefined."],
        [2007, "Vincristine is an antitumor drug that inhibits microtubule polymerization, causes G2/M arrest and induces apoptosis."],
        [1977, "daunorubicin, like its anthracycline analog doxorubicin, is a cardiotoxic antitumor antibiotic."],
        [1999, "One cycle of chemotherapy consisted of mitoxantrone, fluorouracil (5-FU), folinic acid, and cis-platinum."],
        [1976, "This paper deals with the problem of the relative selectivity of the antitumor effect of cyclophosphamide (CP)."],
        [2006, "The effects of fructose-1,6-bisphosphate and dexamethasone on acute inflammation and T-cell proliferation."],
        [1997, "The inclusion of HD 6MP and ID cytarabine in the treatment of AML in first remission appears to be feasible."],
        [2013, "Idarubicin is superior to daunorubicin in remission induction of de novo AML patients with high MDR1 expression."],
        [2021, "We compared outcomes of older patients with newly diagnosed AML receiving 10-day decitabine with venetoclax (DEC10-VEN) vs IC."],
        [2022, "Azacitidine-Induced Pneumonitis in a Patient With AML and Hyperleukocytosis."],
        [2022, "Subsequent AML therapy, including FLT3 inhibitors, was received by 20.3% (GIL+AZA) and 44.9% (azacitidine) of patients."],
        [2017, "These cells were compared with 66 ex vivo chemorefractory samples from cytarabine-treated AML patients."],
        [1980, "mitoxantrone, mitoxantrone, a new antitumor agent was evaluated in nine cancer patients as part of a phase I trial."],
        [2012, "dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia."],
        [1981, "Three patients with AML received high doses of daunorubicin, first in the free form and later as complex with DNA."],
        [2006, "arsenictrioxide also failed to eradicate the primary AML cells in vivo."],
        [2020, "Cost-effectiveness of midostaurin in the treatment of newly diagnosed FLT3-mutated AML in France."],
        [2021, "Subsequently, azacitidine was administered subcutaneously for the AML treatment."],
        [2010, "arsenictrioxide (arsenictrioxide) has shown great promise in the treatment of patients with relapsed or refractory AML (APL)."],
        [1994, "The regional chemotherapy regimen was fluorouracil, doxorubicin, methotrexate, and cyclophosphamidemonohydrate."],
        [2018, "In summary, vyxeos offers an exciting new change to the landscape of AML therapy."],
        [1988, "Thirty-three patients could be evaluated for antitumor effects of cyclophosphamide + vaccine."],
        [2021, "Inhibition of Autophagy Does Not Re-Sensitize AML Cells Resistant to Cytarabine."],
        [2022, "Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AML."],
        [2019, "Cyr61 decreases Cytarabine chemosensitivity in acute lymphoblastic leukemia cells via NF-κB pathway activation."],
        [2014, "High-dose cyclophosphamide for the treatment of refractory T-cell acute lymphoblastic leukemia in children."],
        [2011, "arsenictrioxide priming may have improved the outcome of patients aged <60 years with AML who received Hidac/Ida."],
        [2006, "Role of GSTP1-1 in mediating the effect of arsenictrioxide in the AML cell line NB4."],
        [2015, "Phase I/II study of clofarabine, etoposide, and mitoxantrone in patients with refractory or relapsed acute leukemia."],
        [2014, "Smac mimetic primes apoptosis-resistant AML cells for cytarabine-induced cell death by triggering necroptosis."],
        [2008, "arsenictrioxide (arsenictrioxide) has been recommended for the treatment of refractory cases of AML (APL)."],
        [1994, "A patient is described with undifferentiated AML refractory to two courses of daunorubicin and cytarabine."],
        [1978, "Use of L-asparaginase and cytarabine for refractory acute lymphocytic leukemia with particular reference to T-cell leukemia."],
        [2012, "Evaluation of adrenal reserve in children with acute lymphocytic leukemia treated with 6alpha-methylprednisone or dexamethasone."],
        [2009, "The clinical outcome of FLAG chemotherapy without idarubicin in patients with relapsed or refractory AML."],
        [2013, "Intrathecal therapy with cytarabine is widely used in the treatment of acute lymphocytic leukemia."],
        [2008, "Determinants of cerebrospinal fluid arsenic concentration in patients with AML on oral arsenictrioxide therapy."],
        [2021, "Management of AML with venetoclax-based combinations is expected to evolve over the next few years."],
        [2021, "Anti-cancer daunorubicin and etoposide drugs are mostly used in chemotherapy medicine to treat a wide variety of cancers."],
        [2006, "arsenictrioxide (arsenictrioxide, ATO) is a recently developed drug for the effective treatment of AML (APL)."],
        [1990, "Continuous infusion mitoxantrone in relapsed acute nonlymphocytic leukemia."],
        [2012, "arsenictrioxide (As(2)O(3)) is an effective therapeutic against AML and certain solid tumors."],
        [1996, "cytarabine has been shown to induce apoptosis of human AML HL-60 cells."],
        [2017, "Cytotoxic T lymphocytes promote cytarabine-induced AML cell apoptosis via inhibiting Bcl-2 expression."],
        [2002, "The therapeutic outcome of cyclophosphamide-based chemotherapy corresponded to cellular ALDH1A1 levels in 77% of cases."],
        [2021, "Thus, further validating venetoclax as an attractive therapeutic option in the AML treatment landscape."],
        [2002, "Recent studies have shown that arsenictrioxide (As(2)O(3)) can induce complete remission in patients with AML (APL)."],
        [1984, "Treatment of poor risk acute leukemia with sequential high-dose cytarabine and asparaginase."],
        [1983, "dexamethasone, fluorouracil or methotrexate on human AML cell line KG-1."],
        [2016, "Acrocomia aculeata prevents toxicogenetic damage caused by the antitumor agent cyclophosphamide."],
        [2008, "Previously only acute forms of leukemia particularly AML (APL) have been associated with mitoxantrone treatment in MS."],
        [1993, "Neurotoxicity associated with fludarabine and cytarabine chemotherapy for acute leukemia and myelodysplasia."],
        [2021, "Cyclophosphamide is an antitumor agent that causes disorders in fertility."],
        [2011, "Thrombosis is a common complication in cancer patients receiving chemotherapy regimens that include cyclophosphamide."],
        [1990, "Treatment of epidemic Kaposi's sarcoma with combination chemotherapy (vincristine and bleomycin) and zidovudine."],
        [2022, "Intermediate or high doses of cytarabine (IDAC or HiDAC) were recommended as postremission chemotherapy for AML (AML)."],
        [2022, "In vivo, Venetoclax and TJC4's synergistic anti-tumor effects were evaluated."],
        [2020, "azacitidinecitidine Induces NOXA to Prime AML Cells for Venetoclax-Mediated Apoptosis."],
        [2022, "Evaluation of drug-drug interactions between midostaurin and strong CYP3A4 inhibitors in patients with FLT-3-mutated AML (AML)."],
        [2014, "Treatment consisted of 6 5-day chemotherapy cycles with high-dose methotrexate, high-dose cytarabine."],
        [1999, "Patients were randomized to receive single agent chemotherapy with mitoxantrone, etoposide, aclacinomycin-A or spirogermanium."],
        [2015, "However, high PML expression dampens the anti-tumor effects of arsenictrioxide in HCC cells."],
        [2022, "Additionally, arsenictrioxide provoked specific cytoprotective effects in the AML cell lines HL-60 and U937."],
        [1979, "razoxane alone or in combination with cytarabine has very limited activity in advanced adult acute leukemia."],
        [2017, "Cytarabine activity in AML blasts can be augmented by degrading the expression of a critical hydrolase."],
        [2002, "Methotrexate (MTX) and cytarabine have been widely used for the treatment of acute leukemias and lymphomas for over 30 years."],
        [2018, "One cycle of chemotherapy consisted of mitoxantrone, fluorouracil, folinic acid, and cisplatin."],
        [1985, "After in vivo chemotherapy with low dose cytarabine."],
        [2014, "Azacitidine-associated acute interstitial pneumonitis."],
        [2001, "A novel differentiation-inducing therapy for AML with a combination of arsenictrioxide and GM-CSF."],
        [2009, "Action of melatonin on bone marrow depression induced by cyclophosphamide in acute toxicity phase."],
        [2019, "Furthermore, a potentiating effect of HHT on arsenictrioxide was also observed in primary AML cells and AML xenografted tumors."],
        [2004, "gemtuzumab-ozogamicin for relapsed and refractory AML and myeloid sarcomas."],
        [2021, "Targeted delivery of dexamethasone in acute pneumonia."],
        [1992, "Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for AML in first remission."],
        [2011, "In AML patients, we detected increased expression of PRAME and induction of SSX-2 after demethylating therapy with azacitidine."],
        [2004, "The results showed that both acute restraint stress and dexamethasone impaired retention performance."],
        [1996, "Following exposure of the AML patients' blast cells to the anthracyclines, cytarabine."],
        [2009, "Topoisomerase IIalpha expression in AML cells that survive after exposure to daunorubicin or cytarabine."],
        [1996, "etoposide and cytarabine were omitted in the face of AML (AML)."],
        [2021, "Evaluation of arsenic species in leukocytes and granulocytes of AML patients treated with arsenictrioxide."],
        [2003, "To study the potentiation of anti-tumor effect induced by cytarabine (cytarabine) with (-)-epigallocatechin-3-gallate (EGCG)."],
        [2021, "azacitidine is the standard of care for myelodysplastic syndromes/low-blast AML (AML) across Western and East Asian patients."],
        [2021, "Outcomes of relapsed or refractory AML patients failing venetoclax-based salvage therapies."],
        [2001, "arsenictrioxide (arsenictrioxide) induces remission in a high proportion of patients with AML (APL) via induction of apoptosis."],
        [2016, "Enhancement of arabinocytosine (cytarabine) toxicity to AML cells by a differentiation agent combination."],
        [1985, "Synthesis and antitumor activity of 2'-bromo- and 2'-chloro-3'-acetoxy-3'-deaminodaunorubicin analogs."],
        [2008, "dexamethasone inhibited inflammation but had no influence on TAP levels in experimental mild and severe acute pancreatitis."],
        [1996, "High-dose cytarabine in older adults with acute leukemia."],
        [1991, "We report a patient with AML who had typical AE due to cytarabine with histopathologic ESS."],
        [1999, "arsenictrioxide has recently been introduced as a promising new agent to treat refractory AML (APL)."],
        [2018, "Midostaurin potentiates rituximab antitumor activity in Burkitt's lymphoma by inducing apoptosis."],
        [2021, "Our findings suggest that targeting LSCs could control the AML relapse by using IONPs plus cytarabine."],
        [2014, "The interval between exposure to multidrug chemotherapy including cyclophosphamide and AML diagnosis was 2 years and 9 months."],
        [2021, "Outcomes in patients with newly diagnosed TP53-mutated AML with or without venetoclax-based therapy."],
        [2010, "Both episodes developed immediately after administrations of cyclophosphamide as part of an anti-cancer chemotherapy protocol."],
        [2016, "Thus NVP-AUY922 and cytarabine combination therapy might be a prospective strategy for AML treatment."],
        [2017, "mitoxantrone has antitumor activity in mCRPC and nonoverlapping mechanism of action and toxicity profile."],
        [2015, "Direct binding of arsenictrioxide to AMPK and generation of inhibitory effects on AML precursors."],
        [2022, "A 12-month cytarabine chemotherapy course was begun, during which the patient developed bilateral optic disc edema."],
        [2005, "He was then started on induction chemotherapy with intravenous daunorubicin and cytarabine."],
        [1999, "Use of idarubicin in pre-transplant conditioning in children with high-risk acute leukemia."],
        [2022, "Idarubicin (IDR) is a chemotherapy drug that is classified as an anthracycline antitumor."],
        [2016, "Our findings provide new insights into the role of arsenictrioxide and EZH2 in regulating AML progression."],
        [2000, "Potentiatied anti-tumor effectiveness of combined therapy with interleukin-12 and mitoxantrone of L1210 leukemia in vivo."],
        [2015, "Dual chemotherapy with cytarabine and daunorubicin remains the gold standard treatment in these patients."],
        [2017, "3 patients received concurrent chemotherapy with weekly Inj Vincristine."],
        [2015, "A 50-year-old man with AML underwent chemotherapy with idarubicin and all-trans retinoic acid."],
        [2005, "Reduction of hematotoxicity and augmentation of antitumor efficacy of cyclophosphamide by dopamine."],
        [2015, "The patient with combination therapy and both of the chemotherapy patients were treated with cyclophosphamide."],
        [1998, "arsenictrioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in AML cells."],
        [1998, "On the eighth hospital day, he started a one-week course of chemotherapy with agents of epirubicin and cytarabine."],
        [1991, "Epirubicin and cytarabine for the induction therapy of childhood acute nonlymphocytic leukemia."],
        [2003, "One of spontaneous abortions and one intrauterine death developed during combination chemotherapy (daunorubicin, cytarabine)."],
        [2012, "We conclude that high BMI should not be a barrier to administer high-dose cytarabine-containing regimens for AML induction."],
        [2004, "Additive effects of dexamethasone in nebulized salbutamol or L-epinephrine treated infants with acute bronchiolitis."],
        [2007, "Daunorubicin (daunorubicin) is one of the most important drugs in treatment of acute lymphoblastic leukemia (ALL)."],
        [2015, "Lack of objective response of myelodysplastic syndromes and AML to decitabine after failure of azacitidine."],
        [2019, "Cytarabine remains the backbone of therapy in AML (AML)."],
        [2005, "arsenictrioxide (arsenictrioxide) is an effective drug for treatment of AML (APL) and malignant tumors."],
        [2014, "A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and AML after azacitidine failure."],
        [1983, "Phase II trial of mitoxantrone in refractory acute leukemia."],
        [1983, "mitoxantrone was administered to 41 adults with refractory acute leukemia."],
        [2013, "Beneficial effects of 20(S)-protopanaxadiol on antitumor activity and toxicity of cyclophosphamide in tumor-bearing mice."],
        [2022, "Predictors of the Overall Survival with azacitidine Monotherapy in Untreated AML Patients Ineligible for Intensive Therapy."],
        [2012, "With the introduction of all-trans retinoic acid and arsenictrioxide, the management of AML (APL) has changed dramatically."],
        [2008, "RAS mutations occur in 12% to 27% of patients with AML (AML) and enhance sensitivity to cytarabine in vitro."],
        [1980, "Effect of cholesterol content on antitumor activity and toxicity of liposome-encapsulated cytarabine in vivo."],
        [2013, "azacitidine is widely used for the treatment of myelodysplastic syndromes (MDS) and AML (AML)."],
        [2020, "DNA has been the presumptive target of the front-line prodrug for AML (AML), cytarabine (cytarabine), since the 1980s."],
        [2017, "arsenictrioxide (arsenictrioxide) has been successfully used in the treatment of AML (APL)."],
        [2009, "arsenictrioxide (As(2)O(3)) is widely used in treating human acute polymyelocytic leukemia (APL)."],
        [2016, "Synergistic antitumor activity of triple-regulated oncolytic adenovirus with VSTM1 and daunorubicin in leukemic cells."],
        [1998, "arsenictrioxide (arsenictrioxide) has recently been shown to induce complete remission in AML (APL)."],
        [2021, "Inhibition of Nrf2-mediated d-glucose metabolism by brusatol synergistically sensitizes AML to cytarabine."],
        [2008, "All AML patients and 16 MS patients received cytarabine plus idarubicin or fludarabine as induction remission therapy."],
        [2019, "arsenictrioxide (arsenictrioxide) has been well recognized as an anti-tumor agent for various human cancers."],
        [2017, "Recently, a single dose of arsenictrioxide (arsenictrioxide) has been found especially effective in treating AML (APL)."],
        [1989, "All but one had had radiotherapy and all had chemotherapy (dactinomycin, 16; vincristine, 5)."],
        [2016, "In contrast, DAC/cytarabine combinations are antagonistic in other Ara-C-sensitive AML cells."],
        [1986, "A patient with myelofibrosis transforming into AML (ANLL) was treated with low doses of cytarabine (cytarabine)."],
        [2022, "However, acquiring resistance to venetoclax in AML patients is the primary cause of treatment failure."],
        [2022, "To evaluate efficacy and safety of venetoclax + azacitidine among treatment-naïve patients with IDH1/2-mutant (mut) AML (AML)."],
        [2001, "These results suggest that dose intensification of cytarabine benefits children with AML and inv(16), as is the case in adults."],
        [2008, "We evaluated dexamethasone pharmacokinetics in children with acute lymphoblastic leukemia."],
        [2022, "Cytarabine (cytarabine) is the first-line drug for the treatment of AML (AML)."],
        [2005, "Gene expression and thioguanine nucleotide disposition in acute lymphoblastic leukemia after in vivo mercaptopurine treatment."],
        [2022, "The study purpose was to determine whether ATRA can enhance the antileukemia effect of venetoclax on AML cells."],
        [1994, "Relationship between Daunorubicin dosage delivered during induction therapy and outcome in adult acute lymphoblastic leukemia."],
        [2004, "Adjunctive dexamethasone treatment in acute bacterial meningitis."],
        [2015, "The OPN gene polymorphism confers the susceptibility and response to cytarabine based chemotherapy in Chinese AML patients."],
        [1976, "), a new daunorubicin-derived compound, in 170 patients with acute leukemias and other malignancies."],
        [2012, "The patient was treated with chemotherapy that consisted of cytarabin and daunorubicin."],
        [1996, "Low dose cytarabine in the treatment of acute non-lymphoblastic leukemia."],
        [2020, "arsenictrioxide is a drug used for the treatment of AML (APL)."],
        [2015, "vincristine (vincristine) is a major chemotherapy drug for treatment of childhood acute lymphoblastic leukemia (ALL)."],
        [1998, "Neurotoxicity of combination chemotherapy with procarbazine, lomustine and vincristine (PCV) for recurrent glioma."],
        [2006, "We searched for mechanisms of resistance in 6 patients with AML who had relapses upon midostaurin treatment."],
        [1977, "Combination chemotherapy of thioguanine with various antitumor agents against murine leukemia L-1210."],
        [2006, "Furthermore, MEK inhibitor attenuated the anti-tumor effect of arsenictrioxide."],
        [2006, "arsenictrioxide, as a single agent, has proven efficacy in inducing molecular remission in patients with AML (APL)."],
        [2008, "Rituximab association with chemotherapy needs to be evaluated within approved clinical trials."],
        [2013, "The patient was treated with methylprednisolone, cyclophosphamide and rituximab and acute dialysis."],
        [2016, "SIRT2 might regulate DNR/cytarabine sensitivity in AML cells at least partially through the ERK1/2 pathway."],
        [2003, "A 4.3-year-old girl with acute leukemia, who was being treated with chemotherapy (including vincristine), developed paraplegia."],
        [1997, "The MTDs for patients with a history of prior chemotherapy were 75 mg/m2 of docetaxel and 700 mg/m2 of cyclophosphamide."],
        [2002, "Trials with gemtuzumab-ozogamicin (gemtuzumab-ozogamicin) combined with chemotherapy regimens in AML."],
        [2017, "Cladribine, cytarabine and idarubicin (CLA-Ida) salvage chemotherapy in relapsed AML (AML)."],
        [1985, "Phase I and II clinical and pharmacological study of idarubicin (idarubicin) in adult patients with acute leukemia."],
        [2018, "arsenictrioxide (arsenictrioxide) exhibits substantial clinical efficacy in the treatment of AML (APL)."],
        [2022, "BMX kinase mediates gilteritinib resistance in FLT3-mutated AML through microenvironmental factors."],
        [1990, "High-dose cytarabine and mitoxantrone in previously-treated acute leukemia patients."],
        [2009, "Mechanisms of dexamethasone-mediated chemokine down-regulation in mild and severe acute pancreatitis."],
        [2008, "arsenictrioxide has remarkable efficacy in AML and is approved by the US Food and Drug Administration for this indication."],
        [2022, "Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for AML in Japan."],
        [2015, "Additional evaluation of arsenictrioxide combined with ACM as a potential therapeutic benefit for AML seems warranted."],
        [2003, "The addition of rituximab to the chemotherapy preparative regimens appears to be a significant advance."],
        [2020, "Aprepitant Sensitizes AML Cells to the Cytotoxic Effects of cytarabine in vitro and in vivo."],
        [2004, "Pituitary-adrenal responses to acute hypoxemia during and after maternal dexamethasone treatment in sheep."],
        [1997, "Redox pathway leading to the alkylation of DNA by the anthracycline, antitumor drugs doxorubicin and daunorubicin."],
        [2018, "The antitumor activity of midostaurin was further sensitized with coadministration of liposomal C6 ceramide."],
        [1976, "Two adult male patients with acute leukemia developed a fatal Budd-Chiari-like illness while receiving thioguanine."],
        [1981, "Daunorubicin-prednisone in the treatment of acute nonlymphocytic leukemia."],
        [2015, "Preparation and in vitro antitumor effects of cytarabine.loaded genipin-poly-l-glutamic acid-modified bacterial magnetosomes."],
        [2017, "Midostaurin treatment in FLT3-mutated AML and systemic mastocytosis."],
        [2009, "The combined dexamethasone/CRH Test (DEX/CRH test) and prediction of acute treatment response in major depression."],
        [2020, "Oral azacitidine Maintenance Therapy for AML in First Remission."],
        [2021, "Cyclophosphamide (CP) is a common therapeutic drug for cancer, but exposure to CP can cause acute hepatotoxicity."],
        [2014, "Patterns of infection in patients with myelodysplastic syndromes and AML receiving azacitidine as salvage therapy."],
        [2021, "The Combination of Gefitinib With ATRA and arsenictrioxide Induces Myeloid Differentiation in AML Resistant Cells."],
        [2007, "Induction therapy for AML (AML) usually consists of 7 days of cytarabine at 100-200 mg/m(2)/day and an anthracycline."],
        [2003, "More comprehensive studies are needed to evaluate the apoptotic effect of dexamethasone on AML cells."],
        [2021, "Modulation of IL-6/STAT3 signaling axis in CD4+FOXP3- T cells represents a potential antitumor mechanism of azacitidine."],
        [2012, "Speciation of arsenictrioxide metabolites in peripheral blood and bone marrow from an AML patient."],
        [1992, "and daunorubicin-mediated cytotoxicity of AML cells and normal myeloid progenitors."],
        [2016, "We retrospectively analyzed 80 subjects diagnosed with AML (AML) who underwent chemotherapy with bolus high-dose mitoxantrone."],
        [2003, "In March 2001, stem cell mobilization chemotherapy with cyclophosphamide was performed."],
        [2006, "The patient underwent chemotherapy with a combination of carmustine, vincristinesulfate, and methylprednisolone."],
        [2019, "Young, fit patients are generally treated with chemotherapy approaches that incorporate high-dose cytarabine (e.g."],
        [2017, "Cyclophosphamide use increased the risk of acute pancreatitis (aHR 5.27, 95% CI 1.16 to 23.86)."],
        [2016, "Venetoclax demonstrated activity and acceptable tolerability in patients with AML and adverse features."],
        [2019, "Low-Dose azacitidine with DNMT1 Level Monitoring to Treat Post-Transplantation AML or Myelodysplastic Syndrome Relapse."],
        [2000, "mitoxantrone, etoposide, carboplatinum and cytarabine combination therapy (MECA) in refractory and relapsed acute leukemia."],
        [2022, "This effect was independent of FLT3 mutation, indicating even FLT3- AML patients might benefit from midostaurin therapy."],
        [2022, "Venetoclax penetrates in cerebrospinal fluid of an AML patient with leptomeningeal involvement."],
        [1980, "Nineteen patients received chemotherapy identical to that of younger patients (daunorubicin and cytarabine)."],
        [1999, "Study on the anticarcinogenic effect and acute toxicity of liver-targeting mitoxantrone nanoparticles."],
        [2007, "cytarabine (cytarabine.Ara-C) is the most important antimetabolite used for acute leukemia."],
        [2013, "Phase 2 study of azacitidine plus sorafenib in patients with AML and FLT-3 internal tandem duplication mutation."],
        [2003, "arsenictrioxide in comparison with chemotherapy and bone marrow transplantation for the treatment of relapsed AML."],
        [2009, "Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia."],
        [2004, "FAK+ AML cells displayed significantly higher migration capacities and resistance to daunorubicin, compared with FAK- cells."],
        [2016, "Patients received induction chemotherapy with vincristine, 6alpha-methylprednisone, doxorubicin, and pegylated asparaginase."],
        [2010, "Nausea and vomiting in patients with AML (AML) can be from various causes, including the use of high-dose cytarabine."],
        [2011, "Protective effect of α-lipoic acid against arsenictrioxide-induced acute cardiac toxicity in rats."],
        [2020, "Importantly, this drug enhanced the antitumor effect of venetoclax and ibrutinib."],
        [2020, "A phase II study evaluating the role of bortezomib in the management of relapsed AML treated upfront with arsenictrioxide."],
        [2019, "Venetoclax Synergistically Enhances the Anti-leukemic Activity of voreloxin Against AML Cells Ex Vivo."],
        [2022, "Cyclophosphamide (CP) is widely used as a chemotherapy against various types of cancers."],
        [2017, "Cytarabine (cytarabine) has been an important agent in AML (AML) treatment for more than 40 years."],
        [2012, "After surgery, three cures of chemotherapy including ifosfamide, vincristine, and azetomycini were administered."],
        [2012, "Patients were included if they received intensive chemotherapy with a combination of thiotepa, busulfan and cyclophosphamide."],
        [2004, "First experience with gemtuzumab-ozogamicin plus cytarabine as continuous infusion for elderly AML patients."],
        [2008, "We evaluated the role of rituximab during remission induction chemotherapy in relapsed aggressive CD20+ non-Hodgkin lymphoma."],
        [2007, "The patient received another course of systemic chemotherapy with cytarabine and idarubicin and is in good condition."],
        [2003, "Our results suggest that arsenictrioxide may be superior to chemotherapy and BMT for the treatment of APL in relapse."],
        [2013, "dexamethasone (DXN) is an effective anti-inflammatory drug in the treatment of acute and chronic eye disease such as uveitis."],
        [2022, "Targeted therapy with gilteritinib for relapsed/refractory FLT3-ITD+ AML can be effective in isolated extramedullary relapse."],
        [2015, "Evaluating frequency of PML-RARA mutations and conferring resistance to arsenictrioxide-based therapy in relapsed AML patients."],
        [2021, "Long-term quality of life of patients with AML treated with arsenictrioxide vs chemotherapy."],
        [2011, "Plans for treatment involve adjuvant chemotherapy with vincristine, actinomycind, and cyclophosphamide."],
        [2018, "Cytogenetics and gene mutations influence survival in older patients with AML treated with azacitidine or conventional care."],
        [2022, "dexamethasone Sensitizes AML Cells to cytarabine by Upregulating FKBP51."],
        [2020, "Clonal selection in therapy-related myelodysplastic syndromes and AML under azacitidine treatment."],
        [2000, "arsenictrioxide(arsenictrioxide) has proved highly effective in treating both refractory or primary cases of AML (APL)."],
        [2019, "Multiomics of azacitidine-treated AML cells reveals variable and convergent targets that remodel the cell-surface proteome."],
        [2020, "Tocilizumab, but not dexamethasone, prevents CRS without affecting antitumor activity of bispecific antibodies."],
        [2015, "His tumor was unresectable at diagnosis and he received neoadjuvant chemotherapy with cisplatin, fluorouracil and vincristine."],
        [2020, "Healthcare utilization in patients with higher-risk MDS/low-blast count AML treated with azacitidine in the 'real-world'."],
        [2018, "Cytarabine is a conventionally used chemotherapeutic agent for treating AML (AML)."],
        [2002, "Pharmacokinetics and antitumor activity of vincristine entrapped in vesicular phospholipid gels."],
        [1981, "In 1967 we first started to use daunorubicin and 6alpha-methylprednisone in the treatment of acute nonlymphocytic leukemia."],
        [2015, "Cytarabine is the primary chemotherapeutic agent used for treatment of AML (AML)."],
        [2022, "Rituximab is beneficial in acute lymphoblastic leukemia but four doses during induction is likely to be insufficient."],
        [2016, "Most patients (63 of 110) received chemotherapy consisting of cyclophosphamide alone."],
        [2019, "First-line chemotherapy generally consisted of six cycles of cyclophosphamide, vincristine, low-dose methotrexate (COM)."],
        [2020, "We report the case of a 10-year-old female with AML who developed cytarabine-associated pancreatitis."],
        [2003, "Arsenic species excretion after dimercaptopropanesulfonic acid (DMPS) treatment of an acute arsenictrioxide poisoning."],
        [2020, "A 55-year-old woman developed AML during treatment with all-trans-retinoic acid and arsenictrioxide."],
        [1989, "High-dose cytarabine (HDARA-C) is an effective but toxic treatment for AML (AML)."],
        [1996, "The clinical development of cytarabine for the treatment of AML (AML) provides a useful paradigm for the study of this process."],
        [1983, "Cyclophosphamide (100 mg/kg) given 48 h prior to BCG did not influence the anti-tumor immune response."],
        [2020, "Cytarabine is an effective treatment for AML with associated toxicities including treatment related mortality (TRM)."],
        [2008, "Other immunotherapy, such as the combination of thalidomide with Rituximab, has shown substantial antitumor activity."],
        [1983, "), whereas drugs had no effect on the antitumor activity of cyclophosphamide (100 mg/kg, i.p.)"],
        [2003, "arsenictrioxide (As(2)O(3)) has been found to be remarkably effective in the treatment of patients with AML (APL)."],
        [1993, "A cell culture model for the treatment of AML with fludarabine and cytarabine."],
        [2017, "Daunorubicin is extensively used in chemotherapy for diverse types of cancer."],
        [1983, "Alteration of the pharmacokinetics of high-dose cytarabine by its metabolite, high ara-U in patients with acute leukemia."],
        [2008, "Effect of topical ciprofloxacin/dexamethasone or dexamethasone alone on acute Streptococcus pneumoniae rhinosinusitis in mice."],
        [2010, "A Phase II trial of gemcitabine and mitoxantrone for patients with AML in first relapse."],
        [2016, "Vincristine is an important component of acute lymphoblastic leukemia (ALL) treatment protocols that can cause neurotoxicity."],
        [2018, "Rituximab-containing combination chemotherapy for DLBCL is the most widely used treatment in DLBCL-type RS."],
        [2002, "High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukemia."],
        [2003, "Intestinal toxicity during induction chemotherapy with cytarabine-based regimens in adult AML."],
        [1984, "Interactions of the antitumor agents mitoxantrone and bisantreno with deoxyribonucleic acids studied by electron microscopy."],
        [2011, "The patient received 6 cycles of chemotherapy (Vincristine and Actinomycin)."],
        [1984, "and thioguanine in the treatment of acute nonlymphocytic leukemia in the elderly."],
        [2021, "Furthermore, venetoclax (a BCL2 inhibitor) synergistically enhanced the cytotoxicity of DNR in AML cell lines."],
        [2022, "Gilteritinib clinical activity in relapsed/refractory FLT3 mutated AML previously treated with FLT3 inhibitors."],
        [2009, "Induction chemotherapy comprising idarubicin and cytarabine was administered and steroid pulse therapy was added."],
        [1999, "Enhanced antitumor immune responses of IL-2 gene-modified tumor vaccine by combination with IL-1 and low dose cyclophosphamide."],
        [2021, "Thrombocytosis in a patient with AML during treatment with all-trans retinoic acid and arsenictrioxide."],
        [2016, "dexamethasone sodium phosphate (DXP) is an anti-inflammatory drug commonly used to treat acute and chronic ocular diseases."],
        [2010, "The purpose of the present study is to evaluate the effects of arsenictrioxide (arsenictrioxide) on human AML NB-4 cells."],
        [2021, "Synergistic effect of chidamide and venetoclax on apoptosis in AML cells and its mechanism."],
        [1992, "Combination chemotherapy with rhG-CSF and cytarabine to the patient showed remarkable cytoreduction."],
        [2013, "Idarubicin is associated with better remission induction of de novo AML patients with high MDR1 expression."],
        [1993, "cytarabine (cytarabine) and etoposide are often used in combination in the treatment of AML (AML)."],
        [2021, "The antitumor activities of BAP and/or cyclophosphamide (CTX) were investigated using the model of S180 tumor-bearing mice."],
        [2021, "Successful treatment of AML in a patient under hemodialysis with arsenictrioxide."],
        [1985, "Phase II trial of vincristine infusion in acute leukemia."],
        [2011, "Enhanced T-cell-independent antitumor effect of cyclophosphamide combined with anti-CD40 mAb and CpG in mice."],
        [1978, "Ten patients with late-stage acute lymphocytic leukemia were treated with L-asparaginase and cytarabine."],
        [2021, "Management of relapse in AML treated with up-front arsenictrioxide-based regimens."],
        [2012, "Over 5 years, we treated 16 elderly patients with AML with GO and cytarabine."],
        [2022, "Phase 2 evaluated INCB052793 or itacitinib plus azacitidine in DNA methyltransferase inhibitor (DNMTi)-refractory AML or MDS."],
        [1996, "The use of haemodialysis and 2,3 propanesulphonate (DMPS) to manage acute oral poisoning by lethal dose of arsenictrioxide."],
        [2021, "Cyclophosphamide (CP) is one of the potent and low cost chemotherapy used in clinical setting against a variety of tumors."],
        [1981, "VP 16-213 and cyclophosphamide in the treatment of refractory acute nonlymphocytic leukemia with monocytic features."],
        [2003, "(-)-Epigallocatechin-3-gallate enhances anti-tumor effect of cytarabine on HL-60 cells."],
        [2006, "A comparison of the in vitro cytotoxicity of daunorubicin and liposomaldaunorubicin in pediatric acute leukemia."],
        [2006, "Cytotoxic activity of gemtuzumab-ozogamicin (gemtuzumab-ozogamicin) in AML correlates with the expression of protein kinase Syk."],
        [2010, "The patient received CVP chemotherapy (cyclophosphamide, vincristine, prednisolone)."],
        [2008, "dexamethasone phosphate in antibiotic ear drops for the treatment of acute bacterial otitis externa."],
        [2020, "Resource utilization and cost effectiveness of treating AML using generic arsenictrioxide."],
        [2018, "All-trans retinoic acid (ATRA) and arsenictrioxide (arsenictrioxide) are essential for AML (APL) treatment."],
        [2007, "Combination of all-trans-retinoic acid and gemtuzumab-ozogamicin in an elderly patient with AML and severe cardiac failure."],
        [2014, "Successful repeated treatment of AML in early relapse with gemtuzumab-ozogamicin alone."],
        [2013, "TGF-β-Neutralizing Antibody 1D11 Enhances Cytarabine-Induced Apoptosis in AML Cells in the Bone Marrow Microenvironment."],
        [2020, "The FDA has approved arsenictrioxide (arsenictrioxide) for AML (APL) treatment."],
        [2015, "As a function of dose, Aa and Ap protected or sensitized AML cells against daunorubicin."],
        [2016, "dexamethasone had a profound effect on the microglia morphology and reduced the acute activation of these cells."],
        [2002, "Clinical efficacy of arsenictrioxide has been shown in patients with relapsed AML (APL)."],
        [2012, "Enhanced cellular uptake and in vitro antitumor activity of short-chain fatty acid acylated daunorubicin-GnRH-III bioconjugates."],
        [2007, "The prodrug cytosinearabinoside (cytarabine) is widely used in the treatment of acute leukemias."],
        [2011, "The case was treated with intensive chemotherapy containing high-dose methotrexate, cyclophosphamide, and cytarabine."],
        [1981, "Children with AML were treated with aggressive daunorubicin induction and mercaptopurine and methotrexate maintenance."],
        [2005, "Two patients with all-trans retinoic acid-resistant AML treated successfully with gemtuzumab-ozogamicin as a single agent."],
        [1987, "A phase II study of high-dose cytarabine in the treatment of acute leukemia in adults."],
        [1997, "Phase I clinical and laboratory evaluation of topotecan and cytarabine in patients with acute leukemia."],
        [2016, "Synergisitic and Antagonistic AML Cell Type-specific Responses to azacitidine-2-deoxycitidine and 1-h-D-Arabinofuranoside."],
        [2022, "Long-term follow-up results of cytarabine-containing chemotherapy for AML."],
        [1977, "Combination chemotherapy of malignant melanoma with azomycinriboside carboxamide, carmustine and vincristine."],
        [2001, "Efficacy and safety of gemtuzumab-ozogamicin in patients with CD33-positive AML in first relapse."],
        [2006, "Vincristine chemotherapy is mainly associated with neurotoxic effects."],
        [2017, "Tunneling nanotube (TNT) formation is downregulated by cytarabine and NF-κB inhibition in AML (AML)."],
        [2016, "arsenictrioxide and Tretinoin (AsO/ATRA) for AML (APL)."],
        [2008, "Recent rekindling in the interest of arsenictrioxide is due to its high efficacy in AML (APL)."],
        [1994, "Patients with acute nonlymphocytic leukemia (ANLL) were treated by continuous infusion of cytarabine (100 mg/m2/d x 10 days)."],
        [2004, "dexamethasone and dextran 40 treatment of 32 patients with severe acute pancreatitis."],
        [2021, "For over four decades, AML has primarily been treated by cytarabine combined with an anthracycline."],
        [2008, "Enhancement of the anti-tumor efficacy of a GM-CSF-secreting tumor cell immunotherapy in preclinical models by cytarabine."],
        [2000, "Synergistic anti-tumor activity of a novel immunomodulator, BCH-1393, in combination with cyclophosphamide."],
        [2019, "omacetaxinemepesuccinate potentiates the antileukemic activity of arsenictrioxide against AML cells."],
        [2013, "Downregulation of Mcl-1 through GSK-3β activation contributes to arsenictrioxide-induced apoptosis in AML cells."],
        [1981, "Postoperatively, she received chemotherapy consisting of doxorubicin (Adriamycin) and vincristine."],
        [2000, "With further consolidation chemotherapy without high-dose cytarabine."],
        [2020, "dexamethasone has been widely used to treat acute inflammatory diseases and endotoxic shocks in animal models."],
        [2018, "Moreover, we show that N6L sensitizes AML cells to doxorubicin and cytarabine treatment."],
        [2021, "Unlike other FLT 3 inhibitors, Gilteritinib has been shown to be a highly effective agent in R/R AML with FLT3 mutations."],
        [1983, "The chemotherapy consisted of either melphalan or a combination of doxorubicin, cyclophosphamidemonohydrate, and cisplatin."],
        [1993, "Effects of mast cell growth factor on cytarabine mediated AML cell killing."],
        [1982, "One child with acute lymphocytic leukemia resistant to vincristine had a transient M1 remission bone marrow."],
        [1978, "cytarabine, a phase-specific antitumor agent, is rapidly deactivated by the enzyme cytidine deaminase."],
        [2015, "The treatment continued with hemodialysis 3 times per week with chemotherapy protocol bortezomib, doxorubicin, dexamethasone."],
        [2005, "Recently, arsenictrioxide (arsenictrioxide) was considered as a novel anti-tumor agent."],
        [2016, "arsenictrioxide has achieved great clinical success in the treatment of AML (APL)."],
        [2009, "DNA demethylating agents, including azacitidine (5-aza), display synergistic antitumor activity with several chemotherapy drugs."],
        [2014, "arsenictrioxide (arsenictrioxide) induces clinical remission in AML and growth inhibition in various cancer cell lines in vitro."],
        [2004, "5'-(3')-nucleotidase mRNA levels in blast cells are a prognostic factor in AML patients treated with cytarabine."],
        [1991, "Thirty children with refractory acute lymphocytic leukemia (ALL) were treated with mitoxantrone, 8 mg/m2/day, for 5 days."],
        [2022, "All-trans retinoic acid enhanced the antileukemic efficacy of venetoclax in AML by downregulating the expression of S100A8."],
        [2017, "In addition, cytarabine-induced AML cell apoptosis was enhanced by CTL treatment."],
        [1981, "These data indicate that mitoxantrone has a wide spectrum of in vitro antitumor activity."],
        [2006, "We describe 2 patients with AML (APL) in whom torsade de pointes (TdP) developed during treatment with arsenictrioxide."],
        [2019, "Synergistic killing effects of omacetaxinemepesuccinate and arsenictrioxide on AML stem cells and the underlying mechanisms."],
        [2013, "arsenictrioxide (arsenictrioxide) is a highly effective agent for treatment of AML (APL)."],
        [2010, "The results showed that laser and dexamethasone acted in a similar pattern to reduce acute inflammation."],
        [1982, "Sequential high-dose cytarabine and asparaginase in refractory acute leukemia."],
        [2002, "Recurrent palmar-plantar erythrodysaesthesia following high-dose cytarabine treatment for acute lymphoblastic leukemia."],
        [2022, "The effectiveness of venetoclax (VEN) in relapsed or refractory AML (RR-AML) has not been well established."],
        [2011, "Cyclophosphamide (CP) is a chemotherapy used in combinations that are associated with cognitive impairment."],
        [2011, "The addition of arsenictrioxide to low-dose cytarabine in older patients with AML does not improve outcome."],
        [2011, "Phase I and pharmacological study of cytarabine and tanespimycin in relapsed and refractory acute leukemia."],
        [1999, "Some thioguanine resistant (thioguanine resistance) clones were separated from human T cell acute lymphocytic leukemia, PEER."],
        [1999, "The phosphoinositide 3-kinase/Akt pathway is activated by daunorubicin in human AML cell lines."],
        [2021, "Hypomethylating agents (HMA) with venetoclax is a new standard for older/unfit patients with AML (AML)."],
        [2011, "gemtuzumab-ozogamicin combined with chemotherapy is a feasible treatment regimen in AML patients."],
        [2015, "Cyclophosphamide is a potent DNA alkylating agent used in chemotherapy and immunosuppression."],
        [2021, "Gilteritinib is a FLT3 inhibitor approved by the US FDA for use in adult FLT3-mutated relapsed or refractory AML patients."],
        [1998, "Complete remission after treatment of AML with arsenictrioxide."],
        [2001, "We report a patient with AML (APL) who received two doses of gemtuzumab-ozogamicin for advanced disease."],
        [2006, "arsenictrioxide (arsenictrioxide) induces remission in patients with AML (APL)."],
        [2016, "The role of VDR and BIM in potentiation of cytarabine-induced cell death in human AML blasts."],
        [2020, "Cytarabine is a pyrimidine analogue that is used for the treatment of AML at different doses."],
        [1996, "The effect of vincristine-polyanion complexes in STEALTH liposomes on pharmacokinetics, toxicity and anti tumor activity."],
        [2020, "Gilteritinib in the treatment of relapsed and refractory AML with a FLT3 mutation."],
        [2008, "The reservoir was used for locoregional chemotherapy with mitoxantrone."],
        [1993, "Ruboxyl, a new nitroxyl derivative of daunorubicin - acute toxicity and antitumor effect in animals."],
        [1999, "AV block after arsenictrioxide (arsenictrioxide) treatment for refractory AML is very rare."],
        [2014, "Outcomes of patients with AML (AML) who are refractory to high-dose Cytarabine (HiDAC)-based induction are dismal."],
        [2008, "The triptolide/cytarabine association was also investigated in vitro on primary blast cells from 25 AML patients."],
        [2012, "Therapy-related acute leukemia in two patients with multiple sclerosis treated with mitoxantrone."],
        [2020, "Furthermore its coadministration with cyclophosphamide improved its anti-tumor properties."],
        [2022, "Epigenetic therapy with chidamide alone or combined with 5‑azacitidine exerts antitumour effects on AML cells in vitro."],
        [2000, "Preceding high-dose chemotherapy consisted of cyclophosphamide 6 g/m2 and thiotepa 800 mg/m2."],
        [2019, "Azelaic acid (azacitidine), a small molecular compound is known to exhibit antitumor effect on various tumor cells."],
        [2020, "arsenictrioxide (arsenictrioxide) is one of the most effective drugs for treatment of AML (APL)."],
        [1988, "Prolonged high dose cytarabine infusions in acute leukemia."],
        [2005, "Here, azacitidine-CdR induced apoptosis in AML cells (both p53 mutant and wild-type) but not in epithelial or normal PBMCs."],
        [2019, "arsenictrioxide (arsenictrioxide)-containing therapeutic strategies are widely used in the treatment of AML (APL)."],
        [2017, "dexamethasone is considered as a direct chemotherapeutic agent in the treatment of pediatric acute lymphoblastic leukemia (ALL)."],
        [2019, "In the present study, we showed that miR-204 was significantly increased in AML cells after arsenictrioxide treatment."],
        [2017, "enasidenib, a First-in-Class Therapy Targeting AML Harboring Oncogenic IDH2 Mutations."],
        [2019, "A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients."],
        [2013, "Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine."],
        [2011, "Pediatric AML (AML) remains a challenging disease to treat even with intensified cytarabine-based chemotherapy."],
        [2006, "Real-time PCR analysis of PML-RAR alpha in newly diagnosed AML patients treated with arsenictrioxide as a front-line therapy."],
        [1996, "daunorubicin (DM) is one of the most important antitumor agents."],
        [2021, "Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active."],
        [1982, "Effect of schedule and combinations on clinical effectiveness of cytarabine in adult acute leukemia."],
        [2017, "Induction therapy for AML has not changed much since 1973, when the 7 + 3 regimen of cytarabine and daunorubicin was born."],
        [2018, "Patients received conventional chemotherapy in 14 cases, azacitidine in 10 cases and both of them in one case."],
        [2020, "Our patient received a full course of 7 + 3 chemotherapy with cytarabine and daunorubicin."],
        [2014, "Thioredoxin-1 inhibitor PX-12 induces human AML cell apoptosis and enhances the sensitivity of cells to arsenictrioxide."],
        [2010, "Daunorubicin-polypeptide conjugates with antitumor activity."],
        [1982, "Enhanced antitumor properties of 3'-(4-morpholinyl) and 3'-(4-methoxy-1-piperidinyl) derivatives of 3'-deaminodaunorubicin."],
        [2015, "Following administration of high-dose cyclophosphamide, the patient developed acute congestive heart failure."],
        [2021, "Thus, the introduction of venetoclax has transformed the landscape of AML therapy in elderly patients."],
        [2002, "CMV infection occurred rarely during cytarabine and anthracyclin based induction therapy for AML or RAEB."],
        [2016, "Patients with initial inoperable tumour (group III/R2) received first-line vincristine-dactinomycin chemotherapy (VA)."],
        [2017, "arsenictrioxide (arsenictrioxide) is highly effective in the treatment of patients with AML (APL)."],
        [2019, "MicroRNA-204 Potentiates the Sensitivity of AML Cells to arsenictrioxide."],
        [2010, "Auricular oedema and dyshidrotic eczema in a patient with AML treated with cytarabine."],
        [2018, "Fullerene C60 nanoparticles ameliorated cyclophosphamide-induced acute hepatotoxicity in rats."],
        [2004, "gemtuzumab-ozogamicin (gemtuzumab-ozogamicin) induces remission in approximately 30% of relapsed AML patients."],
        [2019, "Furthermore, SIRT3 enhanced oxidative phosphorylation (OxPhos) in AML cells under both basic and cytarabine-treated conditions."],
        [2019, "Overexpression of miR-204 potentiated arsenictrioxide-induced AML cell growth inhibition and apoptosis."],
        [1981, "Effect of cyclophosphamide on the acute phase of experimental myocardial infarction in rats."],
        [2021, "TBK1 is a potential prognostic factor for AML, and its inhibition may improve the sensitivity of AML cells to daunorubicin."],
        [2019, "cytarabine is the clinically most relevant cytotoxic agent for AML treatment."],
        [2008, "Randomized controlled trial of intravenous dexamethasone to prevent relapse in acute migraine headache."],
        [2016, "Adding rituximab to the ALL chemotherapy protocol improved the outcome for younger adults with CD20-positive, Ph-negative ALL."],
        [1990, "Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly."],
        [2020, "He started chemotherapy based on etoposide, vincristine, carboplatin."],
        [2002, "All patients then received two courses of remission induction chemotherapy with daunorubicin, cytarabine, and etoposide (DAV)."],
        [2009, "The patient was diagnosed with AML (APL) and was treated with all-trans retinoic acid (ATRA) and idarubicin."],
        [2012, "Addition of gemtuzumab-ozogamicin to induction chemotherapy improves survival in older patients with AML."],
        [2003, "arsenictrioxide (arsenictrioxide) therapy for AML in the setting of hematopoietic stem cell transplantation."],
        [2012, "Upfront maintenance therapy with arsenictrioxide in AML provides no benefit for non-t(15;17) subtype."],
        [2000, "Leukocytosis and the retinoic acid syndrome in patients with AML treated with arsenictrioxide."],
        [2019, "Additionally, a course of chemotherapy to study these single-cell-derived spheres was determined by coculture with vincristine."],
        [1991, "Treatment with HGFs resulted in [3H] cytarabine DNA incorporation that was significantly higher in AML blasts versus NBMMC."],
        [2021, "Clonal evolution of AML with FLT3-ITD mutation under treatment with midostaurin."],
        [2019, "arsenictrioxide (arsenictrioxide) is a drug commonly used for the treatment of AML (APL)."],
        [2007, "Cyclophosphamide augments the anti-tumor efficacy of uracil and tegafur by inhibiting dihydropyrimidine dehydrogenase."],
        [2019, "Maintenance therapy such as azacitidine after allo-HSCT for AML with FUS-ERG may be clinically meaningful."],
        [2014, "Health economic impact of high-dose versus standard-dose cytarabine induction chemotherapy for AML."],
        [2015, "Cytarabine is used in the treatment of AML (AML)."],
        [2007, "Results of compassionate therapy with intrathecal depot liposomalcytarabine in AML meningeosis."],
        [1999, "Leukemic cells from ten patients with AML (AML) were sorted on the basis of in vitro daunorubicin (daunorubicin) uptake."],
        [1975, "The combination of arabinosyl cytosine and thioguanine has been effective for the treatment of acute leukemia."],
        [2013, "α-Lipoic acid protects against arsenictrioxide-induced acute QT prolongation in anesthetized guinea pigs."],
        [2017, "Influence of cytarabine metabolic pathway polymorphisms in AML induction treatment."],
        [2016, "arsenictrioxide (AsO3) is used for the treatment of AML in combination with retinoids."],
        [2017, "No adverse effect of intravitreal dexamethasone in the acute management of infectious endophthalmitis was noted."],
        [2020, "High-dose chemotherapy regimens such as DA-EPOCH should be administered to young patients in combination with rituximab."],
        [2021, "Effects of co-administration of arsenictrioxide and Schiff base oxovanadium complex on the induction of apoptosis in AML cells."],
        [2018, "The median number of chemotherapy drugs given prior to the administration of Bleo/Cytarabine was 8.5."],
        [2016, "Cytosine arabinoside and daunorubicin induction therapy in a patient with AML on chronic hemodialysis."],
        [2007, "midostaurin has proven activity in the treatment of AML (AML)."],
        [2013, "We identified 97 patients with AML diagnosed after the age of 60 and treated with cytarabine-based induction chemotherapy."],
        [1994, "Long-term results following treatment of newly-diagnosed AML with continuous-infusion high-dose cytarabine."],
        [2000, "arsenictrioxide has been shown to be effective in leukemia, and AML in particular, both in vitro and in vivo."],
        [2002, "Anthracycline-based chemotherapy was used in all cases and included high-dose methotrexate +/- cytarabine in six patients."],
        [2011, "Inhibition of histone deacetylases 1 and 6 enhances cytarabine-induced apoptosis in pediatric AML cells."],
        [2014, "RUNXOR was upregulated in AML samples and in response to cytarabine treatment in vitro."],
        [1979, "An initial report of a phase-III trial comparing vindesine and vincristine for acute lymphocytic leukemia of childhood."],
        [2015, "Second, SLE patients with severe manifestations of the disease are treated with alkylating chemotherapy agent cyclophosphamide."],
        [2022, "Quantification of Venetoclax for Therapeutic Drug Monitoring in Chinese AML Patients by a Validated UPLC-MS/MS Method."],
        [2007, "Sixty patients with high-risk MDS or AML following MDS were treated with standard doses of daunorubicin and cytarabine."],
        [1989, "Low-dose cytarabine therapy for AML in elderly patients."],
        [2015, "Consolidation therapy of arsenictrioxide alternated with chemotherapy achieves remarkable efficacy in newly diagnosed AML."],
        [2019, "Using a genome-wide CRISPR/Cas9 screen in human AML, we identified genes whose inactivation sensitizes AML blasts to venetoclax."],
        [2006, "We have previously established the activity of clofarabine plus cytarabine in AML relapse."],
        [2001, "Effect of all-trans retinoic acid and arsenictrioxide on tissue factor expression in AML cells."],
        [1981, "Treatment of patients over 50 years of age with AML with a combination of zorubicin and cytarabine."],
        [2015, "All patients received cytarabine-based standard induction chemotherapy regimens."],
        [2021, "Additionally, exogenous miR-451 significantly enhanced the sensitivity of HL-60 cells to the chemotherapy drug arsenictrioxide."],
        [1996, "Captopril augments antitumor activity of cyclophosphamide in mice."],
        [2006, "Use of all-trans retinoic acid plus arsenictrioxide as an alternative to chemotherapy in untreated AML."],
        [2021, "arsenictrioxide (arsenictrioxide) has been successfully applied in the treatment of AML (APL)."],
        [1987, "A new regimen of amsacrine with high-dose cytarabine is safe and effective therapy for acute leukemia."],
        [2019, "dexamethasone protects the glycocalyx on the kidney microvascular endothelium during severe acute pancreatitis."],
        [1978, "Isolation, characterization, and properties of a labile hydrolysis product of the antitumor nucleoside, azacitidine."],
        [2010, "arsenictrioxide in the treatment of AML is relatively safe with minimal side effects."],
        [2002, "Doxorubicin or daunorubicin are routinely used to induce remission in acute lymphoblastic leukemia (ALL)."],
        [2019, "Vincristine is one of the core chemotherapy agents used in the treatment of pediatric acute lymphoblastic leukemia (ALL)."],
        [2021, "Hybrid chemotherapy regimen (FLAG-IDA-vincristine-prednisone) for acute leukemia with mixed-phenotype blasts."],
        [1975, "Combination effect of antitumor agents, including ancitabinehydrochloride and cytarabine."],
        [2014, "The experience with gemtuzumab-ozogamicin has highlighted both the potential value and limitations of antibodies in AML (AML)."],
        [1999, "They were treated with chemotherapy containing vincristine, azetomycini, and doxorubicin and radiotherapy."],
        [1992, "High-dose cytarabine (HDAC) is used to treat adults with acute and chronic leukemia and non-Hodgkin's lymphoma."],
        [1991, "High-dose cytarabine as consolidation chemotherapy for acute nonlymphocytic leukemia in remission."],
        [1995, "Vincristine therapy for children with acute lymphoblastic leukemia impairs conduction in the entire peripheral nerve."],
        [2022, "One patient failed to qualify for high-dose chemotherapy due to progression when receiving Cytarabine/TT."],
        [1999, "Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activity."],
        [2010, "arsenictrioxide cures AML (APL) by initiating PML/RARA oncoprotein degradation, through sumoylation of its PML moiety."],
        [2015, "Anti-leukemic effect of sodium metaarsenite (KML001) in AML with breaking-down the resistance of cytarabine."],
        [2012, "Both cases were sensitive to chemotherapy with cyclophosphamide, vindesine and 6alpha-methylprednisone (COP)."],
        [1999, "2'-C-Cyano-2'-deoxy-cytarabine (CNDAC) is a novel 2'-deoxycytidine (dCyd) analogue with potent antitumor activity."],
        [2016, "The combination of daunorubicin and cytarabine is the cornerstone of induction therapy for AML (AML)."],
        [2018, "arsenictrioxide (TX) has been used successfully for the treatment of AML (APL) patients."],
        [2000, "gemtuzumab-ozogamicin is a promising agent in the treatment of patients with AML that expresses CD33."],
        [2010, "Characteristics and outcome of patients with AML refractory to 1 cycle of high-dose cytarabine-based induction chemotherapy."],
        [1979, "zorubicin (benzoylhydrazone daunorubicin) is a semisynthetic compound with a good experimental antitumor activity."],
        [2017, "Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia."],
        [2021, "Thus, we aimed at evaluating the pulmonary outcomes of acute CYN intoxication and their putative mitigation by dexamethasone."],
        [2019, "Cryopreserved BMMC samples from 49 AML patients were characterized for ex vivo growth and sensitivity to cytarabine."],
        [2005, "GM-CSF and low-dose cytarabine in high-risk, elderly patients with AML or MDS."],
        [2004, "arsenictrioxide (arsenictrioxide) is approved for the treatment of AML and is under investigation for other malignancies."],
        [1995, "Patients were treated with induction chemotherapy, followed by ablative chemotherapy consisting of mitoxantrone and thiotepa."],
        [2016, "Low-dose anti-CD163-dexamethasone conjugate effectively decreased the hepatic acute phase response to LPS."],
        [2009, "Vincristine-induced acute life-threatening hyponatremia resulting in seizure and coma."],
        [2021, "Cost Effectiveness of gemtuzumab-ozogamicin in the First-Line Treatment of AML in the UK."],
        [1984, "The use of intermediate dose cytarabine (ID cytarabine) in the treatment of AML in relapse."],
        [2009, "We show that dexamethasone induced autophagy upstream of apoptosis in acute lymphoblastic leukemia cells."],
        [2005, "More recently, trivalent arsenictrioxide was found to exhibit high antitumor activity towards hematological malignancies."],
        [1983, "fluorouracil, vincristine and hydroxyurea combination chemotherapy in metastatic colorectal cancer."],
        [2016, "Also, this compound is likely not suitable as an adjuvant in chemotherapy treatments that use cyclophosphamide."],
        [2006, "Leukocytosis and retinoic acid syndrome in patients with AML treated with arsenictrioxide."],
        [1986, "aklavin A and behenoyl cytarabine combination chemotherapy for previously untreated acute leukemia."],
        [2019, "In conclusion, gemtuzumab-ozogamicin added to standard intensive chemotherapy has a favorable benefit/risk ratio."],
        [2012, "Subsequently, she received high-dose chemotherapy with an in vivo rituximab-purged autologous stem cell transplant."],
        [2022, "Venetoclax plus cytarabine therapy is approved for elderly AML (AML) patients and needs further improvement."],
        [2021, "Successful Treatment of AML Complicated with Endometrial Cancer by arsenictrioxide."],
        [1997, "Prepubertal patients receiving chemotherapy are relatively resistant to cyclophosphamide-induced germinal cell alterations."],
        [2022, "5‑azacitidine (5‑AZA), a hypomethylating agent, is effective in treating AML (AML) and myelodysplastic syndrome."],
        [1980, "Cyclophosphamide, cytarabine and methotrexate versus cytarabine and thioguanine for AML in adults."],
        [2009, "On the other hand, one arsenic derivative, arsenictrioxide (As(2)O(3)), has important antitumor properties."],
        [2020, "For example, the AML (APL) may be treated with arsenictrioxide."],
        [2021, "Hepatic sinusoidal obstruction syndrome and short-term application of thioguanine in pediatric acute lymphoblastic leukemia."],
        [1994, "The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemia."],
        [2001, "Induction therapy of adult acute lymphocytic leukemia without the use of vincristine or 6alpha-methylprednisone."],
        [2001, "Eight cycles of chemotherapy with carboplatin and vincristine were administered at 3-week intervals over a 6-month period."],
        [2002, "Resistance to cytarabine (cytarabine) is a major problem in treatment of patients with AML (AML)."],
        [1983, "The effects of dexamethasone and tetradecanoyl phorbol acetate on plasminogen activator release by human AML cells."],
        [1987, "Cytarabine, cisplatin, and etoposide chemotherapy for refractory non-Hodgkin's lymphoma."],
        [2001, "Combined effect of all-trans retinoic acid and arsenictrioxide in AML cells in vitro and in vivo."],
        [2005, "We therefore conclude that p73 is a relevant target for methylation-dependent efficacy of azacitidine-CdR in AML cells."],
        [1988, "Enzymatic oxidative activation and transformation of the antitumor agent mitoxantrone."],
        [2012, "All-trans-retinoic acid, idarubicin, and IV arsenictrioxide as initial therapy in AML (APML4)."],
        [2017, "We report two cases of fetal myelosuppression following high-dose cytarabine administration for AML (AML)."],
        [1985, "Eleven patients with heavily pretreated acute leukemia were treated with idarubicin."],
        [1993, "The regimen containing BHAC (or cytarabine), DNR, and 6-MP may be useful as induction chemotherapy for AML-M0."],
        [1977, "All patients received chemotherapy with vincristine, semustine and fluorouracil."],
        [2012, "Prior therapy included azacitidine (n = 7) and chemotherapy (n = 8)."],
        [2020, "Phase II trial of vyxeos in patients with AML at high risk for induction mortality."],
        [1984, "Thymidine as a kinetic and biochemical modulator of cytarabine in human acute nonlymphocytic leukemia."],
        [2019, "Cyclophosphamide (CP), as a chemotherapy drug, causes severe damage in testicular tissue through producing free radicals."],
        [2017, "Cytarabine (cytarabine) and Daunorubicin (Dnr) forms the backbone of AML (AML) therapy."],
        [2015, "Median radiation therapy duration was 6.5 weeks and concurrent single agent vincristine was the most common chemotherapy used."],
        [1975, "Phase II study of procarbazine, lomustine, and vincristine combination chemotherapy in the treatment of malignant brain tumors."],
        [1996, "Peripheral leukaemic cells from 10 patients with AML were incubated with daunorubicin (daunorubicin)."],
        [2019, "In vitro stability of arsenictrioxide-liposome encapsulates for AML treatment."],
        [2009, "Higher liposomal membrane fluidity enhances the in vitro antitumor activity of folate-targeted liposomal mitoxantrone."],
        [1995, "They were followed by maintenance chemotherapy with cytarabine and thioguanine 2 monthly."],
        [2016, "Pediatric low-grade gliomas (LGG) that are unresectable often require adjuvant chemotherapy such as carboplatin/vincristine."],
        [2014, "He underwent chemotherapy with high dose methotrexate (MTX) plus cytarabine (cytarabine)."],
        [2002, "Niosomal daunorubicin hydrochloride exhibited an enhanced anti-tumor efficacy when compared to free drug."],
        [2003, "Daunorubicin (daunorubicin) is one of the most important cytotoxic agents in the treatment of AML (AML)."],
        [1985, "Phase-I trial of idarubicin in acute leukemias."],
        [2014, "Intravitreal dexamethasone implant for acute exudative polymorphous vitelliform maculopathy."],
        [2021, "High dose cytarabine (HIDAC) consolidation has demonstrated a survival benefit in patients with AML (AML)."],
        [2019, "Time course of arsenic species in red blood cells of AML (APL) patients treated with single agent arsenictrioxide."],
        [2016, "Vincristine is a component of acute lymphoblastic leukemia (ALL) treatment with the potential to induce peripheral neuropathy."],
        [2012, "arsenictrioxide (arsenictrioxide) is presently the most active single agent in the treatment of AML (APL)."],
        [2019, "Synthesis and antitumor activity of daunorubicin conjugates with of 3,4-methylendioxybenzaldehyde."],
        [2021, "Moreover, HHT combined with venetoclax suppressed AML cell growth and progression in vivo xenograft model."],
        [2020, "Rituximab-containing chemotherapy regimens constitute standard first-line therapy for mantle cell lymphoma (MCL)."],
        [1992, "Treatment of AML in the elderly with low-dose cytarabine, hydroxyurea, and calcitriol."],
        [2009, "arsenictrioxide, As(2)O(3), has successfully been used to treat AML (APL)."],
        [2015, "azacitidine has been investigated in older AML patients."],
        [2006, "Five patients restarted prednisone; in four (11%) it was for suspected or confirmed acute rejection."],
        [2020, "Adult patients with r/r AML were treated with chidamide, decitabine, cytarabine, aclarubicin, and G-CSF (CDCAG)."],
        [2021, "Curcumin counteracts tumor development by inducing apoptosis in cytarabine‑resistant AML cells."],
        [2022, "Venetoclax has transformed the therapeutic landscape of AML (AML)."],
        [2020, "All-trans retinoic acid (ATRA) and arsenictrioxide (arsenictrioxide) are effective induction therapy for AML (APL)."],
        [2005, "Paricalcitol, when combined with arsenictrioxide, showed a markedly enhanced antiproliferative effect against AML (AML) cells."],
        [2015, "To evaluate immediate and acute adverse effects following TFESI with dexamethasone."],
        [1976, "This phenobarbital-induced change in the antitumor activity of cyclophosphamide appears explainable on a pharmacokinetic basis."],
        [2000, "Heterogeneity of isolated mononuclear cells from patients with AML affects cellular accumulation and efflux of daunorubicin."],
        [2018, "arsenictrioxide (arsenictrioxide) is used as a therapeutic agent in the treatment of AML (APL)."],
        [2018, "The AML (APL) drug arsenictrioxide (arsenictrioxide), causes hepatotoxicity."],
        [1992, "mitoxantrone and continuous infusion of cytarabine in refractory and relapsed acute lymphoblastic leukemia."],
        [1995, "Concurrent chemotherapy was allowed provided it remained constant across all 3 courses of cyclophosphamide."],
        [2012, "Once the presence of LMM was confirmed, the patient received intrathecal chemotherapy with methotrexate, cytarabine."],
        [2013, "Fludarabine plus cyclophosphamide (FC) is the chemotherapy backbone of modern chronic lymphocytic leukemia (CLL) treatment."],
        [1993, "Daunorubicin, a clinically useful antitumor agent, induces mammary adenocarcinoma in Sprague-Dawley rats."],
        [1981, "Adjuvant chemotherapy with procarbazine, vincristine and 6alpha-methylprednisone for medulloblastomas."],
        [2020, "In summary, vyxeos offers finally something new in the landscape of AML therapy."],
        [1984, "Kinetics and sensitivity of daunorubicin in patients with acute leukemia."],
        [1996, "The child was treated with combination chemotherapy comprising ifosphamide, vincristine and doxorubicin."],
        [2021, "Comparing cure rates for gemtuzumab-ozogamicin plus standard chemotherapy vs standard chemotherapy alone in AML patients."],
        [2014, "Inhaled budesonide and oral dexamethasone prevent acute mountain sickness."],
        [1985, "Interactions of antitumor agents Ametantrone and mitoxantrone (Novatrone) with double-stranded DNA."],
        [1993, "One of the differences between AML (AML) and acute lymphoblastic leukemia (ALL) is their sensitivity to vincristine."],
        [1987, "These results indicate that mitoxantrone was highly effective in suppressing development of acute EAE."],
        [2022, "The treatment of choice for TVT is chemotherapy with vincristine."],
        [2008, "Idarubicin is another active AML drug, which has not yet been tested with clofarabine."],
        [2020, "The treatment of high-risk AML (APL) remains an area of contention as arsenictrioxide is not approved for this indication."],
        [2016, "Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groups."],
        [2014, "gemtuzumab-ozogamicin was the first example of antibody-directed chemotherapy in cancer, and was developed for AML."],
        [2014, "We present the first Jehovah's Witness patient with AML (AML) treated successfully with azacitidine."],
        [2020, "Abivertinib synergistically strengthens the anti-leukemia activity of venetoclax in AML in a BTK-dependent manner."],
        [2020, "Our findings support further investigation of midostaurin as a chemosensitizing agent in AML patients without FLT3 mutations."],
        [2022, "The infant received chemotherapy of Cisplatin-5 fluorouracil-Vincristine (C5V) on the fourth day after birth."],
        [1993, "The authors report an acute cerebral and cerebellar syndrome in a patient treated with high-dose cytarabine."],
        [2022, "In the United States, oral azacitidine is unlikely to be cost-effective for AML patients at current prices."],
        [2020, "The distal muscular atrophy is one of side effects of arsenictrioxide (arsenictrioxide) for AML therapy."],
        [2022, "Clinical interaction between dexamethasone and aprepitant in chemotherapy for lymphoma."],
        [2009, "A combination of vincristine or actinomycind with nutlin-3 enhanced the antitumor activity in RMS cell lines with wild-type p53."],
        [2010, "Vincristine and carboplatin were first-line chemotherapy regimen used in all patients."],
        [2017, "DNA-PK inhibition alleviated mitoxantrone resistance for AML cells on and off stromal cells."],
        [2019, "This gene signature was enriched in cytarabine-resistant AML cells in a patient-derived xenograft model."],
        [2008, "gemtuzumab-ozogamicin (gemtuzumab-ozogamicin) monotherapy is reported to yield a 20-30% response rate in advanced AML (AML)."],
        [2020, "The approved FLT3 dl-tyrosine kinase inhibitors (TKIs) midostaurin and gilteritinib improve survival in AML with FLT3 mutations."],
        [2003, "Subsequently she was treated with chemotherapy containing vincristine, cisplatinum and lomustine."],
        [2017, "Cytarabine is considered the most effective chemotherapeutic option in AML (AML)."],
        [1997, "Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas."],
        [2010, "The expression of p38, ERK1 and Bax proteins has increased during the treatment of newly diagnosed AML with arsenictrioxide."],
        [2020, "Resistance to the chemotherapeutic drug azacitidine (5'-AZA) is a major obstacle in the treatment of patients with AML (AML)."],
        [2000, "arsenictrioxide, like all-trans-retinoic acid (RA), induces differentiation of AML (APL) cells in vivo."],
        [2016, "dexamethasone is a key component in the treatment of childhood acute lymphoblastic leukemia (ALL)."],
        [2006, "Taxane-based chemotherapy is active before or after mitoxantrone."],
        [2013, "Evaluation of neuropathy during intensive vincristine chemotherapy for non-Hodgkin's lymphoma and Acute Lymphoblastic Leukemia."],
        [2010, "This is the first report showing the anti-tumor effect of azacitidine-dC on synovial sarcoma."],
        [1990, "Spectrofluorometric studies on the binding of the antitumor drugs ametantrone and mitoxantrone to bovine serum albumin."],
        [2022, "Venetoclax plus azacitidine in Japanese patients with untreated AML ineligible for intensive chemotherapy."],
        [2021, "Finally, we found that arsenictrioxide can reverse chemotherapy resistance induced by overexpression of MTPN."],
        [2009, "Prospective minimal residual disease monitoring to predict relapse of AML and to direct pre-emptive arsenictrioxide therapy."],
        [2011, "arsenictrioxide (arsenictrioxide) has been proven to be highly effective in adults with newly diagnosed or relapsed AML (APL)."],
        [2014, "In addition to treating AML (APL), arsenictrioxide (arsenictrioxide) also suppresses other solid tumors, such as HCC."],
        [1996, "Captopril given for five days before cyclophosphamide treatment did not change the antitumor activity of cyclophosphamide."],
        [2008, "In the last decade, arsenictrioxide (arsenictrioxide) has been used very successfully to treat AML (APL)."],
        [2016, "Daunorubicin-induced acute cardiotoxicity caused by oxidative stress and free radical formation."],
        [2022, "The most common indications for azacitidine use in the adverse event reports were myelodysplastic syndrome (48%) and AML (27%)."],
        [2016, "However, overexpression of miR-27a partly abrogated arsenictrioxide-mediated anti-tumor activity."],
        [2020, "arsenictrioxide Treatment during Pregnancy for AML in a 22-Year-Old Woman."],
        [2022, "Low-dose chemotherapy in combination with decitabine or azacitidine showed a similar response rate and prognosis."],
        [2020, "Effects of the multi-kinase inhibitor midostaurin in combination with chemotherapy in models of AML."],
        [2021, "TANK-binding kinase 1 inhibitor GSK8612 enhances daunorubicin sensitivity in AML cells via the AKT-CDK2 pathway."],
        [2004, "Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA)."],
        [2010, "Unusual nail pigmentation following cyclophosphamide-containing chemotherapy regimen."],
        [2019, "Invasive fungal infections in AML treated with venetoclax and hypomethylating agents."],
        [2018, "dexamethasone may improve the outcome of AML patients receiving intensive chemotherapy."],
        [2010, "Voreloxin is in clinical studies, as a single agent and in combination with cytarabine, for the treatment of AML (AML)."],
        [2010, "arsenictrioxide (As(2)O(3)), a Food and Drug Administration (FDA) approved drug is successfully being used to treat AML (APL)."],
        [2015, "Tamibarotene in patients with AML relapsing after treatment with all-trans retinoic acid and arsenictrioxide."],
        [1996, "It has been shown recently in China that arsenictrioxide (arsenictrioxide) is a very effective treatment for AML (APL)."],
        [2019, "Melatonin enhances arsenictrioxide-induced cytotoxicity by modulating autophagy in an AML cell line."],
        [2017, "Our case demonstrated that acute endophthalmitis can occur following dexamethasone intravitreal implant."],
        [1995, "NEH developed after the anti-leukemic chemotherapy including high dose cytarabine."],
        [2018, "Additionally, the effect of blocking CXCR4 and TGF-β1 on AML cells was tested with and without the addition of cytarabine."],
        [1979, "Enhanced cytarabine accumulation after administration of MTX was also observed in human AML cells."],
        [2015, "In the rituximab group, nausea and skin rash during infusion were common; transient acute arthritis occurred in one child."],
        [1992, "Median survival (with palliative chemotherapy with vincristine and bleomycin) was only seven months."],
        [2019, "Vincristine is a cytotoxic chemotherapeutic agent used as first-line therapy for pediatric acute lymphocytic leukemia."],
        [2021, "Daunorubicin and cytarabine are used as standard induction chemotherapy for patients with AML."],
        [1988, "Synthesis and antitumor activity of cytarabine 5'-diphosphate-1,2-dipalmitins."],
        [2020, "UGT1A1 genotype influences clinical outcome in patients with intermediate-risk AML treated with cytarabine-based chemotherapy."],
        [2018, "Cyclophosphamide may be an additional risk factor for acute hyperglycemic crisis."],
        [2001, "Idarubicin, cytarabine, and topotecan in patients with refractory or relapsed AML and high-risk myelodysplastic syndrome."],
        [2015, "Differentiation syndrome in AML after treatment with azacitidine."],
        [1990, "Synthesis and antitumor activity of cytarabine and cytidine conjugates of thioether lipids."],
        [2006, "Recently, patients with AML (APL) have experienced significant clinical gains after treatment with arsenictrioxide."],
        [1997, "Eight of 10 patients with AML in the phase II portion (12 mg/m2 idarubicin) achieved a complete remission (CR)."],
        [2021, "The efficiency of azacitidine for treatment of posttransplant AML relapse has been documented in several clinical trials."],
        [2017, "Treatment with glasdegib has shown promising results in an early phase study of AML (AML)."],
        [1977, "A test with dexamethasone in acute leukemia."],
        [2012, "The effectiveness of carboplatin and vincristine chemotherapy in the treatment of low-grade glioma (LGG) is well established."],
        [2014, "arsenictrioxide (arsenictrioxide) is a novel form of therapy that has been found to aid AML (APL) patients."],
        [2017, "Proteomic changes in a childhood acute lymphoblastic leukemia cell line during the adaptation to vincristine."],
        [2019, "Injection vincristine is an important component of therapy for acute lymphoblastic leukemia (ALL)."],
        [2010, "Mechanisms of resistance against midostaurin in resistant FLT3-ITD positive human AML cells."],
        [2017, "arsenictrioxide (arsenictrioxide) is an old drug that has recently been reintroduced as a therapeutic agent for AML (APL)."],
        [2017, "Characteristics and outcome of patients with therapy-related AML front-line treated with or without arsenictrioxide."],
        [2021, "She was initially treated with chemotherapy (vincristine/carboplatin), but her tumor progressed at six weeks of treatment."],
        [2018, "The effects of adjuvant chemotherapy with cyclophosphamide (CTX) were also investigated."],
        [2010, "Response rate to chemotherapy was 75%, and the specific response rate to vincristine-dactinomycin was 71%."],
        [2019, "This study aimed to examine the effects of arsenictrioxide (arsenictrioxide) on EVI-1 in AML (AML)."],
        [1988, "Relationship between the in vitro sensitivity to cytarabine of blast progenitors and the outcome of treatment in AML patients."],
        [2021, "Cyclophosphamide (CTX) is an antitumor drug commonly used to treat various cancer types."],
        [2019, "Gilteritinib is approved in Japan for the treatment of relapsed or refractory AML with FLT3 mutation."],
        [2020, "In pSS-associated acute TIN, cyclophosphamide combined with full-dose corticosteroids may achieve good outcomes."],
        [1984, "High-dose cytarabine for acute nonlymphocytic leukemia."],
        [2020, "The standard first-line treatment for AML (AML) is a combination of cytarabine and anthracyclines."],
        [2001, "Cytosine arabinoside, idarubicin and divided dose etoposide for the treatment of AML in elderly patients."],
        [1992, "cytarabine (cytarabine) is one of the most active compounds in the treatment of acute leukemias."],
        [1977, "Ca2+-transport inhibition by the antitumor agents doxorubicin and daunorubicin."],
        [2018, "Vincristine is a cytotoxic chemotherapy agent classified as an antitumor alkaloid and is part of the vinca alkaloid family."],
        [2015, "Knockdown of homeobox A5 by small hairpin RNA inhibits proliferation and enhances cytarabine chemosensitivity of AML cells."],
        [2003, "Safety and efficacy of intravenous pulse cyclophosphamide in acute steroid refractory inflammatory bowel disease."],
        [2003, "Multidrug resistance protein attenuates gemtuzumab-ozogamicin-induced cytotoxicity in AML cells."],
        [2005, "However, the mechanisms underlying the antitumor effect of arsenictrioxide on solid tumors are poorly defined."],
        [2020, "Cyclophosphamide is commonly used in combination chemotherapy to treat dogs with lymphoma."],
        [1985, "Treatment of AML in adults with N4-behenoyl-cytarabine."],
        [2018, "In conclusion, gilteritinib was well tolerated and demonstrated antileukemic activity in a Japanese R/R AML population."],
        [1998, "Induction chemotherapy (CT) consisted of idarubicin 12 mg/m2 i.v."],
        [2010, "arsenictrioxide (As(2)O(3), ATO) has been successfully applied to treat AML (APL)."],
        [2012, "Clofarabine, cyclophosphamide and etoposide for the treatment of relapsed or resistant acute leukemia in pediatric patients."],
        [1997, "Bronchiolitis obliterans organizing pneumonia in three children with acute leukemias treated with cytarabine and anthracyclines."],
        [2003, "Prostate cancer is known to be refractory to chemotherapy with only mitoxantrone showing some benefit."],
        [2019, "We report a 53-year-old Thai woman with AML who developed cytarabine-induced rashes."],
        [2005, "Combined treatment of AML cells by cytarabine or IDA with anti-CD33 mAb resulted in higher levels of SHP-1 phosphorylation."],
        [2016, "Anti-CD163-dexamethasone conjugate inhibits the acute phase response to lipopolysaccharide in rats."],
        [2019, "arsenictrioxide (arsenictrioxide) is widely applied to treat AML (APL)."],
        [1985, "Studies were performed to evaluate the anti-tumor activity of mafosfamid, a new synthetic derivative of cyclophosphamide."],
        [2022, "All received 4 cycles of doxorubicin/cyclophosphamide chemotherapy and pre-treatment with either sunitinib or bevacizumab."],
        [2004, "This study has been carried out in our clinic in order to evaluate the efficiency of the AML protocol which includes idarubicin."],
        [2015, "Ex vivo cytarabine sensitivity was determined in primary AML samples using MTT assay."],
        [2022, "Gilteritinib is approved for relapsed or refractory FLT3 mutated AML as monotherapy based on the ADMIRAL study."],
        [2003, "Abnormal sensation and pain are major dose-limiting factors in cancer chemotherapy with vincristine."],
        [2001, "Combination chemotherapy utilizing continuous infusion of intermediate-dose cytarabine for refractory or recurrent AML."],
        [1997, "Following biopsy, the patient received sequential chemotherapy with vincristine and carboplatin."],
        [1983, "Vincristine neurotoxicity with residual equinocavus deformity in children with acute leukemia."],
        [2022, "Intensive chemotherapy was defined as a cumulative cytarabine dose  700 mg/m2 during induction therapy."],
        [1989, "Third-line chemotherapy with CAVP (CCNU, melphalan, etoposide and prednisone) in refractory Hodgkin's disease."],
        [2004, "arsenictrioxide (As(2)O(3)) treatment induces apoptosis in AML cells through an incompletely understood mechanism."],
        [1983, "Experience with intermediate and high dose cytarabine in refractory acute leukemia."],
        [2021, "Using gastrodin could restore the mechanical and thermal threshold without interfering anti-tumor effect of vincristine."],
        [2021, "The patient received intrathecal chemotherapy with methotrexate and cytarabine, and was started on oral ibrutinib 420mg daily."],
        [2001, "Intensive timed sequential remission induction chemotherapy with high-dose cytarabine for childhood AML."],
        [2020, "Megakaryocytic Expansion in Gilteritinib-Treated AML Patients Is Associated With AXL Inhibition."],
        [2008, "Combinations with cytarabine in AML are feasible and effective."],
        [2022, "Twenty-six AML patients who relapsed after allo-HSCT were enrolled and treated with venetoclax plus azacitidine and DLI."],
        [2008, "Cyclophosphamide and IL-2 with famotidine has evidence of antitumor activity in previously treated kidney cancer and melanoma."],
        [2012, "High Dose cytarabine (HiDAC) is a safe and cost effective consolidation treatment for AML patients in complete remission."],
        [2022, "Vincristine is a chemotherapy drug that belongs to the vinca alkaloids group."],
        [2018, "Oxidative DNA damage in bone marrow cells is the main side effect of chemotherapy drugs including cyclophosphamide (CTX)."],
        [1978, "Seizures following intrathecal cytarabine in young children with acute lymphoblastic leukemia."],
        [1998, "Oral cytarabine ocfosfate in AML and non-Hodgkin's lymphoma--phase I/II studies and pharmacokinetics."],
        [2007, "The role of gemtuzumab-ozogamicin in the treatment of AML patients."],
        [2012, "Phase II trial of vorinostat with idarubicin and cytarabine for patients with newly diagnosed AML or myelodysplastic syndrome."],
        [2021, "Glasdegib is approved for treating AML in elderly patients at 100 mg once daily in combination with low-dose cytarabine."],
        [2021, "The patient was started on chemotherapy with vincristine, ifosfamide, doxorubicin, and etoposide."],
        [2005, "Efficacy of gemtuzumab-ozogamicin on ATRA- and arsenic-resistant AML (APL) cells."],
        [1984, "Prediction of response of acute nonlymphocytic leukemia to therapy with 'high dose' cytarabine."],
        [1987, "Low-dose cytarabine in myelodysplastic syndromes and acute nonlymphoid leukemia."],
        [2009, "Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients."],
        [2021, "Venetoclax and donor lymphocyte infusion for early relapsed AML after allogeneic hematopoietic cell transplantation."],
        [1984, "Low-dose cytarabine in the treatment of acute leukemia."],
        [2015, "azacitidine sensitization to arsenictrioxide treatment was re-capitulated also in primary AML samples."],
        [1985, "Low-dose cytarabine (cytarabine) therapy in the myelodysplastic syndromes and acute leukemia."],
        [2002, "Intrathecal vincristine was inadvertently injected into a twelve-year-old girl with acute lymphocytic leukemia."],
        [2003, "Aphidicolin decreases ex vivo resistance to cytarabine in childhood acute leukemia."],
        [2008, "This is the first trial combining arsenictrioxide with chemotherapy in a solid tumor."],
        [1985, "Modulation of cytarabine metabolism by thymidine in human acute leukemia."],
        [2020, "Recently, novel drugs like venetoclax plus azacitidine (VA) were reported to have promising efficacy in refractory AML (AML)."],
        [1995, "However, neither drug effectively enhanced the antitumor activity of vincristine in tumor-bearing mice."],
        [2018, "Enhanced antitumor activity of combined megestrol acetate and arsenictrioxide treatment in liver cancer cells."],
        [2003, "Synthesis of azacitidine nucleosides with rigid hex-2-ulofuranosylhexopyranoside moiety as potential antitumor agents."],
        [1993, "No difference of intracellular daunorubicin accumulation was observed between CD34+ and CD34- AML cells of 4 P-170- patients."],
        [2010, "Promising reports exist regarding the use of arsenictrioxide (arsenictrioxide) as first-line treatment in AML (APL)."],
        [2011, "Early onset HC is mainly attributed to conditioning chemotherapy consisting of cyclophosphamide."],
        [1989, "Low-dose cytarabine in acute non-lymphoblastic leukemia."],
        [2020, "Salvage chemotherapy with arsenictrioxide, all-trans-retinoic acid and idarubicin was given."],
        [2014, "Salvage therapy with mitoxantrone, etoposide and cytarabine in relapsed or refractory acute lymphoblastic leukemia."],
        [1976, "The response rate with betaTGdR alone in acute leukemia was 26% and in combination with cytarabine was 24%."],
        [1991, "Oral idarubicin plus cytarabine in the treatment of acute non lymphoblastic leukemia in elderly patients."],
        [2022, "Analysis of risk factors for early death in patients with AML treated with arsenictrioxide."],
        [2013, "We explored the differences by scrutinizing a case of gemtuzumab-ozogamicin (gemtuzumab-ozogamicin) in patients with AML (AML)."],
        [1996, "This prompted us to evaluate the antitumor effect of captopril combined with cyclophosphamide."],
        [2019, "Identification of predictive genetic signatures of Cytarabine responsiveness using a 3D AML model."],
        [2002, "The thiopurine thioguanine (S6G) is used to treat acute leukemia."],
        [2021, "Stage I-II diffuse large B-cell lymphoma treated with rituximab and chemotherapy with or without radiotherapy."],
        [1978, "Combination chemotherapy with 1-methyl-1-nitrosourea and cyclophosphamide in metastatic melanoma."],
        [2003, "blast cells from 15 children with ALL and 9 with AML were exposed to a range of concentrations of cytarabine +/- aphidicolin."],
        [2003, "The acute lymphoblastic leukemia cell line CCRF-CEM is sensitive to cytarabine and undergoes apoptosis."],
        [2020, "One hundred seventy-nine patients with R/R AML received ivosidenib and 214 received enasidenib."],
        [2017, "The patient was treated with chemotherapy (vincristine and methotrexate) and rituximab, but he died 1 month after the diagnosis."],
        [2006, "Resistance to cytarabine (cytarabine) is a major problem in the treatment of patients with AML (AML)."],
        [2013, "Preclinical data indicate that DAC is much more effective against human AML than cytarabine."],
        [2022, "Nrf2 overexpression increases the resistance of AML to cytarabine by inhibiting replication factor C4."],
        [2015, "Effects on primary human AML cell viability and proliferation of low-dose cytarabine (0.01-0.5 μM) were also assessed."],
        [2005, "In vivo antitumor activity of folicacid receptor-targeted liposomaldaunorubicin in a murine leukemia model."],
        [2010, "Vincristine chemotherapy after operation is necessary to prevent the enlargement of the remaining tumor."],
        [2002, "To review the role of all-trans retinoic acid (ATRA) and arsenictrioxide in central nervous system (CNS) relapses of AML (APL)."],
        [2011, "Use of gemtuzumab-ozogamicin combined with conventional chemotherapy in patients with AML."],
        [2022, "Commonly used clinical chemotherapy drugs, such as cyclophosphamide (CTX), may cause injury to the ovaries."],
        [2010, "Gefitinib enhances arsenictrioxide (AS2O3)-induced differentiation of AML cell line."],
        [2018, "Mir-pharmacogenetics of Vincristine and peripheral neurotoxicity in childhood B-cell acute lymphoblastic leukemia."],
        [2016, "The clinical use of arsenictrioxide (arsenictrioxide) in the treatment of AML (APL) is limited by its cardiotoxic side effects."],
        [2006, "Cyclophosphamide (CP), an alkylating agent widely used in cancer chemotherapy causes cardiac membrane damage."],
        [2019, "arsenictrioxide [arsenictrioxide, arsenite (AsIII) in solution] has been applied successfully for the treatment of AML (APL)."],
        [2000, "Pathologic, cytogenetic and molecular assessment of AML patients treated with arsenictrioxide (arsenictrioxide)."],
        [1987, "Biochemical pharmacology of high dose cytarabine in childhood acute leukemia."],
        [2020, "Addition of rituximab (R) to chemotherapy has led to better efficacy than other regimens in clinical trials."],
        [2021, "Furthermore, WTAP made AML cells resistant to daunorubicin."],
        [2020, "We explored mechanisms of ivosidenib resistance in 174 patients with confirmed mIDH1 R/R AML from a phase 1 trial."],
        [1998, "Two reports from China have suggested that arsenictrioxide can induce complete remissions in patients with AML (APL)."],
        [2022, "To address whether Curcumin has synergistic effect with cytarabine (cytarabine) in treating AML (AML)."],
        [2022, "gemtuzumab-ozogamicin (gemtuzumab-ozogamicin) improves outcomes when added to intensive AML chemotherapy."],
        [2018, "Cyclophosphamide eradicates murine immunogenic tumor coding for a non-self-antigen and induces antitumor immunity."],
        [2006, "Flushing out of cerebrospinal fluid as a therapy for acute cerebellar dysfunction caused by high dose of cytarabine."],
        [2018, "BET Inhibition Suppresses S100A8 and S100A9 Expression in AML Cells and Synergises with Daunorubicin in Causing Cell Death."],
        [2005, "Heat shock protein 90 inhibition sensitizes AML cells to cytarabine."],
        [2010, "A short-course high-dose dexamethasone (HDD-SC) therapy has recently been reported to be efficacious in acute ITP."],
        [2005, "Serial studies of methylation of CDKN2B and CDKN2A in relapsed AML treated with arsenictrioxide."],
        [1975, "Thirty-seven adults with AML (AML) were treated with a combination of daunorubicin, cytarabine."],
        [2011, "Cytarabine (cytarabine) is an important drug in the treatment of AML (AML)."],
        [1992, "Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with AML."],
        [2004, "JNK activation is a mediator of arsenictrioxide-induced apoptosis in AML cells."],
        [2021, "GSK8612 successfully inhibited TBK1 expression, resulting in the increased sensitivity of AML cells to daunorubicin."],
        [1991, "Oral idarubicin and low dose cytarabine as the initial treatment of AML in elderly patients."],
        [2012, "arsenictrioxide (arsenictrioxide) is used, in current practice, as an effective chemotherapeutic agent for AML (APL)."],
        [2019, "Herein we aimed at exploring potential pre-clinical treatment strategies to surmount Cytarabine resistance in human AML cells."],
        [1977, "A simple test with dexamethasone (dexamethasone) in acute leukemia (AL) is described."],
        [2021, "Thioguanine (6-TG) exerts antitumor effects in cancer."],
        [1987, "Pharmacokinetic studies of intermediate-to high-dose cytarabine in children with acute leukemia and lymphoma."],
        [2010, "Hemorrhagic cystitis (HC) is a common side effect observed in patients under chemotherapy with cyclophosphamide (CYP)."],
        [2022, "Venetoclax is used for the priority treatment of elderly patients with AML (AML)."],
        [1976, "The effect of allopurinol on cyclophosphamide antitumor activity."],
        [2021, "Pharmacokinetics and pharmacogenetics of liposomalcytarabine in AML patients treated with vyxeos."],
        [2019, "Targeting Mitochondrial Structure Sensitizes AML to Venetoclax Treatment."],
        [1993, "The optimal dose and schedule of cytarabine in induction chemotherapy of newly diagnosed AML is not established."],
        [2019, "Of 371 eligible patients, 247 were randomly assigned to the gilteritinib group and 124 to the salvage chemotherapy group."],
        [2014, "venetoclax mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia."],
        [2014, "Cytarabine (cytarabine) is an effective chemotherapeutic drug for the treatment of acute leukemias."],
        [2012, "A cost-effectiveness analysis of dexamethasone versus 6alpha-methylprednisone in pediatric acute asthma exacerbations."],
        [1990, "The original LBN AML is sensitive to the chemotherapeutic agent cyclophosphamide (CY)."],
        [2007, "Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory AML treated with arsenictrioxide."],
        [2017, "Frequently used chemotherapy regimens consisted of vincristine, doxorubicin, and ifosfamide."],
        [1982, "azacitidine had no demonstrable antitumor activity."],
        [1975, "Combinations of arabinosyl cytosine and thioguanine for treatment of adults with acute leukemia."],
        [1984, "On monthly maintenance chemotherapy with ACR and cytarabine, the duration of CRs varied between 10 and 58 weeks."],
        [2019, "Twenty-six adults with acute leukemia were treated with vyxeos for 1-2 induction cycles and  4 consolidation cycles."],
        [1984, "Five weekly doses of triple intrathecal (IT) chemotherapy (methotrexate, hydrocortisonecypionate, cytarabine."],
        [2015, "Immediate and acute adverse effects following transforaminal epidural steroid injections with dexamethasone."],
        [2010, "Twenty-four (40%) patients achieved CR after induction chemotherapy and 23 started maintenance treatment with azacitidine."],
        [2017, "In vitro, exogenous IL-6 reduced mitoxantrone-induced apoptosis in cell lines and primary pediatric AML samples."],
        [2012, "All patients received neoadjuvant chemotherapy (SIOP 2001 protocol) with vincristine, doxorubicin, and actinomycind."],
        [2014, "For rituximab failures, chemotherapy was ineffectual but DLIs were successful."],
        [2011, "The last salvage chemotherapy regimen included rituximab for 74 patients and ASCT for 75 patients."],
        [1991, "Low dose cytarabine (LDARAC) has been commonly used in the treatment of AML (AML) in elderly patients."],
        [2022, "Venetoclax enhances NK cell killing sensitivity of AML cells through the NKG2D/NKG2DL activation pathway."],
        [2007, "Randomized trial of IV dexamethasone for acute migraine in the emergency department."],
        [2018, "arsenictrioxide (arsenictrioxide) is a promising new regimen for the treatment of AML (APL)."],
        [1996, "Retreatment with continuous infusion cytarabine at a later time resulted in recurrence of acute pancreatitis."],
        [2022, "Practical tips for managing FLT3 mutated AML with midostaurin."],
        [1977, "L-Asparaginase, vincristine, and 6alpha-methylprednisone for induction of first remission in acute lymphocytic leukemia."],
        [1989, "There was no evidence of significant antitumor activity for mitoxantrone in our patients with PHC."],
        [2006, "Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance."],
        [2021, "We found increased basal SLC22A4 methylation was associated with decreased cytarabine uptake in AML cell lines."],
        [2014, "Human glioma cell lines were used to explore the mechanism of arsenictrioxide's antitumor effects."],
        [2015, "azacitidine sensitizes AML cells to arsenictrioxide by up-regulating the arsenic transporter aquaglyceroporin 9."],
        [2007, "Dose dependent and cumulative peripheral neuropathy is the main dose limiting side effect of chemotherapy with vincristine."],
        [2016, "Dose-reduced combination of mitoxantrone, etoposide, and cytarabine (miniMEC) for relapsed and refractory acute leukemia."],
        [2016, "Simultaneous high-dose systemic and intrathecal chemotherapy with cytarabine should therefore be avoided."],
        [2021, "Risk factors for invasive fungal infection in azacitidine treated patients with AML and myelodysplastic syndrome."],
        [2016, "Patient survival was improved by 3-4 cycles of chemotherapy with an accumulated concentration of 36 g/m2 of cytarabine."],
        [2021, "ATRA plus arsenictrioxide without chemotherapy was the first attempt to treat low and intermediate-risk patients with APL."],
        [2012, "Systemic intravenous chemotherapy may be necessary with regimens including carboplatin, vincristine and etoposide."],
        [2018, "A pilot study of daunorubicin-augmented hyper-CVAD induction chemotherapy for adults with acute lymphoblastic leukemia."],
        [2011, "Our results indicated that arsenictrioxide may exert an anti-tumor effect by influencing bone marrow micro-environment."],
        [1994, "Structural analysis of the deoxycytidine kinase gene in patients with AML and resistance to cytarabine."],
        [1994, "Combined antileukemic activity of pIXY 321 and cytarabine against human AML cells."],
        [2012, "Combined treatment with an oncolytic adenovirus and antitumor activity of vincristine against retinoblastoma cells."],
        [2004, "Binding of antitumor antibiotic daunorubicin to histones in chromatin and in solution."],
        [2012, "All patients received cytarabine and daunorubicin as chemotherapy regimen."],
        [2003, "Primary chemotherapy based on high-dose MTX and cytarabine is highly efficient in PCNSL."],
        [2013, "Neuropathy is common squeal of intensive chemotherapy protocols that contain vincristine and corticosteroids."],
        [2021, "vyxeos is a liposome encapsulating cytarabine and daunorubicin for treating AML (AML) patients."],
        [1994, "In three AML samples at diagnosis and at their relapse, cytarabine incorporation into the DNA was determined."],
        [1994, "Daunorubicin pharmacokinetics and the correlation with P-glycoprotein and response in patients with acute leukemia."],
        [1981, "Phase I study of pyrazofurin and azacitidine in refractory adult acute leukemia."],
        [2009, "iii) Another anti-tumor drug, vincristine, exhibited the same behavior as doxorubicin."],
        [2022, "Furthermore, we discovered that inhibiting SPAG1 impacted AML cell susceptibility to venetoclax."],
        [2003, "for 4 d with idarubicin (CCI), we performed a 2:1 randomized phase II trial in AML patients aged over 60 years."],
        [1987, "Radiation of the renal fossa (4,000 rad) and chemotherapy with actinomycind and vincristine were administered after surgery."],
        [2013, "Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with AML and myelodysplasia."],
        [2015, "CDK4/6 Inhibitor PD 0332991 Sensitizes AML to Cytarabine-Mediated Cytotoxicity."],
        [2018, "Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with AML."],
        [2009, "Use of dexamethasone and 6alpha-methylprednisone in acute asthma exacerbations in pediatric patients."],
        [2019, "A novel NPM1-RARG-NPM1 chimeric fusion in AML resembling AML but resistant to all-trans retinoic acid and arsenictrioxide."],
        [2012, "They are retained in the cytoplasm of exposed cells for more than 24 h and synergize with chemotherapy and midostaurin."],
        [1992, "Eighteen control patients receiving chemotherapy without vincristine had no comparable orofacial symptoms."],
        [2020, "Rapid Efficacy of gemtuzumab-ozogamicin in Refractory AML Patients with Pulmonary and Kidney Failure."],
        [1990, "The antitumor effect of C18PCA and cytarabine was investigated against the P388 ascites tumor in BDF1 mice."],
        [2011, "Long-term remission after first-line single-agent treatment with arsenictrioxide of relapsed AML in an 8-year-old boy."],
        [2022, "We reported a 2-year-old boy who was treated irregularly for acute lymphoblastic leukemia with daunorubicin."],
        [1998, "Partitioning and structural effects of the antitumor drug daunorubicin on model membranes."],
        [2021, "mitoxantrone (mitoxantrone) is an antitumor drug that can block type II topoisomerase."],
        [2018, "Co-administration of the Bcl-2 inhibitor venetoclax further potentiated ABC294640's anti-tumor activity."],
        [2016, "Four patients received cyclophosphamide-containing chemotherapy at the time of diagnosis."],
        [2011, "arsenictrioxide (As(2)O(3)) is an effective treatment for relapsed or refractory AML (APL)."],
        [1991, "Vincristine overdose (7.5 mg/m2) was accidentally administered to 3 children with acute lymphoblastic leukemia."],
        [2022, "Effective tumor cell abrogation via Venetoclax-mediated BCL-2 inhibition in KMT2A-rearranged acute B-lymphoblastic leukemia."],
        [1997, "Intensive chemotherapy with idarubicin, cytarabine."],
        [2015, "The mechanism of synergistic effects of arsenictrioxide and sirolimus in AML cell lines lacking typical t(15;17) translocation."],
        [2022, "After vincristine chemotherapy decreases the tumor size by 54%, that allowed a safe liver resection."],
        [2011, "These data identify a previously unrecognized mechanism of the anti-tumor effects of arsenictrioxide."],
        [2009, "In 22 patients, the chemotherapy was intensified by adding high-dose cytarabine (HD-AraC) (2g/m(2) for 4 doses for 2 cycles)."],
        [2017, "All-trans retinoic acid and arsenictrioxide fail to derepress the monocytic differentiation driver Irf8 in AML cells."],
        [1999, "Treatment of poor prognosis AML patients using valspodar (valspodar) plus mitoxantrone, etoposide, and cytarabine (PSC-MEC)."],
        [2021, "Therapeutic Targeting of AML by gemtuzumab-ozogamicin."],
        [2011, "thioguanine (6-TG) therapy in childhood acute lymphoblastic leukemia results in chronic hepatotoxicity and portal hypertension."],
        [2019, "Cytarabine (cytarabine) is an essential medicine used in the clinical treatment of acute lymphoblastic leukemia."],
        [2013, "thioguanine induces mitochondrial dysfunction and oxidative DNA damage in acute lymphoblastic leukemia cells."],
        [2002, "Advances in the management of AML and other hematologic malignancies with arsenictrioxide."],
        [2022, "Selective BCL2 inhibitor venetoclax has been approved to treat hematological malignancies including AML (AML)."],
        [2021, "The dual roles of ginsenosides in improving the anti-tumor efficiency of cyclophosphamide in mammary carcinoma mice."],
        [2006, "The role of gemtuzumab-ozogamicin in acute leukemia therapy."],
        [2016, "Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with AML or high-risk MDS."],
        [2012, "The cytarabine (cytarabine)-based chemotherapy is the major remedial measure for AML (AML)."],
        [2003, "Phenobarbital modifies antitumor effect of cyclophosphamide depending on the type of tumor cell death caused by it."],
        [2015, "arsenictrioxide (arsenictrioxide) is used to treat acute pro-myelocytic leukemia."],
        [2015, "Economic evaluation of arsenictrioxide for treatment of newly diagnosed AML in Canada."],
        [2011, "Effect of arsenictrioxide on the treatment of children with newly diagnosed AML in China."],
        [2006, "Clofarabine and cytarabine combination as induction therapy for AML (AML) in patients 50 years of age or older."],
        [1999, "It was recently reported that arsenictrioxide (As(2)O(3)) can induce complete remission in patients with AML (APL)."],
        [2012, "Maintenance chemotherapy with lomustine and vincristine was administered for a year afterwards."],
        [2021, "Dynamics of leucocyte DNA thioguanine nucleotide levels during maintenance therapy of childhood acute lymphoblastic leukemia."],
        [2020, "In the clinical setting, chemotherapy including anthracyclines and cytarabine remains a gold standard for AML treatment."],
        [2021, "Therefore, targeting Bcl-2 with venetoclax has been suggested as an attractive strategy for inducing apoptosis in AML LSCs."],
        [2017, "Furthermore, AZA sensitized AML cells to cytarabine chemotherapy."],
        [2021, "We evaluated whether etoposide + dexamethasone-based chemotherapy regimens might be useful for treating NK/T-LAHLH."],
        [1997, "Cytarabine ocfosfate (SPAC) was administered orally to 19 patients with AML (AML) and myelodysplastic syndrome (MDS)."],
        [2015, "Pyrimidine analogue cytarabine (cytarabine) is among the most effective agents used in the treatment of acute leukemia."],
        [1978, "Treatment of adult acute lymphoblastic leukemia with cytarabine."],
        [1984, "The antitumor activity and the pharmacological fate of N4-palmitoyl-cytarabine (N4-palmitoyl-ara-C) administered p.o."],
        [2021, "Here, we evaluated whether chemotherapy could be replaced or reduced by arsenictrioxide in APL patients at different risks."],
        [1984, "The potential interaction of the antitumor agents vincristine and VP-16-213 was investigated in vivo."],
        [2022, "Following diagnosis, the patient accepted chemotherapy with vindesine, cytarabine and dexamethasone."],
        [2013, "In initial ALL, an impact on long-term response was shown in ITRT for 13 drugs, while in initial AML only for cytarabine."],
        [1995, "Idarubicin in combination with cytarabine and etoposide in the treatment of post myelodysplastic syndrome AML (MDS-AML)."],
        [2021, "Use of dexamethasone in idiopathic, acute pediatric rhabdomyolysis."],
        [2018, "arsenictrioxide promoting ETosis in AML through mTOR-regulated autophagy."],
        [2021, "arsenictrioxide (arsenictrioxide) has been used for the treatment of AML (APL)."],
        [2022, "Total Marrow and Lymphoid Irradiation with Post-Transplantation Cyclophosphamide for Patients with AML in Remission."],
        [2010, "Vincristine has proven to be effective as systemic chemotherapy and in very few reports as intralesional treatment."],
        [2022, "Curcumin sensitizes response to cytarabine in AML by regulating intestinal microbiota."],
        [1990, "One pertinent example is represented by cyclophosphamide, an alkylating agent with a wide spectrum of marked antitumor activity."],
        [2018, "Intravenous arsenictrioxide (arsenictrioxide) has been adopted as the first-line treatment for AML (APL)."],
        [2022, "Cyclophosphamide (CP) is a common chemotherapy drug with the testicular damage."],
        [2022, "The BCL2 inhibitor venetoclax has established therapeutic roles in chronic lymphocytic leukemia (CLL) and AML (AML)."],
        [2021, "Herein, we explore the combination of venetoclax, a BCL2 inhibitor, and embelin, an XIAP inhibitor, in the AML cell lines."],
        [2019, "Purine analogs like cytarabine (cytarabine) are a mainstay for treating AML (AML)."],
        [2012, "This Phase II study assessed the efficacy and safety of elacytarabine in patients with advanced stage AML (AML)."],
        [2022, "Cytarabine is one of the main chemotherapy drugs used to treat hematological malignancies."],
        [2012, "Role of minimal residual disease monitoring in AML treated with arsenictrioxide in frontline therapy."],
        [2004, "Consolidation chemotherapy with idarubicin and ATRA rapidly reversed the HPS."],
        [2020, "AZD4320 demonstrates monotherapy activity in patient-derived AML and venetoclax-resistant xenograft models."],
        [2002, "Neutropenic colitis after treatment of AML with idarubicin and cytarabine."],
        [1997, "Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for older patients with AML."],
        [2015, "Hyperoside enhances the suppressive effects of arsenictrioxide on AML cells."],
        [2019, "Clinical and economic analysis of patients with AML by FLT3 status and midostaurin use at a Comprehensive Cancer Center."],
        [2015, "gemtuzumab-ozogamicin in combination with intensive chemotherapy in relapsed or refractory AML."],
        [2014, "α-ENaC, a therapeutic target of dexamethasone on hydrogen sulfide induced acute pulmonary edema."],
        [2019, "Determination of the DNA repair pathways utilised by acute lymphoblastic leukemia cells following daunorubicin treatment."],
        [2020, "Economic Evaluation of azacitidine in Elderly Patients with AML with High Blast Counts."],
        [1988, "cytarabine is the most important drug in the clinical chemotherapy of AML."],
        [1990, "High dose cytarabine in the initial treatment of adults with acute lymphoblastic leukemia."],
        [1991, "Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow for acute lymphoblastic leukemia."],
        [1992, "The alkaloid vincristine is widely used for its anti-leukemic and anti-tumor activity."],
        [2018, "Clonal heterogeneity of AML treated with the IDH2 inhibitor enasidenib."],
        [2021, "Spermatogenic dysfunction caused by cyclophosphamide (CP) chemotherapy has seriously influenced the life quality of patients."],
        [2021, "cytarabine-based chemotherapy regimens can induce a suboptimal clinical outcome in a fraction of patients."],
        [2004, "Bone marrow necrosis in a patient with AML during re-induction therapy with arsenictrioxide."],
        [2019, "Dual effect of the broad spectrum kinase inhibitor midostaurin in acute and latent HIV-1 infection."],
        [1989, "The antitumor activity of these compounds was very similar to that of daunorubicin."],
        [2022, "Curcumin treatment sensitized response to cytarabine in MNCs of AML mice, but had no direct effect on AML cell lines."],
        [1993, "mitoxantrone (dihydroxyanthracenedione) in acute leukemia."],
        [1992, "Enhanced antitumor activity of daunorubicin conjugated with antigastric cancer monoclonal antibody MGb2."],
        [1987, "Low dose arabinosyl cytosine (cytarabine) is effective for treatment of AML (ANLL)."],
        [1996, "All 3 patients who responded had previous chemotherapy including vincristine."],
        [2012, "Transdermal iontophoresis with verapamil and dexamethasone in the acute phase of peyronie's disease."],
        [2008, "Alleviation of the drug-resistant phenotype in idarubicin and cytarabine double-resistant AML cells by indomethacin."],
        [1998, "Three weeks after the last dose of cisplatin/cytarabine the second course of chemotherapy was started."],
        [2007, "zoledronicacid has an antitumor effect and induces actin rearrangement in dexamethasone-resistant myeloma cells."],
        [1992, "Both MAbs reacted positively in 1 patient with AML (ANLL) at diagnosis who achieved remission with teniposide and cytarabine."],
        [2009, "Subsequently, she received chemotherapy with vincristine, actinomycind and ifosfamide, and was followed up with serial imaging."],
        [2020, "A phase 3 randomized study of azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients."],
        [1991, "High-dose cytarabine and daunorubicin induction and postremission chemotherapy for the treatment of AML in adults."],
        [2016, "Combination chemotherapy with cytarabine reduced the mass in the pituitary stalk."],
        [2015, "Azacitidine for the treatment of relapsed and refractory AML in older patients."],
        [1994, "In vitro cytotoxicity of mitoxantrone, daunorubicin and doxorubicin in untreated childhood acute leukemia."],
        [1989, "Standard induction and low dose cytarabine treatment in patients over 60 with AML or MDS."],
        [2008, "Modulation of the antitumor activity of metronomic cyclophosphamide by the angiogenesis inhibitor axitinib."],
        [2015, "TERT over-expression significantly attenuated azacitidine-mediated DNA damage, telomere dysfunction and apoptosis of AML cells."],
        [1990, "Rapid Remission Induction and Improved Disease Free Survival in AML Using Daunorubicin, cytarabine, and lomustine."],
        [2015, "Cost-Effectiveness Analysis of Treating AML Patients With arsenictrioxide and Retinoic Acid in the United States."],
        [2006, "The second total excision of the recurrent tumor and chemotherapy using cisplatin and vincristine were performed."],
        [2021, "vyxeos, a promising new agent for patients with treatment-related and secondary AML can lead to a severe whole-body rash."],
        [2014, "Daunorubicin (daunorubicin) is a representative anthracycline with anti-tumor bioactivity."],
        [1999, "Phase I study of liposomaldaunorubicin in patients with acute leukemia."],
        [2018, "The patient underwent adjuvant chemotherapy with vincristine and actinomycind based on the EE4A regimen."],
        [1995, "Phase I study of continuous infusion thioguanine in patients with acute leukemia."],
        [1981, "Twenty-eight patients with refractory adult acute leukemia were treated with pyrazofurin and azacitidine."],
        [1975, "The biologic and antitumor activity of azacitidine has been well demonstrated in the past."],
        [2007, "Therapy-related AML following mitoxantrone therapy in a patient with multiple sclerosis."],
        [1984, "Synergistic antitumor activity of vincristine and VP-16-213."],
        [2022, "Targeting AML with Venetoclax; Biomarkers for Sensitivity and Rationale for Venetoclax-Based Combination Therapies."],
        [2004, "Two courses of systemic chemotherapy with high-dose cytarabine and total neural axis irradiation resulted in complete remission."],
        [2013, "daunorubicin, an antitumor DNA intercalator, influences histone-DNA interactions."],
        [2016, "For the treatment of AML (AML), purine analogs, like clofarabine and cytarabine act synergistically."],
        [1995, "These findings suggest that the busulfan/cyclophosphamide preparative regimen may be associated with acute cholecystitis."],
        [2015, "Candidate cytarabine metabolizing gene expression in primary AML cells is proposed to account for this variation."],
        [2022, "Venetoclax combination therapy in AML and myelodysplastic syndromes."],
        [2020, "Neuroanatomical abnormalities related to dexamethasone exposure in survivors of childhood acute lymphoblastic leukemia."],
        [2018, "Patients using docetaxel and cyclophosphamide (TC) were not at increased risk for AML or MDS."],
        [2007, "She also received three cycles of systemic chemotherapy with dtic-dome, nimustine, vincristine and interferon-beta."],
        [1995, "In summary, high-dose cytarabine/DNR consolidation can improve the long-term outcome of a subgroup of de novo AML patients."],
        [2021, "Pretreatment with cyclophosphamidemonohydrate further augmented the antitumor activity of SIRPα-Fc-VV."],
        [1979, "Vincristine-methotrexate combination chemotherapy and the influence of weight loss on experimental tumour growth."],
        [1983, "Reduction by dexrazoxanehydrochloride of acute daunorubicin toxicity in Syrian golden hamsters."],
        [2007, "We report the results of compassionate therapy with IT depot liposomalcytarabine in 10 patients with AML with CNS involvement."],
        [2005, "arsenictrioxide has shown great promise in the treatment of patients with relapsed or refractory AML (APL)."],
        [2011, "Patients received four courses of chemotherapy including two courses of cyclophosphamide."],
        [2022, "The development of Venetoclax, a potent oral BH3 (BCL-2 homology domain 3) mimetic, has transformed the AML treatment."],
        [2014, "Metabolism of arsenictrioxide in AML cells."],
        [2022, "By coculture with  cells, this study revealed that the AML cells resisted apoptosis induced by the anticancer drug cytarabine."],
        [2021, "Shengbai decoction enhances the anti-tumor efficacy of cyclophosphamide on hepatoma 22-bearing mice."],
        [2014, "Dual epigenetic targeting with panobinostat and azacitidine in AML and high-risk myelodysplastic syndrome."],
        [2022, "We describe real-world venetoclax + HMA treatment practices and outcomes in patients with ND AML in the US."],
        [2022, "Polygenic cytarabine Response Score Identifies Pediatric Patients With AML in Need of Chemotherapy Augmentation."],
        [1986, "Treatment of childhood acute lymphoblastic leukemia with intermediate-dose cytarabine and doxorubicin."],
        [1986, "Synthesis and antitumor activity of cytarabine conjugates of 1-butene,2-methyl-4-[(3-methyl-2-butenyl)oxy]- lipids."],
        [1989, "Comparison of Now 85/34 and mitoxantrone (Lederle) acute toxicity and antitumor activity."],
        [1984, "mitoxantrone in relapsed and refractory acute leukemia."],
        [1983, "Cell kinetic responses in childhood acute nonlymphocytic leukemia during high-dose therapy with cytarabine."],
        [1986, "Thus, high-dose cytarabine is an effective regimen with substantial toxicity in patients with acute leukemia."],
        [2013, "The addition of rituximab to standard chemotherapy has improved the results of the treatment of B cell non-Hodgkin's lymphomas."],
        [2015, "arsenictrioxide (arsenictrioxide), an antitumor agent, is widely used for treating AML (APL), in which it induces apoptosis."],
        [2002, "ALL samples were significantly more sensitive than AML samples to melphalan, doxorubicin and etoposide, but not to cytarabine."],
        [2018, "The present study provides a new anti-tumor mechanism of arsenictrioxide treatment in osteosarcoma."],
        [2019, "gemtuzumab-ozogamicin was approved for the treatment of AML by the US Food and Drug Administration in September 2017."],
        [2017, "Metronomic oral cyclophosphamide chemotherapy is safe, well-tolerated and shows promising activity against mCRPC."],
        [2015, "adavosertib sensitizes T cell acute lymphoblastic leukemia cells to cytarabine by promoting apoptosis over DNA repair."],
        [2004, "One patient was treated with induction chemotherapy consisting of high-dose cytarabine and 2CDA but expired due to sepsis."],
        [1994, "Benefit of high-dose cytarabine-based consolidation chemotherapy for adults with AML."],
        [2022, "Azacitidine-induced reconstitution of the bone marrow T cell repertoire is associated with superior survival in AML patients."],
        [1999, "These derivatives are structurally related to the antitumor agent mitoxantrone."],
        [2017, "Daunorubicin hydrochloride is a cell-cycle non-specific antitumor drug with a high therapeutic effect."],
        [2016, "CD33 is variably expressed on AML (AML) blasts and is targeted by gemtuzumab-ozogamicin (gemtuzumab-ozogamicin)."],
        [2014, "arsenictrioxide (arsenictrioxide) is a promising antitumor agent used to treat AML (APL) and, recently solid tumor."],
        [1990, "Concordant changes of pyrimidine metabolism in blasts of two cases of AML after repeated treatment with cytarabine in vivo."],
        [2021, "Exportin 1 knockout is synergistic with midostaurin treatment in AML with FLT3-ITD mutation."],
        [1996, "Generation of reactive oxygen intermediates after treatment of blasts of AML with cytarabine."],
        [2021, "Embelin potentiates venetoclax-induced apoptosis in AML cells."],
        [2015, "Azacitidine improves the T-cell repertoire in patients with myelodysplastic syndromes and AML with multilineage dysplasia."],
        [2005, "Phase II pilot trial of gemtuzumab-ozogamicin (gemtuzumab-ozogamicin) as first line therapy in AML patients age 65 or older."],
        [2015, "Cyclophosphamide is one of the most commonly used chemotherapy drugs worldwide."],
        [2015, "She was given chemotherapy including idarubicin, fludarabine, and cytarabine."],
        [2018, "In addition, we show that JQ1 synergises with daunorubicin in causing AML cell death."],
        [2013, "High frequency of streptococcal bacteraemia during childhood AML therapy irrespective of dose of cytarabine."],
        [2022, "Evidence that a venetoclax (VEN)-combined regimen is effective in relapsed/refractory AML (R/R AML) is emerging."],
        [2002, "We now investigated the ability of trimidox to increase the antitumor effect of 1-beta-D-arabinofuranosyl cytosine (cytarabine)."],
        [1975, "Treatment consisted of nephrectomy, irradiation, and chemotherapy with actinomycind and vincristine."],
        [2011, "arsenictrioxide (arsenictrioxide) as an anti-tumor drug could induce differentiation and apoptosis in tumor cells."],
        [2008, "Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia."],
        [2013, "Both groups received consolidation chemotherapy consisting of vincristine and cyclophosphamide."],
        [2017, "These results support clinical testing of combined venetoclax and alvocidib for the treatment of AML and advanced MDS."],
        [1987, "Amsacrine and high-dose cytarabine (HiDAc), when administered as single agents, are effective treatment of acute leukemia."],
        [2022, "Lymphocyte Exhaustion in AML Patients and Impacts of HMA/Venetoclax or Intensive Chemotherapy on Their Biology."],
        [2018, "Quantitative assessment of the sensitivity of dormant AML cells to the BAD mimetics venetoclax and ABT-737."],
        [2020, "Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemia."],
        [1996, "arabinofuranosylcytosine (cytarabine) is a cytotoxic agent with major activity against acute leukemias."],
        [1996, "daunorubicin is an antitumor antibiotic known to inhibit DNA replication and transcription."],
        [2017, "Primary AML samples with high ex-vivo IC50 to cytarabine, ATO, Dnr had significantly high NRF2 RNA expression."],
        [2021, "Irruption of decitabine and azacitidine has led to profound changes in the upfront management of older AML (AML)."],
        [2017, "The impact of 10 polymorphisms in cytarabine metabolic pathway genes were evaluated in 225 adult de novo AML patients."],
        [2011, "Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease."],
        [2006, "Chemotherapy for AML by cytarabine."],
        [2013, "Superior long-term outcome with idarubicin compared with high-dose daunorubicin in patients with AML age 50 years and older."],
        [1994, "High-dose chemotherapy consisted of cyclophosphamide/cisplatin/carmustine."],
        [2021, "arsenictrioxide replacing or reducing chemotherapy in consolidation therapy for AML (APL2012 trial)."],
        [2018, "We report an AML (AML) patient who developed massive pericardial effusion after a second cytarabine exposure."],
        [2021, "Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory AML."],
        [2021, "Increments in DNA-thioguanine level during thiopurine-enhanced maintenance therapy of acute lymphoblastic leukemia."],
        [2019, "However, no randomized clinical trials have directly compared GLAS + low-dose cytarabine with other AML treatments."],
        [2010, "Vincristine and carboplatin chemotherapy for unresectable and/or recurrent low-grade astrocytoma of the brainstem."],
        [2021, "Using CX-4945, alongside the cytotoxic chemotherapeutic drug daunorubicin, augments BCL-XL suppression and AML cell apoptosis."],
        [2020, "Impact of TP53 mutations in AML patients treated with azacitidine."],
        [2021, "Most had acute leukemia (62.5%) and received vincristine (98.7%)."],
        [2002, "arsenictrioxide (arsenictrioxide) can induce clinical remission in patients with AML (APL) through induction of apoptosis."],
        [2013, "Aurora B inhibitor barasertib and cytarabine exert a greater-than-additive cytotoxicity in AML cells."],
        [2014, "In summary, children with DS and AML should be treated with a moderate-intensity cytarabine-based regimen with curative intent."],
        [2014, "Two tracheal BALT lymphoma patients successfully treated with chemotherapy including rituximab."],
        [1984, "These data demonstrate synergistic antitumor activity between vincristine and VP-16-213 in a murine model."],
        [2011, "On the sixth postpartum day, remission induction chemotherapy with idarubicin and cytarabine was started."],
        [1981, "Relative mutagenicity of some urinary metabolites of the antitumor drug cyclophosphamide."],
        [2020, "Gilteritinib is a FLT3 kinase inhibitor approved for FLT3-mutated AML (AML)."],
        [2022, "Liposome encapsulating cytarabine (CYT) and daunorubicin (daunorubicin) is applied for treating AML (AML) patients."],
        [1982, "Treatment of refractory acute nonlymphocytic leukemia with a combination of pyrazofurin and cytarabine."],
        [1984, "Comparison of antitumor effects of daunorubicin covalently linked to poly-L-amino acid carriers."],
        [2006, "Finally, the patient received combination chemotherapy with etoposide, methotrexate, actinomycind, cisplatin, and vincristine."],
        [2005, "Patients with AML and an activating mutation in FLT3 respond to a small-molecule FLT3 dl-tyrosine kinase inhibitor, midostaurin."],
        [1979, "Daunorubicin reductase activity was estimated in peripheral leukocytes drawn from 23 patients with acute or chronic leukemia."],
        [2000, "We treated 53 patients with newly diagnosed AML (AML) with high-dose cytarabine-based chemotherapy followed by ATRA."],
        [2022, "arsenictrioxide (arsenictrioxide) is the standard treatment for relapsed AML (APL)."],
        [2021, "He received leukoreduction apheresis and he was started on induction chemotherapy with daunorubicin and cytarabine."],
        [2014, "She elected to undergo chemotherapy with fludarabine, cyclophosphamide, and rituximab, with clinical remission."],
        [1976, "The effect of phenobarbital on cyclophosphamide antitumor activity."],
        [1981, "vincristine, and 6alpha-methylprednisone (ROAP) to 91 patients with AML who were 50 yr of age or older."],
        [2016, "For new-onset CDI with LCH, chemotherapy with cytarabine might be useful for preventing APHD and ND-CNS."],
        [2003, "gemtuzumab-ozogamicin (gemtuzumab-ozogamicin) is a novel immunoconjugate therapy for AML (AML)."],
        [2014, "Cytarabine (cytarabine) is one of the most effective drugs for the treatment of patients diagnosed with AML (AML)."],
        [2021, "Radiotherapy has obvious and rapid anti-tumor effect on cyclophosphamide-Adriamycin-vincristine-prednisone refractory PTCL-NOS."],
        [2017, "High-dose ascorbate and arsenictrioxide selectively kill AML and AML blasts in vitro."],
        [1987, "mitoxantrone in the treatment of acute leukemia."],
        [2004, "In vitro and in vivo antitumor activity of novel amphiphilic dimers consisting of pyrrolo[1,2-a]pyrazine and cytarabine."],
        [2017, "A phase 1/2 trial of lenalidomide and dexamethasone in adult patients with refractory/relapsed acute lymphoblastic leukemia."],
        [2002, "The antimetabolite thioguanine (6-TG) is utilized in the management of AML (AML)."],
        [2009, "Compounds 4b, 4d, and 3a showed highly significant antitumor activity against EAC in comparison with vincristine as standard."],
        [1979, "The synthesis and the antitumor activities of a group of 4-demethoxy-4-alkoxydaunorubicins (VIII) are reported."],
        [1997, "Furthermore, 11 AML and four ALL patients were treated with fractionated daunorubicin at a dose of 50 mg/m2/week."],
        [1996, "This case illustrates that cytarabine treatment may cause acute pancreatitis, and that this toxicity may be schedule dependent."],
        [2009, "Potentiating effects of everolimus (Everolimus) on vincristine therapy in childhood acute lymphoblastic leukemia."],
        [2021, "Monomethylated arsenic was the Major methylated arsenic in Red blood cells of AML patients treated with arsenictrioxide."],
        [2022, "arsenictrioxide and Venetoclax Synergize against AML Progenitors by ROS Induction and Inhibition of Nrf2 Activation."],
        [2020, "Enasidenib is an FDA-approved isocitrate dehydrogenase 2 (IDH2) inhibitor, which is used in the treatment of AML (AML)."],
        [2017, "Despite aggressive chemotherapy including mitoxantrone and etoposide, relapse occurs for almost half of children with AML (AML)."],
        [2018, "Anthracyclines in combination with cytarabine have been the standard therapy for AML (AML) for decades with high efficacy."],
        [1993, "The results obtained indicate that azacitidine-CdR may be an agent for the chemotherapy of neuroblastoma."],
        [1976, "Fab dimers of antitumor immunoglobulins as covalent carriers of daunorubicin."],
        [1986, "Phase I/II-studies suggested that mitoxantrone is effective in the treatment of acute leukemia."],
        [1987, "Forty-six patients with acute leukemia were treated with mitoxantrone as a single agent."],
        [1979, "Eleven patients with acute lymphocytic leukemia in relapse were treated with L-asparaginase and cytarabine (cytarabine."],
        [1986, "Thioguanine and mercaptopurine are clinically important agents in widespread use for the treatment of acute leukemia."],
        [1992, "All patients received triple intrathecal chemotherapy (hydrocortisone, cytarabine, methotrexate) for prevention of CNS leukemia."],
        [1991, "hydrocortisonecypionate in culture protects the blast cells in AML from the lethal effects of cytarabine."],
        [2017, "Further study will confirm them as biomarkers for AML patients after cytarabine-based chemotherapy."],
        [1987, "Thirty-eight patients with AML (AML) were treated with mitoxantrone (Mto) combined with cytarabine (cytarabine)."],
        [2013, "Cytarabine (cytarabine) has served as the backbone of AML (AML) treatment for nearly forty years."],
        [2015, "After achieving hematologic CR, arsenictrioxide was alternated with chemotherapy for consolidation therapy."],
        [2006, "Long-term results of an ultra low-dose cytarabine-based regimen for the treatment of AML in children with Down syndrome."],
        [1986, "These data suggest that arsenictrioxide induced an acute fibrogenic response."],
        [2006, "She received cyclophosphamide chemotherapy after surgical enucleation."],
        [1992, "Cyclophosphamide mobilized PBSC infused following high dose chemotherapy enables rapid haematological recovery."],
        [2020, "Cytarabine, 100-200 mg/mE+2/day, is commonly used in induction therapy of AML (AML)."],
        [1978, "Sequential therapy with daunorubicin and L-asparaginase in relapses of acute lymphoblastic leukemia in children."],
        [2005, "Remission induction in a Jehovah's witness patient with AML using gemtuzumab-ozogamicin."],
        [2020, "Vincristine is the first-line drug for the chemotherapy of canine transmissible venereal tumor (CTVT)."],
        [2016, "Patients with B-lineage acute lymphoblastic leukemia (ALL) may also have the CD20 antigen, which is targeted by rituximab."],
        [2022, "mitoxantrone-loaded nanoinducer (MTO@SAPC NP) promote immunogenic cell death and anti-tumor immune response."],
        [2010, "arsenictrioxide enhances the cytotoxic effect of thalidomide in a KG-1a human AML cell line."],
        [2003, "Aphidicolin significantly increased sensitivity to cytarabine in blast cells from both ALL (p=0.001) and AML (p0.05)."],
        [2002, "The patient recovered from the episode, but this article further highlights the acute adverse effects of cytarabine."],
        [1994, "Phase II trial of procarbazine, vincristine and lomustine (POC) chemotherapy in metastatic cutaneous malignant melanoma."],
        [2020, "The effects of cytarabine combined with ginsenoside compound K synergistically induce DNA damage in AML cells."],
        [2017, "Combination thalidomide, dexamethasone, and cyclophosphamide chemotherapy was administered."],
        [2001, "This assay was applied to the analysis of serum from AML patient treated by high doses cytarabine (3 g/m2 body surface)."],
        [2021, "The FDA recently approved eight targeted therapies for AML (AML), including the BCL-2 inhibitor venetoclax."],
        [2019, "Surmounting Cytarabine-resistance in AML cells and specimens with a synergistic combination of hydroxyurea and zidovudine."],
        [2019, "arsenictrioxide is an approved chemotheraputic agent for the treatment of AML (APL)."],
        [1989, "Experience with combinations containing mitoxantrone in the treatment of adult acute leukemias."],
        [2012, "Verapamil and dexamethasone iontophoresis is a safe and reliable treatment resolving painful erections in the acute phase of PD."],
        [2009, "However, rituximab-induced acute thrombocytopenia is an extremely rare side effect."],
        [1994, "Effects of fluidity and vesicle size on antitumor activity and myelosuppressive activity of liposomes loaded with daunorubicin."],
        [1991, "14 patients with AML (AML) and 7 with myelodysplastic syndrome (MDS) were treated with cytarabine in low dosage."],
        [2012, "AML (AML) is the most common type of adult leukemia for which cytarabine.based chemotherapy is the main treatment."],
        [2014, "Synergistic antitumor effects of a TGFβ inhibitor and cyclophosphamide."],
        [1978, "The combination of vincristine and procarbazine is discussed and recommended for chemotherapy of medulloblastomas."],
        [2022, "Dasatinib does not exacerbate dexamethasone-induced osteonecrosis in murine models of acute lymphoblastic leukemia therapy."],
        [1986, "A critical appraisal of low-dose cytarabine in patients with AML and myelodysplastic syndromes."],
        [2020, "Venetoclax is a highly selective BCL-2 inhibitor that has been approved by the FDA for treating elderly AML patients."],
        [2020, "Biomarkers of gemtuzumab-ozogamicin Response for AML Treatment."],
        [1999, "FLAG (fludarabine, high-dose cytarabine, and G-CSF) for refractory and high-risk relapsed acute leukemia in children."],
        [2009, "The standard therapeutic approaches for AML (AML) continue to be based on anthracyclines and cytarabine."],
        [2010, "Nanobin encapsulation of arsenictrioxide improves the pharmacokinetics and antitumor efficacy of this cytotoxic agent in vivo."],
        [2021, "Upregulation of CCNA1 promoted resistance of AML cells to midostaurin, AC220, and AraC."],
        [2006, "Treatment of AML with arsenictrioxide without ATRA and/or chemotherapy."],
        [2017, "The authors propose an intravitreal dexamethasone injection/implant as initial and acute therapy."],
        [2015, "The treatment response to cytarabine-based chemotherapy was evaluated."],
        [2015, "liposomalcytarabine, DepoCyt, is a chemotherapy agent which is used in cancer treatment."],
        [2016, "Personalization of dexamethasone therapy in childhood acute lymphoblastic leukemia."],
        [1975, "Cytarabine is an effective agent in the treatment of acute leukemia."],
        [1987, "daunorubicin and doxorubicin are widely used antitumor agents which induce dose-dependent cardiotoxicity."],
        [2016, "arsenictrioxide (arsenictrioxide) has demonstrated clinical efficacy in AML (APL) and in vitro activity in various solid tumors."],
        [2016, "arsenictrioxide-based therapy is suitable for patients with psoriasis-associated AML - A retrospective clinical study."],
        [2018, "In the V group, a single dose of the chemotherapy drug vincristine was"],
        [1992, "Maintenance with low-dose cytarabine for AML in complete remission."],
        [1975, "Cytarabine and thioguanine in combination are effective agents in the treatment of acute leukemia in adults."],
        [2009, "Low-dose arsenictrioxide can effectively alleviate AML (APL)."],
        [1981, "mitoxantrone alone had significant antitumor activity as evidenced by prolonged mean survival times; radiation was ineffective."],
        [2020, "arsenictrioxide (arsenictrioxide; ATO) has shown to be an effective anti-cancer drug targeting AML (APL)."],
        [2020, "Advances in AML (AML) genomics and targeted therapies include the recently approved BCL2 inhibitor venetoclax."],
        [1987, "Suppression of acute and relapsing experimental allergic encephalomyelitis with mitoxantrone."],
        [1985, "In addition, patients given intrathecal chemotherapy within 24 hours of cytarabine developed neurologic toxicity."],
        [1999, "Complete atrioventricular block after arsenictrioxide treatment in an acute promyelocytic leukemic patient."],
        [2017, "Intensive combination chemotherapy including gemtuzumab-ozogamicin emerged as an effective salvage therapy in refractory AML."],
        [2002, "Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia."],
        [2021, "arsenictrioxide synergistically promotes the antileukaemic activity of venetoclax by downregulating Mcl-1 in AML cells."],
        [1992, "A six year old Chinese boy with relapsed AML (APML) failed to respond to reinduction with Daunorubicin and Cytarabine infusion."],
        [1998, "Cisplatin/vincristine chemotherapy for hypothalamic/visual pathway astrocytomas in young children."],
        [2000, "Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or 6alpha-methylprednisone."],
        [1994, "Pharmacokinetics of vincristine in children and adolescents with acute lymphocytic leukemia."],
        [2013, "arsenictrioxide has received approval for use in patients with relapsed AML for remission induction."],
        [2007, "A 19-year-old male with primary refractory AML received salvage therapy with mitoxantrone and cytarabine combination."],
        [1995, "Daunorubicin (daunorubicin) is a major front-line drug in the treatment of childhood acute lymphoblastic leukemia (ALL)."],
        [2004, "Hence, the addition of rituximab to FCM chemotherapy significantly improves the outcome of relapsed or refractory FL and MCL."],
        [2012, "High-dose cytarabine induction is well tolerated and active in patients with de novo AML older than 60 years."],
        [1977, "Combination chemotherapy for disseminated malignant melanoma with dtic-dome, vincristine, and semustine."],
        [1995, "We evaluated the efficacy and toxicity of aclarubicin for AML (ANLL) refractory to daunorubicin in childhood."],
        [2004, "Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme."],
        [2014, "In this phase 2 study, newly diagnosed older AML (AML) patients were randomized 2:1 to first-line vyxeos or 7+3 treatment."],
        [2008, "Cyclophosphamide therapy was administered to animals during acute and late chronic phases of infection."],
        [2003, "arsenictrioxide (arsenictrioxide) has been used as an effective chemotherapy agent for some human cancer, such as AML."],
        [2019, "Vincristine combination with Ca+2 channel blocker increase antitumor effects."],
        [2012, "She received induction chemotherapy combining daunorubicin and cytarabine, complicated by thrombotic thrombocytopenic purpura."],
        [2003, "The third course of chemotherapy with mitoxantrone and etoposide was completed without further cardiopulmonary complications."],
        [2015, "Resistance to cytarabine and anthracycline-based chemotherapy is a major cause of treatment failure for AML (AML) patients."],
        [2003, "Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in AML patients treated with cytarabine."],
        [2008, "arsenictrioxide (As(2)O(3)) is an effective agent for the treatment of relapsed AML (APL)."],
        [1994, "Thirty-two patients received an adjuvant chemotherapy regimen of vincristine and lomustine with or without procarbazine."],
        [2005, "Cyclophosphamide (CP), a potent antitumor drug is known to cause severe cardiotoxicity."],
        [2015, "This report shows our experience in 38 patients with AML treated with azacitidine or palliative treatment."],
        [2004, "The four patients, all with low-grade astrocytomas, who treated with chemotherapy alone, received carboplatin and vincristine."],
        [2021, "Gene mutations in AML early death in patients treated with arsenictrioxide alone."],
        [2014, "vincristine (vincristine) is a standard component in the treatment of childhood acute lymphoblastic leukemia (ALL)."],
        [2018, "Pegylated hollow gold-mitoxantrone nanoparticles combining photodynamic therapy and chemotherapy of cancer cells."],
        [2017, "Severe cyclophosphamide-related hyponatremia in a patient with acute glomerulonephritis."],
        [2004, "In vitro cytotoxicity of mitoxantrone-incorporated albumin microspheres on AML cells."],
        [2003, "To detect the expression of cytokines by AML (APL) cells before and after exposure to arsenictrioxide."],
        [2003, "Pericarditis is a rare but possibly severe complication of treatment of acute leukemia with cytarabine."],
        [2013, "A total of 146 patients with mCRPC who received first-line chemotherapy (docetaxel or mitoxantrone) were identified."],
        [2021, "DCK was also mutated in cytarabine-resistant but not parental AML cell lines."],
        [1984, "Procarbazine, lomustine and vincristine (PCV) combination chemotherapy for brain tumors."],
        [2010, "The chemotherapy drugs consisted of cisplatin, doxorubicin, etoposide, ifosphamide, vincristine and cyclophsophamide."],
        [2004, "Effects of T-activin and vitamin E on toxicity and antitumor activity of cyclophosphamide."],
        [2014, "arsenictrioxide (arsenictrioxide) has been used in the treatment of AML (APL) and many malignant solid tumors."],
        [2019, "MALAT1 knockdown inhibits proliferation and enhances cytarabine chemosensitivity by upregulating miR-96 in AML cells."],
        [2009, "Effects of dexamethasone on cardiovascular functions in acute phase in meconium-injured rabbits."],
        [2018, "Dapagliflozin for prednisone-induced hyperglycaemia in acute exacerbation of chronic obstructive pulmonary disease."],
        [2000, "arsenictrioxide (arsenictrioxide)-treatment is effective in AML (APL) patients with t(15;17)."],
        [2020, "Venetoclax-based therapy can induce responses in approximately 70% of older previously untreated patients with AML (AML)."],
        [1984, "Clinical trial of low-dose cytarabine in the treatment of acute leukemia and myelodysplasia."],
        [2021, "Cyclophosphamide enhances the antitumor potency of GITR engagement by increasing oligoclonal cytotoxic T cell fitness."],
        [2015, "Glycolysis inhibitor combined with dexamethasone produced a similar antitumor effects in vitro."],
        [2008, "Vincristine pharmacokinetics is related to clinical outcome in children with standard risk acute lymphoblastic leukemia."],
        [2012, "vincristine (vincristine) is a fundamental component of various chemotherapy protocols."],
        [2006, "Treatment included chemotherapy alone and chemoimmunotherapy with rituximab."],
        [2009, "arsenictrioxide (arsenictrioxide) induces differentiation and apoptosis in AML (APL)."],
        [2002, "Compared with DS ALL, DS AML cells were significantly more sensitive to cytarabine only (21-fold)."],
        [2009, "The anti-leukaemic activity was assessed on NB4 AML cells (vs solutions of arsthinol, arsenictrioxide and melarsoprol)."],
        [1985, "doxorubicin and cytarabine contribute equally to prediction of response in AML with improved confidence level."],
        [2003, "We compare oral dexamethasone with placebo for the relief of pain in children with acute pharyngitis."],
        [2020, "dexamethasone (dextromethorphan) has an anti-immunoinflammatory effect, and is often used in acute kidney injury (AKI)."],
        [2014, "IR patients received 4 courses of chemotherapy with vincristine, doxorubicin, and cyclophosphamide (VDC)."],
        [1993, "Fludarabine potentiates metabolism of cytarabine in patients with AML during therapy."],
        [2022, "Anticancer properties of vincristine is modulated by microRNAs in acute lymphoblastic leukemia Nalm6 cell line."],
        [1987, "Oral idarubicin as single-agent treatment of acute nonlymphocytic leukemia in poor-risk patients."],
        [2006, "Currently, arsenictrioxide (arsenictrioxide) is considered the treatment of choice for patients with relapsed AML (APL)."],
        [2006, "We derived nine highly cytarabine-resistant murine BXH-2 strain AML sublines via in vitro selection."],
        [2020, "A local recurrence occurred leading to a single-dose chemotherapy with Vincristine and a second surgery after 15 weeks."],
        [2016, "Hypomethylating drugs such as azacitidine are active in AML (AML) as monotherapy."],
        [2012, "Here, we investigated the possible role of miR-181a in AML cytarabine resistance."],
        [2019, "One month following the resection, chemotherapy with vincristine plus actinomycind (EE-4A regimen) was commenced."],
        [2011, "Treatment of relapsed AML by arsenictrioxide in Iran."],
        [2021, "Targeting the metabolic vulnerability of AML blasts with a combination of venetoclax and 8-chloro-adenosine."],
        [2021, "Venetoclax plus low-dose cytarabine in Japanese patients with untreated AML ineligible for intensive chemotherapy."],
        [2005, "Thirteen SVS patients who received dexamethasone during acute episodes were studied."],
        [2014, "Mechanism for the protective effect of diallyl disulfide against cyclophosphamide acute urotoxicity in rats."],
        [2000, "thioguanine (thioguanine) is undergoing investigation for use in the maintenance phase of acute lymphoblastic leukemia (ALL)."],
        [1986, "This study confirms that idarubicin is effective in acute leukemia also by oral route."],
        [2022, "The cure rate for core-binding factor AML (AML) is 75% with fludarabine, high-dose cytarabine, and gemtuzumab-ozogamicin."],
        [2006, "High-dose intermittent calcitriol plus dexamethasone appears to be safe, feasible, and has antitumor activity."],
        [2013, "However, cyclophosphamide conditioning was implicated in acute post-transplant cardiac decompensation in several cases."],
        [2013, "Certain chemotherapeutics, particularly cyclophosphamide, can enhance the antitumor efficacy of immunotherapy."],
        [2015, "Eight patients underwent complete surgical removal of the tumor, or partial removal with subsequent chemotherapy of vincristine."],
        [1986, "Cellular pharmacology and antitumor activity of N-(p-azidobenzoyl)-daunorubicin, a photoactive anthracycline analogue."],
        [2021, "Low-Dose Triptolide Enhanced Activity of Idarubicin Against AML Stem-like Cells Via Inhibiting DNA Damage Repair Response."],
        [2007, "gemtuzumab-ozogamicin is an MAb conjugated with a cytotoxic antitumor antibiotic, calicheamicin."],
        [2019, "We conclude that azacitidine maintenance after CR/CRi after intensive chemotherapy is feasible and significantly improves DFS."],
        [1983, "Therapeutic responses included a partial remission in a patient with AML (AML) refractory to cytarabine."],
        [2010, "Report of a phase 1/2 study of a combination of azacitidine and cytarabine in AML and high-risk myelodysplastic syndromes."],
        [1993, "Based on this trial, thioguanine is not felt to have significant antitumor activity in this patient population."],
        [2009, "The high-dose chemotherapy consisted of bischloroethylnitrosourea, etoposide, cytarabine, and melphalan (BEAM) regimen."],
        [2014, "arsenictrioxide induces autophagy and antitumor effects in Burkitt's lymphoma Raji cells."],
        [1985, "We evaluated the CNS complications in 118 adults with acute leukemia who received IV high-dose cytarabine therapy."],
        [2020, "Rituximab added to chemotherapy prolongs survival among adults with B-cell cancer."],
        [1986, "The treatment of melanoma B16 with free cytarabine as well as with the prodrug-liposomes exhibit rather weak antitumor activity."],
        [2015, "The combination of ATRA and arsenictrioxide is reportedly superior to chemotherapy and ATRA as induction therapy for APL."],
        [1983, "We believe that mitoxantrone has definite utility in the treatment of acute leukemia in relapse."],
        [2018, "Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for AML in elderly patients."],
        [2022, "The pharmacokinetics of therapeutic arsenictrioxide in AML patients."],
        [2001, "Effect of granulocyte colony-stimulating factor on chemotherapeutic activity of cytarabine in acute leukemic cell lines."],
        [2020, "Genomic markers of midostaurin drug sensitivity in FLT3 mutated and FLT3 wild-type AML patients."],
        [2007, "Addition of rituximab to ESHAP chemotherapy did not have any adverse effects on PBPC mobilization."],
        [2014, "Dose intensity of cytarabine given during consolidation chemotherapy appeared to have no influence on RI."],
        [1989, "idarubicin (idarubicin) in combination with cytarabine in the treatment of relapsed or refractory acute leukemia."],
        [2018, "C‑Myc inhibitor 10058‑F4 increases the efficacy of dexamethasone on acute lymphoblastic leukemia cells."],
        [1982, "Response to azacitidine in patients with refractory acute nonlymphocytic leukemia and association with chromosome findings."],
        [2021, "Outcomes of TP53-mutant AML with decitabine and venetoclax."],
        [1999, "Intensive chemotherapy using enocitabine, mitoxantrone, and etoposide was effective to induce hematological remission."],
        [2007, "Reversible posterior leukoencephalopathy syndrome after repeat intermediate-dose cytarabine chemotherapy in a patient with AML."],
        [1997, "Altered intracellular distribution of daunorubicin in immature AML cells."],
        [2015, "Obatoclax potentiates the cytotoxic effect of cytarabine on AML cells by enhancing DNA damage."],
        [1992, "Thus, AML blasts respond to fazarabine in culture with a pattern similar to that of 5-aza and opposite to that of cytarabine."],
        [2008, "In conclusion, the combination of everolimus and metronomic cyclophosphamide showed synergistic anti-tumor activity."],
        [2020, "Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide."],
        [2022, "These results suggest that the ONO-7475/venetoclax combination may be effective for AML therapy."],
        [1985, "Subacute pulmonary failure complicating therapy with high-dose cytarabine in acute leukemia."],
        [2006, "arsenictrioxide (As(2)O(3)) induces both the differentiation and apoptosis of AML cells in a concentration dependent manner."],
        [2020, "MicroRNA-33b regulates sensitivity to daunorubicin in AML by regulating eukaryotic translation initiation factor 5A-2."],
        [1993, "Ablative chemotherapy included cytarabine, teniposide, and cyclophosphamide followed by total body irradiation."],
        [2018, "miR-134 increases the antitumor effects of cytarabine by targeting Mnks in AML cells."],
        [2001, "Combination of SN6j and cyclophosphamide using an antiangiogenic schedule of drug dosing showed synergistic antitumor efficacy."],
        [2018, "dexamethasone exhibited the highest effect on paclitaxel anti-tumor activity, in a dose-dependent fashion."],
        [2018, "Rituximab in combination with chemotherapy for the treatment of chronic lymphocytic leukemia in clinical practice."],
        [2011, "Effect of azole antifungal therapy on vincristine toxicity in childhood acute lymphoblastic leukemia."],
        [1989, "Cytosine-arabinoside (cytarabine) in low doses induces complete remissions in myelodysplastic syndromes and acute leukemia."],
        [2016, "Randomized studies with gemtuzumab-ozogamicin have validated CD33 as a target for antigen-specific immunotherapy of AML (AML)."],
        [2022, "Enhanced cytotoxicity of bisantreno when combined with venetoclax, panobinostat, decitabine and olaparib in AML cells."],
        [2022, "Time spent at home among older adults with AML receiving azacitidine- or venetoclax-based regimens."],
        [2016, "vincristine (vincristine) is an important drug used in the treatment of acute lymphoblastic leukemia (ALL)."],
        [1996, "mitoxantrone (816 +/- 132%) had no antitumor effect, nor did NaCl injections (868 +/- 116%)."],
        [2019, "Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients."],
        [1989, "The present study demonstrates the possible efficacy of verapamil in the chemotherapy of CML with mitoxantrone."],
        [2001, "The pyrimidine analogue cytarabine (cytarabine) is one of the most effective drugs used in the treatment of acute leukemia."],
        [2013, "Eight hours of hypoxia, but not dexamethasone, increased the sensitivity of pulmonary artery pressure to acute hypoxia."],
        [2008, "arsenictrioxide (arsenictrioxide) induces remission in 85% of adults with refractory AML (APL)."],
        [2013, "For many years mitoxantrone was the only chemotherapy for CRPC, but it had only a palliative effect with no effect on survival."],
        [2018, "Cyclophosphamide (CP), as a chemotherapy drug, induces hepatotoxicity through causing oxidative stress."],
        [2020, "Cytarabine, a pyramidine analog, is used for treating various hematological malignancies such as acute leukemias and lymphomas."],
        [2011, "Combinations with arsenictrioxide, sorafenib, and cytarabine demonstrated synergistic in vitro effects in AML cell lines."],
        [2020, "Safety and Feasibility of Outpatient High Dose Cytarabine for AML in the Brazilian Amazon."],
        [2022, "The noncanonical NF-κB2/Rel B signalling pathway was found to mediate gilteritinib-induced NKG2DL upregulation in AML cells."],
        [2002, "Studies of mitoxantrone demonstrated that chemotherapy can substantially reduce this debilitating symptom."],
        [2021, "A budget impact analysis of gilteritinib for the treatment of relapsed or refractory FLT3 mut+ AML in a US health plan."],
        [2009, "The success of arsenictrioxide in the treatment of AML has renewed interest in the cellular targets of As(III) species."],
        [2014, "Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy."],
        [2022, "All-trans retinoic acid (ATRA) induces apoptosis when used in combination with midostaurin in FLT3-mutated AML cells."],
        [2021, "Long noncoding RNA DANCR confers cytarabine resistance in AML by activating autophagy via the miR-874-3P/ATG16L1 axis."],
        [2020, "The addition of rituximab to intensive chemotherapy improves outcomes in patients with B-cell acute lymphoblastic leukemia."],
        [1993, "Synthesis and antitumor activity of cytarabine conjugates of thioether lipids with improved fluazinam.eugenolwater solubility."],
        [2005, "arsenictrioxide mediates intrinsic and extrinsic pathways of apoptosis and cell cycle arrest in acute megakaryocytic leukemia."],
        [2003, "arsenictrioxide-induced mitotic arrest and apoptosis in AML cells."],
        [2020, "The chemotherapy regimen was changed to cyclophosphamide, epirubicin, vincristine, and oral apatinib for two cycles."],
        [2013, "Vincristine chemotherapy trials and pharmacokinetics in tasmanian devils with tasmanian devil facial tumor disease."],
        [2017, "arsenictrioxide (arsenictrioxide) has been used clinically as an anti-tumor agent."],
        [1986, "Vincristine neurotoxicity enhanced in combination chemotherapy including both teniposide and vincristine."],
        [2020, "arsenictrioxide induces autophagic degradation of the FLT3-ITD mutated protein in FLT3-ITD AML cells."],
        [1986, "Halothane exposure for 2 h after cyclophosphamide had no effect on the antitumor activity of cyclophosphamide."],
        [2010, "Prospective study of 11 patients with acute myeloic leukemia treated with high-dose cytarabine."],
        [2022, "Additionally, gilteritinib is more effective than salvage chemotherapy for relapsed or refractory FLT3-mutated AML."],
        [1983, "mitoxantrone in patients with acute leukemia in relapse."],
        [2018, "arsenictrioxide (TX) has been used in the treatment of both de novo and relapsed AML (APL) patients."],
        [2021, "Our study shows that CD44 is a potential molecular target for sensitizing AML cells to venetoclax-based therapies."],
        [2021, "arsenictrioxide (arsenictrioxide)‑induced hepatotoxicity limits the therapeutic effect of AML treatment."],
        [2002, "Functional role of alternatively spliced deoxycytidine kinase in sensitivity to cytarabine of acute myeloid leukemic cells."],
        [1990, "A phase I study of intermittent continuous infusion high dose cytarabine for acute leukemia."],
        [2014, "Our study provides a novel clue that CD44 plays a significant role in the chemoresistance of AML cells to cytarabine and ADM."],
        [2022, "We conclude that our patient showed a spontaneous remission of his AML rather than an exquisite response to azacitidine."],
        [2018, "High-Risk AML with Unusual T/Myeloid Immunophenotype Successfully Treated with ATRA and arsenictrioxide-Based Regimen."],
        [1985, "Preliminary results in secondary AML (ANLL) treated with Idarubicin."],
        [2021, "After the diagnosis, the patient received systemic chemotherapy and drugs containing cytarabine, azacitidine, and methotrexate."],
        [2020, "arsenictrioxide encapsulated liposomes prepared via copper acetate gradient loading method and its antitumor efficiency."],
        [2020, "All-Trans Retinoic Acid Synergizes with Enasidenib to Induce Differentiation of IDH2-Mutant AML Cells."],
        [2010, "Single cycle of arsenictrioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of AML."],
        [2022, "vincristine (vincristine) is an important component of curative chemotherapy for many childhood cancers."],
        [2015, "Idarubicin, cytarabine, and pravastatin as induction therapy for untreated AML and high-risk myelodysplastic syndrome."],
        [2010, "Consequently, chemotherapy with idarubicin and cytarabine was initiated."],
        [2001, "Cyclophosphamide (CP) is widely used in high-dose chemotherapy regimens in combination with thioTEPA."],
        [2013, "Arsenic methylation metabolism and liver injury of AML patients undergoing arsenictrioxide treatment."],
        [2004, "Idarubicin and standard-dose cytarabine in adults with recurrent and refractory acute lymphocytic leukemia."],
        [2018, "We analyzed 128 patients from two institutions with MDS or AML treated with azacitidine to identify prognostic indicators."],
        [2013, "Treatment of dexamethasone-induced hiccup in chemotherapy patients by methylprednisolone rotation."],
        [1993, "Therapy of refractory/relapsed AML and blast crisis of chronic myeloid leukemia with the combination of cytarabine."],
        [2020, "Fatty acid metabolism underlies venetoclax resistance in AML stem cells."],
        [1980, "Synthesis and antitumor activity of cyclophosphamide analogues."],
        [1996, "A prospective randomized trial of idarubicin vs daunorubicin in combination chemotherapy for AML of the age group 55 to 75."],
        [2010, "She received 6 cycles of chemotherapy with cyclophosphamide, epirubicin, and fluorouracil."],
        [2017, "ERG amplification, the most frequent CNA, was related to cytarabine resistance, a cornerstone drug of AML therapy."],
        [2007, "Effects of etoposide and cyclophosphamide acute chemotherapy on growth plate and metaphyseal bone in rats."],
        [2010, "gemtuzumab-ozogamicin (gemtuzumab-ozogamicin) is an anti-CD33 antibody linked to the antitumor antibiotic calicheamicin."],
        [2013, "Interestingly, angiocidin+cytosine arabinoside (cytarabine) combination therapy reduced human AML in bone marrow by 79%."],
        [2008, "The role of dexamethasone on decreasing urinary cytokines in children with acute pyelonephritis."],
        [2014, "Cytarabine plays a pivotal role in the treatment of patients with AML (AML)."],
        [2022, "Overall, 64 anti-leukemic drugs were screened in 31 primary high-risk AML samples with or without venetoclax."],
        [2013, "Aquaporin 9, a promising predictor for the cytocidal effects of arsenictrioxide in AML cell lines and primary blasts."],
        [2001, "arsenictrioxide in combination with chemotherapy as postremission therapy results in longer survival than arsenic alone."],
        [2021, "BCL-2 inhibition through venetoclax (VEN) targets AML (AML) blast cells and leukemic stem cells (LSCs)."],
        [2009, "mitoxantrone therapy for acute posterior multifocal placoid pigment epitheliopathy with cerebral vasculitis."],
        [2012, "Use of surgery and mitoxantrone chemotherapy in a dog with disseminated lymphangiosarcoma."],
        [1993, "Acute neurotoxicity after intrathecal cytarabine in two adolescents with acute lymphoblastic leukemia of B-cell type."],
        [2021, "Using venetoclax combined with HMA in R/R AML should be kept in mind as an alternative salvage option."],
        [1969, "Remission induction with cytarabine and L-asparaginase in acute lymphoblastic leukemia."],
        [2010, "Potentiation of the anti-tumor effects of imidazoquinoline immune response modifiers by cyclophosphamide."],
        [2021, "These findings provide a new strategy to selectively remove venetoclax-resistant AML cells."],
        [2005, "Cytarabine (cytarabine) is the most effective agent for the treatment of AML (AML)."],
        [2003, "Effect of arsenictrioxide on cytokine expression by AML cells."],
        [2019, "Daunorubicin and mitoxantrone considered as crucial components of almost all standard AML induction regimens."],
        [2011, "The investigations involved 22 patients with AML undergoing chemotherapy with daunorubicin, cytarabine."],
        [1976, "Adults with previously treated acute nonlymphocytic leukemia received either azacitidine or guanazole in a randomized study."],
        [1992, "We conclude that intermediate dose cytarabine did not substantially improve results of induction chemotherapy for AML."],
        [2002, "Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin."],
        [2013, "Myocardial toxicity of AML drug-arsenictrioxide."],
        [1983, "Resection of the right kidney with tumour and dissection of enlarged lymph nodes were followed by chemotherapy with Vincristine."],
        [1986, "Ametantrone (HAQ) and mitoxantrone (DHAQ) are structurally similar antitumor drugs of the anthracenedione class."],
        [1989, "Vincristine treatment of acute lymphoblastic leukemia induces transient autonomic cardioneuropathy."],
        [2021, "Anthracycline and cytarabine‑based therapy has remained the standard treatment for AML over the last four decades."],
        [1995, "mitoxantrone is effective in treating childhood T-cell lymphoma/T-cell acute lymphoblastic leukemia."],
        [2012, "Effects of selective checkpoint kinase 1 inhibition on cytarabine cytotoxicity in AML cells in vitro."],
        [1987, "High-dose cytarabine in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemia."],
        [2014, "In conclusion, azacitidine may reinduce durable remissions in very few patients with AML or myelodysplastic syndrome."],
        [2007, "Clinical outcomes of dexamethasone-eluting stent implantation in ST-elevation acute myocardial infarction."],
        [2002, "She was admitted and received chemotherapy with vincristine, ifosfamide, and cisplatin."],
        [2003, "Antibody-targeted chemotherapy of AML using gemtuzumab-ozogamicin (gemtuzumab-ozogamicin)."],
        [2012, "Accordingly, further investigation of the cytarabine/SCH 900776 combination in AML appears warranted."],
        [2022, "We present a rare case of SS which developed shortly after starting midostaurin in a patient with AML (AML)."],
        [2002, "Systemic chemotherapy was comprised of carboplatin, lomustine, and vincristine administered every 2 months."],
        [2021, "Review of Venetoclax in CLL, AML and Multiple Myeloma."],
        [2019, "Notably, AKT inhibition increased the susceptibility of KG1α cells to chemotherapy with idarubicin and AraC."],
        [2019, "Standard treatment for higher risk myelodysplastic syndromes, chronic myelomonocytic leukemia and low blast AML is azacitidine."],
        [2019, "Glasdegib is the first Hedgehog pathway inhibitor to be approved for AML in the USA."],
        [2017, "Treatment for AML (AML) generally consists of a combination of cytarabine and an anthracycline."],
        [2017, "We report the first adult AML cohort in which the influence of these SNPs in cytarabine efficacy and toxicity was analyzed."],
        [2020, "Moreover, ectopic expression of miR-143 further decreases cell viability in cytarabine-treated AML cells."],
        [2000, "Recently, DNR has been replaced in many centers by idarubicin (IDA) as the first choice anthracycline in AML treatment."],
        [2017, "cytarabine-resistant AML cell lines were sensitive to BTZ and DSF/Cu2+."],
        [2004, "A randomized trial of dexamethasone before remission induction, in de novo childhood acute lymphoblastic leukemia."],
        [2004, "We studied the effect of herbimycin A, 6,7-dimethoxy-2-phenylquinoxaline and midostaurin on primary AML blasts."],
        [2015, "However, sodium sodiumvalproate significantly improved the acute headache in patients with aura but dexamethasone did not."],
        [2000, "Forty-seven patients with recurrent or refractory AML were treated with cytarabine, 0.5 gm/m2, intravenously (i.v.)"],
        [2008, "PML has been observed after both chemotherapy and bone marrow transplantation and, recently, in association with rituximab."],
        [1985, "The utility and indication for low-dose cytarabine therapy of AML remains to be determined."],
        [2015, "The TC (docetaxel [Taxotere] and cyclophosphamide) chemotherapy regimen is typically associated with complete alopecia."],
        [2012, "Vitamin D protects acute lymphoblastic leukemia cells from dexamethasone."],
        [2018, "Comparison of induction therapy in non-high risk AML with arsenictrioxide or in combination with ATRA."],
        [2004, "High-dose intermittent cytarabine is an effective postremission treatment for patients with AML (AML)."],
        [1990, "High-dose cytarabine and L-asparaginase therapy for poor-risk adult acute nonlymphocytic leukemia."],
        [2013, "Cyclophosphamide promotes chronic inflammation-dependent immunosuppression and prevents antitumor response in melanoma."],
        [2003, "Preclinical antitumor activity of 4'-thio-beta-D-arabinofuranosylcytosine (4-thio-cytarabine)."],
        [2014, "Intensive chemotherapy with daunorubicin (daunorubicin) is associated with serious side effects in AML (AML) patients."],
        [2010, "Vincristine-induced peripheral neuropathy in a neonate with congenital acute lymphoblastic leukemia."],
        [2020, "Events were observed in 10 patients in the rituximab-chemotherapy group and in 28 in the chemotherapy group."],
        [2018, "Cyclophosphamide is a drug used for chemotherapy and as an immune-suppressive in the organ transplantation."],
        [2015, "30 eligible patients above 60 years old with newly diagnosed AML were assigned to receive decitabine or cytarabine."],
        [1985, "Low-dose cytarabine was given to 6 patients with symptomatic myelodysplastic syndromes and 2 patients with acute leukemia."],
        [2021, "For that reason, midostaurin has been approved for treatment of AML patients with FLT3-mutation."],
        [2010, "Rituximab not only combined with chemotherapy but also given sequentially improved survival."],
        [2007, "In conclusion, acute dexamethasone induced an enduring anhedonic state that was reversed by repeated paroxetine treatment."],
        [1984, "Delayed growth arrest was observed in HL-60 AML cells after exposure to thioguanine (thioguanine)."],
        [1998, "A 7-year-old girl with recurrent acute lymphoblastic leukemia was inadvertently injected intrathecally with 1.5 mg vincristine."],
        [2017, "arabinofuranosylcytosine (cytarabine) is a mainstay in the initial treatment of AML (AML), although relapses are common."],
        [2022, "dexamethasone and SNRB are useful and safe treatment options for treating patients with acute radicular pain."],
        [2005, "Three courses of chemotherapy (dacarbazine, nimustine, and vincristine) were given postoperatively."],
        [2011, "Effect of doxorubicin and daunorubicin on the activity of acetylcholinesterase in acute lymphoblastic leukamia."],
        [2003, "cytarabine (cytarabine) is a potent antineoplastic drug used in the treatment of acute leukemia."],
        [2016, "We gave rituximab (375 mg/m(2)) on day 1 and day 6 during the first two courses of chemotherapy (total of four infusions)."],
        [2021, "gemtuzumab-ozogamicin for the treatment of AML in adults."],
        [2015, "Azacitidine/lenalidomide as maintenance therapy for high-risk AML warrants further exploration."],
        [2007, "The good therapeutic effects of large dose of dexamethasone on severe acute pancreatitis (SAP) patients have been proved."],
        [2003, "arsenictrioxide (arsenictrioxide) is capable of inducing a high hematologic response rate in patients with relapsed AML (APL)."],
        [2007, "All trans-retinoic acid and arsenictrioxide have already demonstrated efficacy in AML in both adults and children."],
        [2019, "Midostaurin for the management of FLT3-mutated AML and advanced systemic mastocytosis."],
        [2013, "The TNS-PV may be a useful tool for assessing vincristine toxicity in children with acute lymphoblastic leukemia."],
        [2000, "Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia."],
        [1987, "Successful oral chemotherapy with idarubicin in refractory anaemia with excess blasts."],
        [2006, "Treatment of AML with gemtuzumab-ozogamicin."],
        [1992, "All patients received intensive, multiagent chemotherapy that included daunorubicin."],
        [2018, "The current standard of care for the treatment of patients with newly diagnosed AML (AML) is an anthracycline plus cytarabine."],
        [2014, "Furthermore, Se-REPS exhibited comparable in vivo antitumor efficacy to cyclophosphamide at same concentrations."],
        [1996, "Complete remission was obtained following standard chemotherapy for AML (doxorubicin, cytosin-arabinoside, thioguanine)."],
        [2015, "Dose-adjusted arsenictrioxide for AML in chronic renal failure."],
        [2010, "Induction chemotherapy usually consisted of vincristine, cyclophosphamide, cisplatin, and etoposide."],
        [2021, "Importance of monitoring arsenic methylation metabolism in AML patients receiving the treatment of arsenictrioxide."],
        [2021, "Neutral polysaccharide from Panax notoginseng enhanced cyclophosphamide antitumor efficacy in hepatoma H22-bearing mice."],
        [1996, "Peripheral administration of a mu-opioid agonist did not reduce vincristine-induced acute hyperalgesia."],
        [2020, "arsenictrioxide (arsenictrioxide) has been proved useful for the treatment of AML (APL)."],
        [2016, "The clinical use of arsenictrioxide (arsenictrioxide) for treating AML (APL) is limited due to its severe cardiotoxicity."],
        [1989, "The role of low-dose cytarabine and aggressive chemotherapy in advanced myelodysplastic syndromes."],
        [2018, "A dexamethasone, melphalan, actinomycind and cytarabine chemotherapy protocol as a rescue treatment for feline lymphoma."],
        [2015, "dexamethasone exerted profound effects on both TTFields and chemotherapy efficacy resulting in lower patient OS."],
        [2017, "Chidamide in FLT3-ITD positive AML and the synergistic effect in combination with cytarabine."],
        [2010, "Adjuvant chemotherapy with cisplatin and vincristine was started following tumor resection."],
        [1997, "Ultrastructure of myelinated fibers of sciatic nerve in acute vincristine intoxication."],
        [2019, "Effect of combination of all-trans retinoic acid and arsenictrioxide on apoptosis of AML cells."],
        [1993, "Therapeutic efficacy of new dimercaptosuccinic acid (DMSA) analogues in acute arsenictrioxide poisoning in mice."],
        [2022, "In patients with mTP53 AML and MDS, post-HCT maintenance therapy with eprenetapopt combined with azacitidine was well tolerated."],
        [2021, "We used MTT assays, Transwell assays, and flow cytometry to measure the anti-tumor effects of ivosidenib in NSCLC cells."],
        [2015, "arsenictrioxide (As(2)O(3)), which induces demethylation of DNA and causes apoptosis, has been used as an anti-tumor agent."],
        [2011, "Phase 1 and pharmacokinetic study of bolus-infusion alvocidib followed by cytarabine and mitoxantrone for acute leukemias."],
        [2021, "Vincristine induced neurotoxicity in children who underwent chemotherapy for acute lymphoblastic leukemia and Wilms tumor."],
        [2007, "Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine."],
        [2009, "Taken together, these findings demonstrate that dCK can regulate the in vitro cellular response to cytarabine in AML cells."],
        [2019, "Factors affecting thrombohemorrhagic early death in patients with AML treated with arsenictrioxide alone."],
        [2004, "Early occurrence of AML following adjuvant radiotherapy and higher cumulative dose of cyclophosphamide in carcinoma breast."],
        [2017, "Afterwards, he received rituximab combined with chemotherapy and local radiotherapy."],
        [2021, "Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with AML."],
        [2007, "Arsenic in the cerebrospinal fluid of a patient receiving arsenictrioxide for relapsed AML with CNS involvement."],
        [1999, "midostaurin showed in vivo antitumor activity as single agent and inhibited angiogenesis in vivo."],
        [2015, "arsenictrioxide has been successfully used for the treatment of patients with AML (APL) worldwide."],
        [2020, "Disulfiram/cytarabine eradicates a subset of AML stem cells with high aldehyde dehydrogenase expression."],
        [2000, "In vivo we did not find a significant influence of rhIGF-I on HxRh30 cell growth, or on the antitumor activity of vincristine."],
        [2022, "Intensive LMBbased chemotherapy with rituximab achieved excellent survival in children/adolescents with PMLBL."],
        [2019, "Toward Candidate Proteomic Biomarkers in Clinical Monitoring of AML Treatment with arsenictrioxide."],
        [2012, "She received radiotherapy and chemotherapy by vincristine, actinomycind, doxorubicin, and ifosfamide."],
        [2022, "There is tremendous use of Venetoclax for AML recently specially in unfit and elderly population."],
        [2017, "We compared 92 and 107 patients treated, respectively, with intensive chemotherapy or azacitidine within two centres."],
        [2015, "All 86 patients completed one cycle of chemotherapy with cisplatin or lobaplatin in combination with MMC and vincristine."],
        [2014, "Cationic lipid-conjugated dexamethasone as a selective antitumor agent."],
        [2012, "These results show that hesperidin interacts with cyclophosphamide to inhibit its antitumor effect."],
        [2001, "A better controlled regimen for administering vincristine and intrathecal chemotherapy is recommended."],
        [2015, "Retinoic acid and arsenictrioxide trigger degradation of mutated NPM1, resulting in apoptosis of AML cells."],
        [1996, "All patients with relapsed or persistent AML had been pretreated with idarubicin and cytarabine."],
        [2006, "dexamethasone mediates protection against acute pancreatitis via upregulation of pancreatitis-associated proteins."],
        [2022, "Intensified-Dose Chemotherapy in Combination With Gemtuzumab-Ozogamicin for the Treatment of Favorable-Risk AML (AML)."],
        [2021, "Azacitidine for the treatment of patients with relapsed AML after allogeneic stem cell transplantation."],
        [1994, "Cytarabine (cytarabine) is currently used in the treatment of adult AML (AML)."],
        [1993, "Phase-II study of treatment of refractory acute leukemia with intermediate-dose cytarabine and amsacrine."],
        [2018, "Midostaurin (midostaurin) is being investigated for the treatment of AML (AML) and advanced systemic mastocytosis (advSM)."],
        [2021, "Data on the use of azacitidine and decitabine as salvage therapy for AML are limited."],
        [1980, "teniposide and cytarabine combination chemotherapy for initial induction failures in childhood lymphocytic leukemia."],
        [1986, "A comparison of in vitro sensitivity of AML precursors to mitoxantrone, 4'deoxydoxorubicin, idarubicin and daunorubicin."],
        [2009, "MEK inhibitors potentiate dexamethasone lethality in acute lymphoblastic leukemia cells through the pro-apoptotic molecule BIM."],
        [1987, "High-dose etoposide with intermediate-dose cytarabine in the treatment of relapsed acute nonlymphocytic leukemia."],
        [2015, "Icariin enhanced the in vitro antitumor activity of arsenictrioxide against APL."],
        [2018, "Synergistic suppression effect on tumor growth of AML by combining cytarabine with an engineered oncolytic vaccinia virus."],
        [2016, "and abrogated resistance to cytarabine in AML cells cocultured with HS-5 stromal cells."],
        [1981, "A clinical trial of pyrazofurin in combination with azacitidine in acute adult nonlymphocytic leukemia."],
        [2018, "Cytarabine has been an integral part of AML (AML) chemotherapy for over four decades."],
        [2021, "An Outcome Analysis of Childhood AML Treated with Atra and arsenictrioxide, and Limited Dose Anthracycline."],
        [2021, "Cost-Effectiveness Analysis of gemtuzumab-ozogamicin for First-Line Treatment of Patients with Cd-33 Positive AML in Spain."],
        [2021, "Randomized evaluation of quizartinib and low-dose cytarabine vs low-dose cytarabine in older AML patients."],
        [2018, "Retinoic acid and arsenictrioxide sensitize AML cells to ER stress."],
        [2013, "Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo."],
        [2021, "Another drug, arsenictrioxide (arsenictrioxide) or arsenic drug (RIF), exerts antitumor effects via inducing DNA damage."],
        [2018, "arsenictrioxide disrupts MDM2-DAXX-HAUSP complex and activates p53, cell cycle regulation and apoptosis in acute leukemia cells."],
        [2021, "Whether DCK mutations make AML cells resistant to cytarabine is controversial."],
        [2022, "Real-World Experience of Measurable Residual Disease Response and Prognosis in AML Treated with Venetoclax and Azacitidine."],
        [2013, "PI-103 sensitizes AML stem cells to daunorubicin-induced cytotoxicity."],
        [2012, "Interstitial pneumonitis is a rare complication of docetaxel/cyclophosphamide chemotherapy that carries a high mortality rate."],
        [1987, "In vitro and in vivo enhancement of vincristine antitumor activity on B16 melanoma cells by calcium antagonist flunarizine."],
        [2020, "dexamethasone enhances the antitumor efficacy of Gemcitabine by glucocorticoid receptor signaling."],
        [2008, "Acute intestinal pseudo-obstruction after induction treatment of relapsed AML with arsenictrioxide."],
        [2013, "azacitidine and lenalidomide both have meaningful single-agent clinical activity in HR-MDS and AML with del(5q)."],
        [2012, "The patient recovered well from surgery, and mitoxantrone chemotherapy was administered."],
        [1993, "This led us to administer fludarabine and cytarabine to 59 patients with AML in relapse or unresponsive to initial therapy."],
        [1996, "Pharmacokinetics and antitumor effects of mitoxantrone after intratumoral or intraarterial hepatic administration in rabbits."],
        [2017, "The standard therapy protocol included high-dose methotrexate (intravenous and intrathecal) and chemotherapy with cytarabine."],
        [2011, "dexamethasone (DXN) is an effective anti-inflammatory drug in the treatment of acute and chronic eye disease such as uveitis."],
        [2018, "The antitumor effects of 5 azacitidine were examined in cultured HCC cells and patient derived xenograft (PDX) models."],
        [2022, "Twenty-one patients were treated with chemotherapy plus rituximab."],
        [2022, "Thioguanine, a chemotherapy drug used to treat acute lymphoblastic leukemia, has been shown to cause VOD/SOS."],
        [2015, "Secondary AML arising early after cyclophosphamide treatment."],
        [1976, "A comparative clinical trial of azacitidine and guanazole in previously treated adults with acute nonlymphocytic leukemia."],
        [2011, "This study was designed to examine the role of autophagy in the death of human AML NB4 cells initiated by arsenictrioxide."],
        [2022, "PCE may become a potential supportive treatment in patient to whom cyclophosphamide-based chemotherapy is used."],
        [1986, "5-Iminodaunorubicin is an anthracycline derivative exhibiting promising antitumor activity."],
        [2022, "From 2008, rituximab was added before each chemotherapy course."],
        [2012, "Dynamics of antitumor resistance after cyclophosphamide injection."],
        [1999, "Acute pancreatitis in AML (AML) has been rarely associated with cytarabine therapy."],
        [2020, "Venetoclax and alvocidib are both cytotoxic to AML cells resistant to cytarabine and clofarabine."],
        [2021, "Deoxycytidine Kinase (DCK) Mutations in Human AML Resistant to Cytarabine."],
        [2014, "Adding ascorbic acid to arsenictrioxide produces limited benefit in patients with AML excluding AML."],
        [2020, "The economic research of arsenictrioxide for the treatment of newly diagnosed AML in China."],
        [2018, "This study investigated whether arsenictrioxide has an antitumor effect on glioma and explored the underlying mechanism."],
        [2021, "One could reasonably expect other subsets of AML to benefit from this regimen or other applications of venetoclax combinations."],
        [2015, "high-dose cytarabine therapy followed by allo-HSCT could improve the prognosis of MK-positive AML patients."],
        [2020, "Effect of daunorubicin on AML cells using nuclear magnetic resonance spectroscopy-based metabolomics."],
        [2019, "Post-Myelofibrosis AML Effectively Treated with a Combination of Ruxolitinib and azacitidinecytidine."],
        [1981, "High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children."],
        [2021, "The BCL2 inhibitor, venetoclax, has transformed clinical care in AML (AML)."],
        [1994, "mitoxantrone and standard dose cytarabine therapy in refractory or relapsed acute leukemia."],
        [2019, "Topoisomerase inhibitor mitoxantrone was the least effective drug against NUP98-NSD1+/FLT3-ITD+ AML cells."],
        [1985, "A therapeutic trial with low-dose cytarabine in myelodysplastic syndromes and acute leukemia."],
        [1984, "Daunorubicin-arachidonic acid complex as a potential new antitumor agent."],
        [2008, "Protamine sulfate and cyclophosphamide were used to induce acute bladder inflammation."],
        [1996, "Steady progress has been made in the treatment of AML since the discovery of daunorubicin in the 1960s."],
        [2017, "However, the molecular mechanism of arsenictrioxide-triggered anti-tumor activity has not been fully elucidated."],
        [2010, "Currently, treatment of childhood acute lymphoblastic leukemia (ALL) includes cytarabine, especially in high-risk patients."],
        [2018, "The proportion of patients with AML (AML) cured is increased by administering high-dose cytarabine (HiDAC)."],
        [2020, "arsenictrioxide has shown a strong anti-tumor effect with little toxicity when used in the treatment of AML (APL)."],
        [2002, "arsenictrioxide has shown substantial efficacy in treating both newly diagnosed and relapsed patients with AML (APL)."],
        [1995, "Such an effect will be concerned with the antitumor activity of daunorubicin."],
        [2009, "Their in vitro cytotoxicity and in vivo anti-tumor activity were determined and compared with that of cytarabine."],
        [2020, "MicroRNA-143 sensitizes AML cells to cytarabine via targeting ATG7- and ATG2B-dependent autophagy."],
        [2010, "arsenictrioxide (As(2)O(3)) is widely used to treat AML (APL)."],
        [2021, "To investigate the curative effects of montmorillonite powder combined with dexamethasone on acute radiation enteritis."],
        [1999, "Pancreatitis in the setting of AML therapy may be an infrequent and self-limited toxicity of cytarabine."],
        [1997, "Thus the Ce(IV)-mitoxantrone complex may become a more potent antitumor drug than mitoxantrone."],
        [2021, "We report 7 relapsed/refractory (R/R) AML (AML) patients treated with venetoclax and hypomethylating agents (HMA)."],
        [2019, "One shot NEPA plus dexamethasone to prevent multiple-day chemotherapy in sarcoma patients."],
        [2015, "Lack of vincristine infiltrates in patients with retinoblastoma receiving chemotherapy by peripheral intravenous lines."],
        [2010, "Effect of genetic alterations of cytarabine- metabolizing enzymes in childhood acute lymphoblastic leukemia."],
        [2014, "The use of vincristine, a known antitumor agent, in hepatoma therapy is limited particularly because of its toxic effect."],
        [1986, "Patients with prior chemotherapy or radiotherapy received 1000 mg/m2 of cyclophosphamide."],
        [2009, "cytarabine (cytarabine, Cytarabine) is one of the drugs used for acute nonlymphocytic leukemia (ANLL)."],
        [2017, "Eating behavior during dexamethasone treatment in children with acute lymphoblastic leukemia."],
        [2018, "Cytarabine (cytarabine) is the backbone of AML (AML) chemotherapy."],
        [2021, "arsenictrioxide [ATO, inorganic arsenite (iAsIII) in solution] plays an important role in the treatment of AML (APL)."],
        [1990, "The alkaloid vincristine is used for the chemotherapy of tumours in man."],
        [2001, "Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia."],
        [2011, "arsenictrioxide (arsenictrioxide) treatment induces clinical remission in AML patients."],
        [2003, "The interaction of daunorubicin and mitoxantrone with the red blood cells of AML patients."],
        [2010, "All patients received 3-drug chemotherapy with vincristine, actinomycind, and doxorubicin."],
        [2021, "Oral arsenictrioxide (arsenictrioxide) has demonstrated a favorable clinical efficiency in the treatment of AML (APL)."],
        [2022, "arsenictrioxide (arsenictrioxide) treats AML (APL)."],
        [2018, "Comprehensive cytarabine SNP score predicts leukemic cell intracellular ara-CTP levels in pediatric AML patients."],
        [2011, "Sixteen patients (89%) were treated with chemotherapy that consisted of procarbazine, nimustine (ACNU) and vincristine."],
        [2015, "We previously reported that FLT3-ITD confers resistance to cytarabine (cytarabine), a key cytotoxic agent in AML treatments."],
        [1972, "Fourty-four patients with AML were treated with RP 22050, a new, semisynthetic derivative of daunorubicin."],
        [2022, "Venetoclax is a highly selective, potent, oral BCL-2 inhibitor that induces apoptosis in AML cells."],
        [1991, "Growth factors also affect the sensitivity of AML blast cells to cytarabine (cytarabine)."],
        [2017, "Glucocorticoid, such as dexamethasone (Dex) is often used along with chemotherapy to antagonize side effects of chemotherapy."],
        [2013, "Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia."],
        [2022, "Midostaurin combined with ATRA exerts antitumor activity against AML with wild-type FLT3 mutations in vitro and in vivo."],
        [2011, "Synthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticles."],
        [2002, "arsenictrioxide (arsenictrioxide) has been reported to be a safe and effective treatment for relapsed AML (APL)."],
        [2010, "We suggest that higher levels of cure can be obtained in DS-ML with SD chemotherapy including cytarabine and anthracyclines."],
        [1995, "Characteristic antitumor activity of cytarabine ocfosfate against human colorectal adenocarcinoma xenografts in nude mice."],
        [2013, "Monosomal karyotype improves IPSS-R stratification in MDS and AML patients treated with Azacitidine."],
        [2019, "BRD4 Inhibition Enhances azacitidine Efficacy in AML and Myelodysplastic Syndromes."],
        [1970, "Combination chemotherapy using L-asparaginase, daunorubicin, and cytarabine in adults with AML."],
        [2016, "FLT3 is implicated in cytarabine transport by human equilibrative nucleoside transporter 1 in pediatric acute leukemia."],
        [2022, "Translatome changes in AML cells post exposure to pegcrisantaspase and venetoclax."],
        [2021, "CD44 loss of function sensitizes AML cells to the BCL-2 inhibitor venetoclax by decreasing CXCL12-driven survival cues."],
        [2021, "Venetoclax combines synergistically with FLT3 inhibition to effectively target leukemic cells in FLT3-ITD+ AML models."],
        [1989, "Idarubicin in combination with intermediate-dose cytarabine in the treatment of refractory or relapsed acute leukemias."],
        [2020, "arsenictrioxide alleviates acute graft-versus-host disease by modulating macrophage polarization."],
        [1989, "The urine of a patient who suffered from AML was red coloured after administration of mitoxantrone and etoposid."],
        [2014, "Metronomic cyclophosphamide is an active and well tolerated chemotherapy and can be an option for metastatic CRPC patients."],
        [2007, "Feasibility and efficacy of chemotherapy with gemcitabine mono and with paclitaxel/mitoxantrone in gynaecological cancers."],
        [2022, "We hypothesized that the pretreatment with G-CSF may enhance the antitumor effect of arsenictrioxide in non-APL AML cells."],
        [2009, "Combined chemotherapy with CHOP (cyclophosphamide, doxorubicin, vincristine and prednisone) and rituximab."],
        [2019, "Knockdown of MALAT1 inhibited the proliferation, induced apoptosis, and enhanced cytarabine sensitivity of AML cells."],
        [2004, "Arsenic speciation in urine from AML patients undergoing arsenictrioxide treatment."],
        [2003, "Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma."],
        [2021, "We report here that cytarabine (cytarabine) treatment elevates DANCR expression in human AML cells."],
        [1985, "Synthesis and antitumor activity of 3'-C-methyl-daunorubicin."],
        [2008, "gemtuzumab-ozogamicin (gemtuzumab-ozogamicin) is effective as single agent in the treatment of AML (AML)."],
        [2022, "AHA STEROID trial, dexamethasone in acute high-risk abdominal surgery, the protocol for a randomized controlled trial."],
        [2015, "Induction of AML with Idarubicin, Cytarabine and Cladribine."],
        [1986, "cyclosporine A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro."],
        [1993, "Infusion of fludarabine before cytarabine augments the rate of ara-CTP synthesis in circulating AML blasts during therapy."],
        [2022, "Recently, venetoclax-based regimens have become the standard of care for patients with newly diagnosed AML who are unfit for IC."],
        [2015, "Three patients underwent only the chemotherapy of vincristine."],
        [2012, "dexamethasone (1 mg/kg) was given by intramuscular injection 1 h after acute pancreatitis."],
        [2011, "Palonosetron (0.25 mg IV) and dexamethasone (8 mg IV) were administered before chemotherapy on day 1."],
        [2017, "Long-term outcome of AML treated with all-trans-retinoic acid, arsenictrioxide, and gemtuzumab."],
        [2020, "Midostaurin, a multikinase inhibitor, is approved for treatment of FLT3-mutant AML (AML)."],
        [1998, "arsenictrioxide was administered intravenously at the dose of 10 mg per day for the treatment of 8 relapsed AML (APL) patients."],
        [2021, "The hypomethylating agents (HMA) decitabine and azacitidine are used in AML (AML) for induction therapy in select patients."],
        [2008, "The microtubule-depolymerizing drug, vincristine, is effective in the treatment of acute lymphoblastic leukemia (ALL)."],
        [1988, "In vivo uptake of daunorubicin by AML (AML) cells measured by flow cytometry."],
        [2019, "Cytarabine (cytarabine) is a nucleoside analog used in the treatment of AML (AML)."],
        [2014, "Maintenance chemotherapy consisted of eight courses (vincristine, lomustine, cisplatin)."],
        [2012, "Anti-inflammatory efficacy of dexamethasone and Nrf2 activators in the CNS using brain slices as a model of acute injury."],
        [1988, "A case of persistent cerebellar dysfunction following high-dose cytarabine (cytarabine) treatment of AML is reported."],
        [2022, "arsenictrioxide for AML in a patient on chronic hemodialysis."],
        [2021, "Venetoclax plus low-dose cytarabine was well tolerated in Japanese patients with AML ineligible for intensive chemotherapy."],
        [2005, "The patient was treated with chemotherapy (etoposide, vincristine, doxorubicin, ifosfamide and dactinomycin) and radiotherapy."],
        [2022, "vyxeos and venetoclax and azacitidine (ven/aza) are both indicated as initial therapy for AML (AML) in older adults."],
        [2020, "A RAF-1/MEK/ERK pathway was founded to be associated with enasidenib and ATRA-induced differentiation in IDH2-mutant AML cells."],
        [1992, "CNDAC had a unique in vitro antitumor spectrum for human cancers different from that of cytarabine."],
        [1980, "Infusion chemotherapy in all patients was based on fluorouracil, Mitomycin and Vincristine."],
        [2013, "In this review, we present a reappraisal of the usefulness of high-dose cytarabine for AML treatment."],
        [2009, "However, the anti-tumor effect of weekly cyclophosphamide (CPA) treatment (140 mg/kg BW i.p.)"],
        [2022, "These findings support gilteritinib for FLT3-mutated R/R AML after prior sorafenib or midostaurin."],
        [1996, "Daunorubicin-induced internucleosomal DNA fragmentation in acute myeloid cell lines."],
        [2022, "The combination of dactolisib and venetoclax exhibits a synergistic anti-tumor effect in AML by down-regulating MCL-1 protein."],
        [2007, "Vincristine is one of the frontline chemotherapy drugs for the treatment of numerous lymphoid neoplasias."],
        [2021, "KDM4C contributes to cytarabine resistance in AML via regulating the miR-328-3p/CCND2 axis through MALAT1."],
        [2017, "Long-term consequences of topical dexamethasone treatment during acute corneal HSV-1 infection on the immune system."],
        [2021, "The patient was given chemotherapy with VDPI regimen (Vinorelbine, daunorubicin, 6alpha-methylprednisone, imatinib)."],
        [1975, "Synthesis and antitumor activity of cyclophosphamide analogs."],
        [2022, "daunorubicin (DN) is a well-known chemotherapy drug frequently used in treating acute myeloid and lymphoblastic leukemia."],
        [1988, "Daunorubicin in patients with relapsed and refractory AML previously treated with anthracycline."],
        [2010, "DCE parameters (V(p) and K(ep)) were identified as a relevant endpoints for cyclophosphamide chemotherapy in our tumor models."],
        [2019, "Thus, curcumin and tetrahydrocurcumin have potential applications in the treatment of AML with cytarabine resistance."],
        [2016, "dexamethasone-induced acute excitotoxic cell death in the developing brain."],
        [2015, "Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia."],
        [2020, "Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in AML models."],
        [2006, "Cross-resistance to cytarabine in human AML cells selected for resistance to vincristine."],
        [1998, "Evaluation of single-agent mitoxantrone as chemotherapy for relapsing canine lymphoma."],
        [2017, "The antitumor effect of arsenictrioxide on hepatocellular carcinoma is enhanced by andrographolide."],
        [2021, "DNA-thioguanine nucleotide as a treatment marker in acute lymphoblastic leukemia patients with NUDT15 variant genotypes."],
        [2015, "Unusual massive bone marrow fibrosis in AML following arsenictrioxide therapy."],
        [2020, "arsenictrioxide (TX) is successfully used for both de novo and relapsed AML (APL) treatment."],
        [2019, "High-dose cytarabine is the backbone of AML (AML) treatment."],
        [2022, "Patients received 2 mg of dexamethasone daily from days 2 to 6 after chemotherapy with pemetrexed."],
        [2017, "Thereafter, AML was treated with azacitidine."],
        [2010, "arsenictrioxide, the trade name arsenictrioxide, is a drug used to treat acute promyleocytic leukemia (APL)."],
        [2010, "Optimization of vincristine-topotecan combination--paving the way for improved chemotherapy regimens by nanoliposomes."],
        [1984, "Pericarditis with tamponade developed in a patient treated with high-dose cytarabine for acute lymphocytic leukemia."],
        [1996, "Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas."],
        [2009, "Cytarabine (cytarabine) is the key agent for treating AML (AML)."],
        [1993, "These results might explain the previously reported sequence dependency of the antitumor effect of etoposide and cytarabine."],
        [2011, "arsenictrioxide (arsenictrioxide) was successfully used in the treatment of AML (APL) etc."],
        [2016, "arsenictrioxide (As(III) in solution) has been shown to be the most active single agent in combating AML (APL)."],
        [2015, "azacitidine may be an important treatment option for this difficult-to-treat AML population."],
        [1988, "Neurotoxicity is the principal limiting side effect of the widely used antitumor agent, vincristine."],
        [2016, "Inhibition of Mnk enhances apoptotic activity of cytarabine in AML cells."],
        [2006, "Rituximab with or without chemotherapy was found to have major activity in patients with SMZL."],
        [1992, "The standard chemotherapy cohort received cyclophosphamide, doxorubicin, and fluorouracil."],
        [2013, "However, survival benefit from gemtuzumab-ozogamicin was not associated with MFC-MRD chemotherapy sensitivity."],
        [1988, "Interleukin 3 enhances the cytotoxic activity of cytarabine (cytarabine) on AML (AML) cells."],
        [2012, "arsenictrioxide (arsenictrioxide) has been successfully used as a treatment for AML (APL) for more than a decade."],
        [2017, "cytarabine (cytarabine) is one of the key drugs for treating AML (AML)."],
        [1990, "In addition, the records of all pediatric oncology patients who received high-dose cytarabine (HDAC) chemotherapy were reviewed."],
        [2013, "arsenictrioxide (arsenictrioxide) shows substantial anticancer activity in patients with AML (APL)."],
        [1998, "Seven relapsed and/or refractory AML patients were treated by arsenictrioxide (arsenictrioxide)."],
        [2021, "Moreover, combination of Tomivosertib and Venetoclax resulted in synergistic anti-leukemic responses in AML cell lines."],
        [2009, "arsenictrioxide has been used as a therapeutic agent for AML and recently for some solid tumors."],
        [1978, "Normal infant after treatment of AML in pregnancy with daunorubicin."],
        [2020, "All‑trans retinoic acid (ATRA) and arsenictrioxide (arsenictrioxide) are currently first‑line treatments for AML (APL)."],
        [2019, "Induction schedules in AML (AML) are based on combinations of cytarabine and anthracyclines."],
        [2005, "Cyclophosphamide is an alkylating agent widely used from cancer chemotherapy to immunotherapy purposes."],
        [2004, "Toll-like receptors 2 and 4, and acute phase cytokine gene expression in dexamethasone and growth hormone treated dairy calves."],
        [2011, "We identified 3888 patients with M1 PC, of whom 24% (n = 930) received chemotherapy (primarily docetaxel and mitoxantrone)."],
        [2003, "arsenictrioxide (As(2)O(3)) is an effective treatment for AML (APL), but is less effective against other leukemias."],
        [2011, "Notable success was observed in the treatment of AML (APL) with arsenictrioxide (arsenictrioxide)."],
        [1993, "A 43-year-old man was treated for refractory AML with a regimen of high-dose cytarabine."],
        [2013, "However, core-binding factor (CBF) AML treated with FLAGdaunorubicinresulted in pOS of 82% versus 58% with FLAG (P =.04)."],
        [2018, "Our results demonstrated that GLUT3 plays a fundamental role in the survival and resistance of AML cells to vincristine."],
        [2021, "These data confirm the efficacy and safety of vyxeos in high-risk AML (t-AML and MRC-AML) in a real-life setting."],
        [2016, "miR-29c is of prognostic value and influences response to azacitidine treatment in older AML patients."],
        [1990, "Few acute toxic side effects were observed thanks to the constant rate of infusion of daunorubicin."],
        [2002, "We report a patient with AML who developed fulminant rhabdomyolysis after treatment with a cytarabine-containing regimen."],
        [1993, "A young patient with AML was treated with high-dose cytarabine (3.0 g/m2 every 12 hours)."],
        [2005, "The purine antimetabolite, thioguanine (6-TG), is an effective drug in the management of acute leukemias."],
        [2021, "The combination effects of ST1326 and venetoclax were studied in AML cells and primary patients."],
        [2015, "Azacitidine access program for Belgian patients with myelodysplastic syndromes, AML or chronic myelomonocytic leukemia."],
        [1989, "Eight patients with AML were treated with a combination of daunorubicin (1.5 mg/kg body weight) and cytarabine."],
        [2021, "Analysis of gamma-glutamyltransferase in AML patients undergoing arsenictrioxide treatment."],
        [2007, "Comparative efficacy of dexamethasone versus hydrocortisonecypionate in severe acute pediatric asthma."],
        [2022, "BCL-2 inhibition has been shown to be effective in AML (AML) in combination with hypomethylating agents or low-dose cytarabine."],
        [2020, "High-definition ultrasound characterization of acute cyclophosphamide-induced cystitis in the mouse."],
        [2019, "With the introduction of arsenictrioxide and all-trans retinoic acid, the prognosis of AML has greatly improved."],
        [2017, "Combination of bortezomib and daunorubicin in the induction of apoptosis in T-cell acute lymphoblastic leukemia."],
        [2014, "ABT-737, Synergistically Enhances Daunorubicin-Mediated Apoptosis in AML Cell Lines."],
        [2021, "High-dose cytarabine-containing chemotherapy showed significant clinical benefit in 5-year OS (72.1% vs. 55.9%, p = 0.010)."],
        [1984, "mitoxantrone in the treatment of relapsed and refractory acute leukemia."],
        [1983, "Twenty-six patients with acute leukemia in relapse were treated with mitoxantrone (dihydroxyanthracenedione dihydrochloride)."],
        [2016, "mitoxantrone and Etoposide for the Treatment of AML Patients in First Relapse."],
        [2020, "We identified 122 proteins whose conjugation by these posttranslational modifiers marks AML resistance to DNR and/or cytarabine."],
        [2008, "All-trans-retinoic acid (ATRA) and arsenictrioxide (arsenictrioxide) induce differentiation and apoptosis in AML (APL) cells."],
        [2018, "Emodin and Its Combination with Cytarabine Induce Apoptosis in Resistant AML Cells in Vitro and in Vivo."],
        [2012, "Potentiation of vincristine toxicity with concomitant fluconazole prophylaxis in children with acute lymphoblastic leukemia."],
        [1997, "We have used Xenopus egg extracts to investigate the effects of the antitumor drug daunorubicin on DNA replication in vitro."],
        [1990, "Seventeen of 40 patients (42%) with AML (AML) achieved CR, including 6 of 20 (30%) with high-dose cytarabine resistance."],
        [2021, "Midostaurin was registered in combination with chemotherapy to treat newly diagnosed AML."],
        [1995, "Etoposide/cytarabine proved to be the most emetogenic of the chemotherapy treatments studied."],
        [1984, "The current status of, and the future prospects for, low-dose cytarabine therapy in patients with AML is discussed."],
        [2002, "Synergic effects of arsenictrioxide and cAMP during AML cell maturation subtends a novel signaling cross-talk."],
        [2012, "Feasibility of azacitidine added to standard chemotherapy in older patients with AML--a randomised SAL pilot study."],
        [2018, "arsenictrioxide (arsenictrioxide) has a dramatic therapeutic effect on AML (APL) patients."],
        [1981, "Sequential combination of pyrazofurin and azacitidine in patients with AML and carcinoma."],
        [2019, "To date, the first-line treatment of AML is still based on daunorubicin and cytarabine or idarubicin and cytarabine regimen."],
        [2011, "Treatment of AML cells, that have RIZ1 methylation, with azacitidine-dC, induced growth suppression with RIZ1 restoration."],
        [2008, "A role for altered microtubule polymer levels in vincristine resistance of childhood acute lymphoblastic leukemia xenografts."],
        [2018, "arsenictrioxide (arsenictrioxide) has attracted wide attention owing to its antitumor activities."],
        [1984, "High-dose cytarabine and amsacrine is effective therapy in relapsed acute nonlymphocytic leukemia."],
        [2007, "dexamethasone-induced apoptosis in acute lymphoblastic leukemia involves differential regulation of Bcl-2 family members."],
        [1983, "Sequential studies on the role of mitoxantrone in the treatment of acute leukemia."],
        [2005, "Daunorubicin (daunorubicin) is commonly used to treat AML (AML)."],
        [2002, "Daunorubicin was administered as single chemotherapy to 70% of the patients."],
        [1998, "Cranial irradiation and permeability of blood-brain barrier to cytarabine in children with acute leukemia."],
        [2020, "Phase 2 study of hyper-CMAD with liposomal vincristine for patients with newly diagnosed acute lymphoblastic leukemia."],
        [2021, "Targeting NF-κB-dependent alkaliptosis for the treatment of venetoclax-resistant AML cells."],
        [2008, "In AML and APL cell lines, but not primary patient samples, basal catalase levels matched sensitivity to arsenictrioxide."],
        [2022, "Cytarabine based therapy has been the standard consolidation regimen for AML (AML) for decades."],
        [2017, "Sorafenib and azacitidine as salvage therapy for relapse of FLT3-ITD mutated AML after allo-SCT."],
        [1984, "Combination chemotherapy with fluorouracil, lomustine, and vincristine in metastatic colorectal carcinoma."],
        [2002, "Atypical blasts and bone marrow necrosis associated with near-triploid relapse of AML after arsenictrioxide treatment."],
        [2015, "Budgetary impact of treating AML patients with first-line arsenictrioxide and retinoic acid from an Italian payer perspective."],
        [1993, "All responders to cyclophosphamide were patients who had not received prior chemotherapy (13% of 38 patients)."],
        [2006, "arsenictrioxide (arsenictrioxide) is a potent antitumor agent used to treat AML (APL) and, more recently, solid tumors."],
        [2021, "Successful treatment of AML in a patient undergoing hemodialysis with arsenictrioxide."],
        [2022, "Venetoclax (VEN), an anti-tumor drug that is a substrate of cytochrome P450 3A enzyme (CYP3A4), is used to treat leukemia."],
        [2015, "Cyclophosphamide related AML is seen, in most cases, many years after exposure to the drug."],
        [1986, "A case of persistent cerebellar toxicity following systemic high dose cytarabine (HDCA) treatment of AML is reported."],
        [2020, "Here, we report that cytarabine treatment reduces miR-143 expression in AML cell lines and primary AML cells."],
        [2019, "The BCL-2 inhibitor venetoclax demonstrated activity as monotherapy and in combination with chemotherapy or HMA in AML."],
        [2022, "Venetoclax synergizes with Gilteritinib in FLT3 wildtype high-risk AML by suppressing MCL-1."],
        [2017, "Toxic epidermal necrolysis after actinomycind and vincristine combination chemotherapy for nephroblastoma."],
        [1999, "Furthermore, prophylactic systemic chemotherapy with cytarabine and etoposide was added."],
        [2005, "We report 2 cases of reticulate hyperpigmentation associated with cancer chemotherapy with fluorouracil and idarubicin."],
        [2001, "arsenictrioxide has been shown to be effective in treating AML (APL), with minimal overall toxicity reported to date."],
        [1995, "An effective salvage regimen with aclarubicin for daunorubicin-resistant AML in children."],
        [2018, "This study examined how cyclophosphamide, a chemotherapy drug, affects salt taste in mice."],
        [2004, "Pharmacokinetics of erythrocyte-bound daunorubicin in patients with acute leukemia."],
        [1997, "Cytarabine is a useful agent in the management of acute leukemias, but is not thought to have activity in solid tumours."],
        [2022, "Azacitidine maintenance in AML post induction and posttransplant."],
        [1983, "Combination chemotherapy involving eflornithine and cytarabine in murine L1210 leukemia."],
        [1991, "Drug resistance is one of the major reasons for failure of chemotherapy of acute leukemia with cytarabine (cytarabine)."],
        [2017, "combination effects of arsenictrioxide and sorafenib in two AML cell lines, KG-1 and U937."],
        [2018, "Combined treatment with a PARP inhibitor and daunorubicin had an additive effect on the killing of IDH1/2MUT AML cells."],
        [2006, "Cyclophosphamide (CP), an alkylating agent widely used in cancer chemotherapy causes fatal cardiotoxicity."],
        [2018, "Daunorubicin and Cytarabine Liposome in Newly Diagnosed Therapy-Related AML (AML) or AML With Myelodysplasia-Related Changes."],
        [2010, "Today, arsenictrioxide is used as one of the standard therapies for AML (APL)."],
        [1996, "mitoxantrone provided efficient antitumor therapy without producing major side effects."],
        [2002, "High-dose cytarabine as consolidation treatment for patients with AML with t(8;21)."],
        [1990, "The toxicity and antitumor activity of liposomal vincristine preparations have been examined."],
        [2001, "Chemotherapy for treatment of AML with fludarabine, cytarabine."],
        [1984, "Systemic chemotherapy with doxorubicin, cytarabine."],
        [1990, "mitoxantrone is effective therapy for patients with acute leukemia and blastic phase of chronic myelogenous leukemia (CML)."],
        [2015, "The effects of dexamethasone on sleep in young children with acute lymphoblastic leukemia."],
        [2019, "Midostaurin added to intensive chemotherapy is approved in FLT3-mutated AML."],
        [2008, "Mitomycin C and cyclophosphamide are well known anti-tumor drugs."],
        [1985, "Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas."],
        [2000, "Vincristine-induced apoptosis in vivo in peripheral blood mononuclear cells of children with acute lymphoblastic leukemia (ALL)."],
        [2019, "A phase II study of guadecitabine in higher-risk myelodysplastic syndrome and low blast count AML after azacitidine failure."],
        [2013, "azacitidinecytidine treatment for relapsed or refractory AML after intensive chemotherapy."],
        [1997, "These improvements in the mode of administering cytarabine could provide better results following chemotherapy for leukemia."],
        [2021, "EVs derived from both new cases and relapsed AML patients significantly reduced idarubicin-induced apoptosis in the U937 cells."],
        [1990, "Acute toxicity from BOPP (carmustine, vincristine, procarbazine, cisplatinum) chemotherapy for glioblastoma multiforme."],
        [2009, "arsenictrioxide may reduce hyperfibrinolysis in AML by downregulation of Ann II."],
        [2018, "Similarly for IGF1R, knockdown increased the cytarabine sensitivity of AML cell lines consistent with results in AML patients."],
        [1997, "Experimental antitumor activity of the Ce(IV)-mitoxantrone complex and its interaction with deoxyribonucleic acid."],
        [2022, "Acquired genetic mutations can confer resistance to arsenictrioxide (arsenictrioxide) in the treatment of AML (APL)."],
        [2011, "Fludarabine and cytarabine in patients with AML refractory to two different courses of front-line chemotherapy."],
        [2019, "Nucleoside analog, cytarabine (cytarabine) is the mainstay of AML (AML) chemotherapy."],
        [2020, "The AML cells overexpressing hsa-miR-12462 had increased sensitivity to cytarabine chemotherapy."],
        [2000, "Rituximab may be an ideal agent to combine with chemotherapy because of its lack of classical myelotoxicity."],
        [2010, "Urotoxicity is one of the major problems associated with cyclophosphamide (CP) chemotherapy in cancer patients."],
        [2005, "Biopsy was performed followed by chemotherapy with vincristine, cyclohexylchloroethylnitrosourea (CCNU), 6-TG, and procarbazine."],
        [2022, "Measurable Residual Disease Response and Prognosis in Treatment-Naïve AML With Venetoclax and Azacitidine."],
        [2021, "Impact of splicing mutations in AML treated with hypomethylating agents combined with venetoclax."],
        [2002, "Resistance of bcr-abl-positive acute lymphoblastic leukemia to daunorubicin is not mediated by mdr1 gene expression."],
        [2010, "High-dose chemotherapy regimens were thiotepa-based (n = 7) or melphalan and cyclophosphamide (n = 3)."],
        [1977, "N4-Behenoyl-cytarabine as a potential new antitumor agent."],
        [2015, "azacitidine seems a reasonable therapeutic option for most unfit AML patients, i.e."],
        [2011, "The efficacy of arsenictrioxide (arsenictrioxide) against AML (APL) and relapsed APL has been well documented."],
        [2013, "This study was conducted to determine the in vitro and in vivo combination effects of arsenictrioxide and chemotherapy in SCLC."],
        [1997, "Effects of a 5-HT1A receptor agonist on acute and delayed cyclophosphamide-induced vomiting."],
        [2001, "Sudden death among patients with AML treated with arsenictrioxide."],
        [1990, "Chemotherapy for AML with low-dose cytarabine (cytarabine)."],
        [2002, "Neutropenia associated with vincristine and L-asparaginase induction chemotherapy for canine lymphoma."],
        [2022, "She was treated with neoadjuvant chemotherapy of eribulin and cyclophosphamide followed by doxorubicin and cyclophosphamide."],
        [2009, "Defective expression of deoxycytidine kinase in cytarabine-resistant AML cells."],
        [2008, "To evaluate the contribution of an autophagic mechanism to the arsenictrioxide- induced death of human AML cell line HL60 cells."],
        [2019, "Cost Effectiveness of Midostaurin in the Treatment of Newly Diagnosed FLT3-Mutated AML in the United States."],
        [2022, "Combination of midostaurin and ATRA exerts dose-dependent dual effects on AML cells with wild type FLT3."],
        [2021, "It induced the DNA damage response kinase WEE1, and rendered human AML cell lines more resistant to cytarabine."],
        [1994, "The use of leukapheresis or low-dose chemotherapy (hydroxyurea or cytarabine."],
        [2005, "Notably, in comparison to the standard chemotherapy drug cytarabine (cytarabine), PTL is much more specific to leukemia cells."],
        [2003, "The most important component of the postremission chemotherapy continues to be several courses of high-dose cytarabine."],
        [1987, "Variables predicting response to high dose cytarabine therapy in patients with refractory acute leukemia."],
        [2002, "arsenictrioxide promotes histone H3 phosphoacetylation at the chromatin of CASPASE-10 in AML cells."],
        [2017, "Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated AML cells."],
        [2014, "Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemia."],
        [2009, "The antitumor activity of arsenictrioxide on retinoblastoma was investigated."],
        [1990, "Formulation, stability, and antitumor activity of cytarabine conjugate of thioether phospholipid."],
        [2016, "Cytarabine (cytarabine) is a first line clinical therapeutic agent for treatment of AML (AML)."],
        [1989, "Attenuated high-dose cytarabine in the treatment of the elderly patient with acute nonlymphocytic leukemia."],
        [2021, "MiR-15a-5p Confers Chemoresistance in AML by Inhibiting Autophagy Induced by Daunorubicin."],
        [1990, "Twenty-four patients with acute leukemia and blastic CML received mitoxantrone 20 mg/m2 I.V."],
        [1998, "vincristine (vincristine) is an active agent in the treatment of acute lymphoblastic leukemia (ALL)."],
        [1975, "had AML and developed CNS disease after 5 years' treatment with arabinofuranosylcytosine and thioguanine."],
        [2016, "cytarabine, sorafenib) in all tested AML cell lines regardless of their FLT3 mutation status."],
        [2021, "Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant."],
        [2000, "Twelve courses of CSF perfusion chemotherapy with cytarabine, MTX, and nimustinehydrochloride were administered."],
        [2019, "Daunorubicin is commonly used in the treatment of acute lymphoblastic leukemia (ALL)."],
        [2007, "To investigate the long-term outcome of idarubicin- and cytarabine-based intensive chemotherapy in adult AML (AML)."],
        [2002, "arsenictrioxide (As(2)O(3)) has been found effective in the treatment in the treatment of AML (APML)."],
        [2002, "Samples with chromosome 5/7 abnormalities were median 3.9-fold (P =.01) more resistant to cytarabine than other AML samples."],
        [2008, "Clinical efficacy of dexamethasone for acute exudative pharyngitis."],
        [2014, "Upregulation of ID2 antagonizes arsenictrioxide-induced antitumor effects in cancer cells."],
        [2022, "G-CSF upregulated the expression of AQP9 and enhanced the intracellular concentrations of arsenictrioxide in AML cells."],
        [2014, "After surgery, the dog was initiated on a chemotherapy protocol with carboplatin and metronomic cyclophosphamide."],
        [2017, "Causes and prognostic factors for early death in patients with AML treated with single-agent arsenictrioxide."],
        [1986, "Patients with AML received cytarabine, either 2 or 6 g/m2/72 h by continuous infusion."],
        [2018, "arsenictrioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD AML Cells."],
        [1987, "Etoposide in combination with cytarabine, doxorubicin, and thioguanine for treatment of AML in a protocol adjusted for age."],
        [2018, "arsenictrioxide (arsenictrioxide) is successfully used as an anticancer agent against AML and some solid tumors."],
        [2021, "azacitidine (azacitidine) is a standard of care for higher-risk myelodysplastic syndrome (MDS)/low blast-count AML (AML)."],
        [2004, "In fact, there is evidence that low-dose chemotherapy with cytarabine can induce responses in patients with MDS."],
        [1996, "Induction chemotherapy was a combination of cytarabine and mitoxantrone."],
        [2017, "In patients with AML and FA, azacitidine can be considered an alternative to conventional chemotherapy."],
        [1994, "Fludarabine has the effect of increasing the triphosphate form of cytarabine in acute and chronic leukemic cells."],
        [2018, "arsenictrioxide Enhances the NK Cell Cytotoxicity Against AML While Simultaneously Inhibiting Its Bio-Genesis."],
        [2006, "SCG shows antitumor activity and also enhances the hematopoietic response in cyclophosphamide (CY)-treated mice."],
        [2022, "Combination strategies to promote sensitivity to cytarabine-induced replication stress in AML with and without DNMT3A mutations."],
        [2014, "Azacitidine as salvage therapy for AML in a severely ill patient."],
        [1991, "A new class of cytarabine prodrug with improved antitumor activity."],
        [2018, "vincristine (vincristine) is one of the main drugs of acute lymphoblastic leukemia (ALL) treatment."],
        [2010, "Brief dexamethasone treatment during acute infection prevents virus-induced autoimmune diabetes."],
        [2015, "Inhibition of PI3K can restore cytarabine sensitivity of AML blasts at hypoxic conditions."],
        [2017, "Azacitidine or intensive chemotherapy for older patients with secondary or therapy-related AML."],
        [2022, "We found that roflumilast is efficient when combined with other chemotherapy drugs, especially cytarabine."],
        [2020, "arsenictrioxide (arsenictrioxide) is a frontline chemotherapy drug used in the therapy of AML."],
        [2013, "Day 2 and liposomalcytarabine 50 mg Day 3) followed by high-dose chemotherapy with carmustine 400 mg/m(2) i.v."],
        [2021, "Cytarabine and daunorubicin are old drugs commonly used in the treatment of AML (AML)."],
        [2022, "A phase 1b study of glasdegib + azacitidine in patients with untreated AML and higher-risk myelodysplastic syndromes."],
        [1996, "For patients with low-grade lymphoma, chemotherapy consisted of mitoxantrone 5 mg/sqm on days 1 to 3."],
        [2011, "Safety and efficacy of the immunosuppressive agent thioguanine in murine model of acute and chronic colitis."],
        [2016, "Exceptions in patterns of arsenic compounds in urine of AML patients treated with arsenictrioxide."],
        [2009, "6MP and thioguanine have long been used in cancer chemotherapy for treatment of acute lymphoblastic or myeloblastic leukemia."],
        [1998, "Overall median duration of response after mitoxantrone chemotherapy was 21 days."],
        [2018, "arsenictrioxide (arsenictrioxide) is used in the clinic for the treatment of AML by targeting the protein PML."],
        [1985, "Radiotherapy and combination chemotherapy with carmustine, vincristine, and procarbazine (BVP) in primary brain tumors."],
        [2018, "Cytarabine arabinoside (cytarabine) has been the core of chemotherapy for adult AML (AML)."],
        [2019, "HMGA2 regulates AML progression and sensitivity to daunorubicin via Wnt/β-catenin signaling."],
        [2000, "Growth and endocrine function in children with AML after bone marrow transplantation using busulfan/cyclophosphamide."],
        [1979, "High dose cytarabine (HDARAC) in refractory acute leukemia."],
        [2018, "arsenictrioxide enhance reactive oxygen species levels and induce apoptosis and suppresses proliferation in AML cells."],
        [2003, "Iontophoretic administration of dexamethasone sodium phosphate for acute epicondylitis."],
        [2010, "Cytarabine resistance characterizes relapsed and refractory AML (AML)."],
        [1998, "Nine of 15 (60%) dogs attained a complete remission with additional chemotherapy after failing mitoxantrone chemotherapy."],
        [2009, "Furthermore, the effect of axitinib on the antitumor activity of combination treatments with cyclophosphamide was examined."],
        [2008, "Nicotinic signaling ameliorates acute bladder inflammation induced by protamine sulfate or cyclophosphamide."],
        [2018, "Eugenol may be used in combination with arsenictrioxide in chemotherapy to reduce oxidative damage to the hepatic system."],
        [1984, "Initial chemotherapy ranged from single agent to three-drug combination (actinomycin, vincristine, adriamycin)."],
        [2020, "HL-60 human AML cells were used to develop the cytarabine- or clofarabine (CAFdA)-resistant variants."],
        [2003, "The disease progressed despite chemotherapy with 6alpha-methylprednisone, L-asparginase, and vincristine."],
        [2021, "Mechanisms for resistance in AML insights into molecular pathways mediating resistance to venetoclax."],
        [2015, "In total, 263 Chinese intermediate-risk AML patients treated with anthracycline and cytarabine were enrolled."],
        [2000, "Hemostatic abnormalities associated with AML and corrective effects of all-trans-retinoic acid or arsenictrioxide treatment."],
        [1991, "We present a case of hypoplastic acute leukemia, which responded well to low dose cytarabine."],
        [2008, "dexamethasone suppressed the expression of luciferase gene both in the acute sepsis model and in the acute arthritis model."],
        [2016, "Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in AML."],
        [2009, "Resistance to cytarabine (cytarabine) incapacitates the therapeutic effort during the treatment of AML (AML)."],
        [2008, "mitoxantrone-related acute leukemia in two MS patients."],
        [2020, "Differential sensitivity of AML cells to daunorubicin depends on P2X7A versus P2X7B receptor expression."],
        [2021, "Successful bridge therapy of gilteritinib to cord blood transplantation in relapsed AML after bone marrow transplantation."],
        [2011, "Vincristine is one of the cornerstones of the treatment of children with acute lymphoblastic leukemia (ALL)."],
        [2013, "The HSP90 inhibitor NVP-AUY922-AG inhibits the PI3K and IKK signalling pathways and synergizes with cytarabine in AML cells."],
        [2010, "The present data may support the use of dexamethasone to treat acute sensorineural hearing loss."],
        [2022, "Treatment of acute erythroleukemia with high-dose cytarabine in a cat with feline leukemia virus infection."],
        [2017, "A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with 30% blasts."],
        [2021, "NPPN has a potential antitumor activity for the treatment of liver cancer combined with cyclophosphamide."],
        [2014, "Knockdown of CD44 enhances chemosensitivity of AML cells to ADM and cytarabine."],
        [1985, "Radioimmunoassay for mitoxantrone, a new antitumor agent."],
        [2007, "Combined low-dose cytarabine, melphalan and mitoxantrone for older patients with AML or high-risk myelodysplastic syndrome."],
        [2015, "To highlight the acceptable results seen after use of low dose cytarabine in elderly patients of AML (AML) with comorbidities."],
        [2018, "A randomized phase 3 trial of glasdegib in combination with chemotherapy (7 + 3 schedule) is ongoing."],
        [2010, "Induction chemotherapy generally included vincristine, cisplatin or carboplatin, cyclophosphamide, and etoposide."],
        [2000, "P-glycoprotein in primary AML and treatment outcome of idarubicin/cytosine arabinoside-based induction therapy."],
        [2011, "arsenictrioxide (arsenictrioxide) is used in patients with AML and is active in vitro in several solid tumor cell lines."],
        [2011, "Use of cytarabine and idarubicin in a newly diagnosed AML patient with a severe wound."],
        [2022, "venetoclax/venetoclax potentiates the cytotoxicity of alkylating agents and fludarabine in AML cells."],
        [2020, "Safety and efficacy of arsenictrioxide and all-trans retinoic acid therapy in AML patients with a high risk for early death."],
        [2016, "Furthermore, glasdegib sensitized AML cells to cytarabine."],
        [2021, "Resistance to cytarabine is an important cause of therapy failure in persons with AML (AML)."],
        [2019, "BATF2 inhibits chemotherapy resistance by suppressing AP-1 in vincristine-resistant gastric cancer cells."],
        [1987, "A 3 1/2-yr-old boy with acute leukemia rapidly developed quadriparesis during induction treatment that included vincristine."],
        [2015, "When combined with cyclophosphamide, analog 1 enhanced the mutagenic and apoptotic effects of this anti-tumor agent."],
        [2017, "Combined anthracycline and cyclophosphamide regimens have been recently reclassified as highly emetogenic chemotherapy regimen."],
        [1994, "Accelerated chemotherapy with mitoxantrone plus g-csf in heavily pretreated patients with metastatic breast-cancer."],
        [2021, "Phase II-like murine trial identifies synergy between dexamethasone and dasatinib in T-cell acute lymphoblastic leukemia."],
        [2019, "Midostaurin offers a novel strategy to treat both FLT3-mutated AML and advanced SM."],
        [1980, "thioguanine, plus BCG may be superior to the sequence of chemotherapy regimens plus BCG which was employed."],
        [2000, "arsenictrioxide (arsenictrioxide) was recently identified as a very potent agent against AML (APL)."],
        [2006, "Among the 36 patients included, 30 could complete chemotherapy schedule, and 24/36 received rituximab."],
        [2002, "Antibody-targeted chemotherapy of older patients with AML in first relapse using gemtuzumab-ozogamicin (gemtuzumab-ozogamicin)."],
        [1996, "We evaluated the role of ABMT in late 1st CR AML adult patients using busulfan plus cyclophosphamide as preparative regimen."],
        [2010, "Palonosetron and dexamethasone for prevention of nausea and vomiting in patients receiving high-dose chemotherapy with auto-SCT."],
        [2013, "He received standard induction chemotherapy with cytarabine and daunorubicin."],
        [1990, "Therefore, the combination chemotherapy of fluorouracil, vincristine and doxorubicin, picibanil was applied."],
        [2015, "Daunorubicin and cytarabine has been the standard-of-care for induction therapy for AML (AML)."],
        [2021, "Venetoclax, combined with hypomethylating agents, seems to be an effective option for young relapsed/refractory AML patients."],
        [2014, "Prognostic value of TP53 gene mutations in myelodysplastic syndromes and AML treated with azacitidine."],
        [2014, "Intratympanic dexamethasone plus melatonin versus melatonin only in the treatment of unilateral acute idiopathic tinnitus."],
        [1976, "Maintenance of remission in adult AML using intermittent courses of cytarabine (cytarabine) and thioguanine (thioguanine)."],
        [2015, "A patient treated with cyclophosphamide due to vasculitis, subsequently developed AML months after treatment."],
        [2013, "Determination of arsenic metabolites in patients with newly diagnosed AML treated with arsenictrioxide."],
        [2000, "liposomaldaunorubicin plasmatic and renal disposition in patients with acute leukemia."],
        [1979, "Synthesis and antitumor activity of sugar-ring hydroxyl analogues of daunorubicin."],
        [2000, "arsenictrioxide has recently been used in the treatment of both relapsed and de novo AML (APML)."],
        [2012, "Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with AML (AML)."],
        [2022, "G-CSF upregulates the expression of aquaporin-9 through CEBPB to enhance the cytotoxic activity of arsenictrioxide to AML cells."],
        [1982, "High dose cytarabine in the management of refractory acute leukemia."],
        [2008, "Cyclophosphamide was used to induce acute and chronic bladder inflammation."],
        [2005, "Adjuvant chemotherapy consisting of carboplatin and vincristine was given followed by radiotherapy."],
        [1985, "Brachial plexus neuropathy following high-dose cytarabine in acute monoblastic leukemia."],
        [1982, "Physical properties of cytarabine diphosphate diacylglycerol, an antitumor liponucleotide."],
        [2016, "In summary, arsenictrioxide exerts antitumor activity against RMS, especially in combination with antimicrotubule drugs."],
        [2006, "In vitro synergy of irinotecan followed by cytarabine was confirmed in a human AML cell line as a basis for the clinical trial."],
        [2020, "Effects of dexamethasone on hepatic macrophages in normal livers and thioacetamide-induced acute liver lesions in rats."],
        [2015, "Patients receiving high-dose cytarabine as part of their chemotherapy regimen have a chance of experiencing neurotoxicities."],
        [2014, "arsenictrioxide (arsenictrioxide) is presently the most active single agent in the treatment of AML (APL)."],
        [2001, "Moreover, this complex destroyed AML blast cells as efficiently as free daunorubicin."],
        [2018, "HMGB1 knockdown in MM cells enhanced the inhibitory effect of chemotherapy with dexamethasone (Dex) via apoptosis induction."],
        [2003, "One of the major side effects of cytarabine chemotherapy is neurotoxicity."],
        [2010, "PURPOSE In patients with AML (AML), induction chemotherapy is based on standard doses of anthracyclines and cytarabine."],
        [2005, "Grosstotal resection of an anaplastic astrocytoma was followed by chemotherapy with temozolomide and vincristine."],
        [2017, "A 13-year-old male with FA and refractory AML was given azacitidine, achieved morphologic remission and underwent HCT."],
        [1991, "200 mg/m2) plus cytarabine as part of continuation therapy for acute lymphocytic leukemia."],
        [2016, "Future plans include studying VSLI as substitution for standard vincristine with combination chemotherapy in children with ALL."],
        [2012, "After induction chemotherapy with idarubicin, cytarabine, and imatinib, she achieved complete remission."],
        [2022, "A novel polyethylene glycol (PEG)-drug conjugate of Venetoclax, a Bcl-2 inhibitor, for treatment of AML (AML)."],
        [1999, "The induction chemotherapy consisted of doxorubicin 60 mg/m2, cyclophosphamide 750 mg/m2 and fluorouracil 750 mg/m2 on day 1."],
        [2010, "Mosaic Down syndrome-associated AML does not require high-dose cytarabine treatment for induction and consolidation therapy."],
        [2009, "arsenictrioxide is already used clinically to treat AML demonstrating its safety profile."],
        [2022, "The combination of G-CSF and arsenictrioxide may be a potential therapeutic strategy for AML patients."],
        [2022, "The cardiotoxicity induced by arsenictrioxide (arsenictrioxide) limits its clinical application in AML treatment."],
        [2000, "High dose chemotherapy (mostly Cyclophosphamide) was administered after the FTBI."],
        [1989, "Efficient formation of cytarabine.5'-triphosphate in leukemic blasts of human T-cell acute lymphoblastic leukemia."],
        [1999, "Successful low-dose cytarabine treatment in a patient with acute leukemia from idiopathic myelofibrosis."],
        [2011, "Conversely, arsenictrioxide (AsTO) has successfully been employed in the treatment of AML (APL)."],
        [2003, "Tiazofurin (TF) and thioguanine (thioguanine) are also used as chemotherapy agents in the treatment of malignancies."],
        [2013, "The efficacy of arsenictrioxide (arsenictrioxide) in the treatment of AML (APL) is widely accepted."],
        [1977, "Studies by other investigators have shown that doxorubicin and daunorubicin exhibit antitumor and antiviral activity."],
        [2017, "Preclinical data have suggested synergy in vitro between cytarabine and imatinib mesylate (IM) on AML cell growth inhibition."],
        [2002, "Development of resistance to cytarabine (cytarabine) is a major problem in the treatment of patients with AML (AML)."],
        [1987, "daunorubicin and thioguanine in relapsed or refractory acute nonlymphocytic leukemia."],
        [2018, "CDA as a predictive marker for life-threatening toxicities in patients with AML treated with cytarabine."],
        [2015, "Benefits of azacitidine treatment of patients with AML with >30% blasts have also been shown in a recent phase III trial."],
        [2020, "mitoxantrone is a chemotherapy anti-cancer drug, which can have side effects on healthy cells like secondary cancers."],
        [2010, "Vincristine (1.50 mg/m(2)) was administered as part of the standard chemotherapy regimen."],
        [2020, "A case series of 3 patients with acute colonic pseudo-obstruction after vincristine administration."],
        [1979, "Cytarabine and thioguanine for acute nonlymphocytic leukemia."],
        [2019, "Chidamide Enhances the Cytotoxicity of Cytarabine and Sorafenib in AML Cells by Modulating H3K9me3 and Autophagy Levels."],
        [2021, "225Ac-labeled CD33-targeting antibody reverses resistance to Bcl-2 inhibitor venetoclax in AML models."],
        [2018, "The dose escalation of cytarabine in induction therapy lead to improved remission rates in the elderly AML patients."],
        [2003, "We report a possibly cytarabine-induced acute pericarditis and pleuritis with a rapid onset."],
        [2018, "Similarly, samples collected from patients with AML treated with midostaurin showed a reduction in Tregs markers."],
        [2020, "CHOP plus intrathecal cytarabine, methotrexate was given as chemotherapy regimen."],
        [2018, "Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms."],
        [1976, "Synthesis and antitumor activity of idarubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers."],
        [1999, "arsenictrioxide selectively induces AML cell apoptosis via a hydrogen peroxide-dependent pathway."],
        [1977, "Remission induction with daunorubicin, vincristine, and 6alpha-methylprednisone in adult acute lymphocytic leukemia."],
        [2017, "Midostaurin plus Chemotherapy for AML with a FLT3 Mutation."],
        [1994, "His chemotherapy had consisted mainly of cyclophosphamide and methotrexate, but no epipodophyllotoxins."],
        [2001, "Successful treatment of a case of relapsed AML with arsenictrioxide."],
        [2018, "Cyclophosphamide (CY)-induced acute cardiotoxicity is a common side effect which is dose dependent."],
        [2021, "Curative effects of montmorillonite powder combined with dexamethasone on acute radiation enteritis."],
        [2019, "To review the available data about venetoclax in AML and how it can influence the treatment in older patients."],
        [2008, "Histologically cyclophosphamide induced more inflammatory changes than protamine sulfate during acute bladder inflammation."],
        [1990, "Short course high-dose mitoxantrone with high-dose cytarabine is effective and well-tolerated in patients with acute leukemia."],
        [2009, "Inhibition of MEK signaling enhances the ability of cytarabine to induce growth arrest and apoptosis of AML cells."],
        [2012, "Combination of cytarabine and topotecan in patients treated for AML with persistent disease after frontline induction."],
        [2013, "The anti-tumor effects of arsenictrioxide (arsenictrioxide) were well established in AML, but not in renal cell carcinoma (RCC)."],
        [2018, "Effects of dexamethasone on autophagy and apoptosis in acute spinal cord injury."],
        [1979, "Combination chemotherapy of colorectal cancer with fluorouracil, methyl-1,3-cis(2-chloroethyl)-1-nitrosourea, and vincristine."],
        [2004, "The combination of fludarabine, cytarabine (cytarabine) and G-CSF (FLAG) is routinely used in the treatment of AML (AML)."],
        [1998, "Liposomal vincristine for the treatment of human acute lymphoblastic leukemia in severe combined immunodeficient (SCID) mice."],
        [2017, "Histone deacetylase inhibitors reduce differentiating osteoblast-mediated protection of AML cells from cytarabine."],
        [1990, "mitoxantrone (mitoxantrone) is a recently synthesized antitumor intercalative molecule, currently in use in chemotherapy."],
        [2000, "Treatment consists of chemotherapy (cytarabine and anthracycline) and local radiation of the intracranial tumor."],
        [2022, "Downregulation of MSK1 enhanced the sensitivity of AML cells to cytarabine."],
        [2004, "Comparison of methylprednisolone with dexamethasone in treatment of acute spinal injury in rats."],
        [2020, "Daunorubicin and cytarabine are first-line chemotherapy for AML, with bone marrow transplantation in most cases."],
        [2014, "Data and articles related to arsenictrioxide effect in AML treatment were selected and reviewed."],
        [2003, "Multiple complete remissions in a patient with AML (M4eo) with low-dose cytarabine and all-trans retinoic acid."],
        [1984, "mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia."],
        [2005, "Cyclophosphamide may have the capacity to augment DC-induced antitumor immunity."],
        [2014, "We aimed to examine the role of 14-3-3ζ in AML chemosensitivity using HL-60 and vincristine-resistant HL-60/VCR cells."],
        [2021, "High dose cyclophosphamide for cytoreduction in patients with AML with hyperleukocytosis or leukostasis."],
        [2004, "We report two cases of acute poisoning with an unwettable formulation of arsenictrioxide."],
        [1994, "Detection of cytarabine resistance in patients with AML using flow cytometry."],
        [2020, "Cyclophosphamide as a chemotherapeutic agent induces acute cardiotoxicity through its toxic metabolite, acrolein."],
        [2021, "Hotspot DNMT3A mutations in clonal hematopoiesis and AML sensitize cells to azacitidine via viral mimicry response."],
        [1987, "Sequential hydroxyurea-cytarabine chemotherapy for refractory non-Hodgkin's lymphoma."],
        [2015, "Expression of P-gp in AML and the reversal function of arsenictrioxide on drug resistance."],
        [1995, "This fever enhancement was inhibited by acute or chronic glucocorticoid, dexamethasone (DEX), treatment."],
        [2006, "Results of treatment of AML and myelodysplastic syndrome with etoposide, thioguanine, cytarabine (ETC) in elderly patients."],
        [1998, "Inv(16) AML cells show an increased sensitivity to cytarabine in vitro."],
        [2021, "A 69-year-old patient with AML progressed from myelodysplastic syndrome and was treated with azacitidine."],
        [2015, "Cyclophosphamide (CY) is a cytostatic drug commonly used for chemotherapy in children with cancer."],
        [2006, "Cytarabine (cytarabine) is a key drug in the treatment of acute leukemia."],
        [2014, "cAMP protects AML cells from arsenictrioxide-induced caspase-3 activation and apoptosis."],
        [1986, "mitoxantrone (mitoxantrone), an anthracenedione, is a novel anticancer agent with a wide spectrum of antitumor activity."],
        [2022, "ONO-7475 synergizes with venetoclax to potently kill FLT3-mutant AML cell lines and primary cells."],
        [2012, "Moreover, we were able to show that JQ1 synergizes with cytarabine in inducing growth inhibition in AML cells."],
        [2022, "For acute presentations, we recommend limiting dexamethasone treatment to <14 days."],
        [2008, "BMSCs were found to maintain cytarabine-exposed primary AML cells by protection against spontaneous apoptosis."],
        [2009, "In mature B-ALL, survival rates increased above 80% with the combination of short intensive chemotherapy and rituximab."],
        [2012, "Combination therapy with arsenictrioxide, all-trans retinoic acid, and chemotherapy in AML patients with various relapse risks."],
        [2016, "Six cycles of adjuvant systemic chemotherapy with carboplatin, vincristine and etoposide were given."],
        [2017, "Moreover, AZD2811 nanoparticles increased antitumor activity when combined with cytarabine."],
        [1989, "Idarubicin combined with intermediate-dose cytarabine in the treatment of refractory acute leukemia."],
        [2018, "Cyclophosphamide is an alkylating agent used as chemotherapy for cats with lymphoma, carcinomas and sarcomas."],
        [2015, "Comparison of therapeutic effects of magnesium sulfate vs. dexamethasone/metoclopramide on alleviating acute migraine headache."],
        [2015, "arsenictrioxide (arsenictrioxide) is an effective drug used in AML (AML)."],
        [1987, "Four patients with AML (AML) and three with myelodysplastic syndrome (MDS) were given low dose cytarabine (cytarabine) therapy."],
        [2014, "Enhanced skin toxicity associated with the combination of clofarabine plus cytarabine for the treatment of acute leukemia."],
        [1985, "Low-dose cytarabine treatment for acute nonlymphocytic leukemia in elderly patients."],
        [2001, "The anthracycline idarubicin is highly active alone or in combination chemotherapy for the treatment of APL."],
        [2011, "We identified 3,888 patients with M1 PC, of whom 24% (n = 930) received chemotherapy (primarily docetaxel and mitoxantrone)."],
        [2016, "By targeting MCL-1 and BCL-XL, resistant AML cell lines could be resensitized to venetoclax."],
        [2019, "Time dependent response of daunorubicin on cytotoxicity, cell cycle and DNA repair in acute lymphoblastic leukemia."],
        [2019, "The histone deacetylase (HDAC) inhibitor panobinostat potentiates anthracycline and cytarabine cytotoxicity in AML (AML) cells."],
        [2016, "Addition of rituximab to a short intensive chemotherapy programme improves EFS in adults with Burkitt's leukemia or lymphoma."],
        [2018, "Influence of UGT1A1 polymorphisms on the outcome of AML patients treated with cytarabine-base regimens."],
        [2014, "vincristinesulfate (VCR) is a potent and widely used anti-tumor drug."],
        [2015, "Cost per cycle of chemotherapy in INR was 24,200 for decitabine and 1,600 for low-dose cytarabine group."],
        [2021, "The pterocarpanquinone LQB‑118 compound induces apoptosis of cytarabine‑resistant AML cells."],
        [2015, "MK-2206 induces apoptosis of AML cells and enhances the cytotoxicity of cytarabine."],
        [1994, "In stages II-IV, cisplatin-based chemotherapy produced better results than mitomycin, fluorouracil, cytarabine (MFC) therapy."],
        [2019, "The recommended dose of midostaurin is 50 mg orally twice daily for AML and 100 mg orally twice daily for ASM, SM-AHN and MCL."],
        [1983, "Two patients with acute leukemia developed abnormal liver function tests after the administration of cytarabine."],
        [1976, "The induction phase of chemotherapy should include the use of at least 6alpha-methylprednisone and vincristine."],
        [2022, "For DLBCL, hardly any patients received concurrent rituximab with chemotherapy for six cycles."],
        [1986, "High-dose cytarabine therapy was administered to 29 patients with poor-prognosis acute nonlymphocytic leukemia."],
        [2010, "Vincristine chemotherapy after the operation was necessary to prevent the enlargement of the remaining tumor."],
        [2016, "Clinical response to azacitidine therapy depends on microRNA-29c (miR-29c) expression in older AML (AML) patients."],
        [2021, "Gilteritinib use in the treatment of relapsed or refractory AML with a FLT3 mutation."],
        [2005, "arsenictrioxide (arsenictrioxide) and MEK1 inhibition synergize to induce apoptosis in AML cells."],
        [2022, "Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidine."],
        [2012, "Oral arsenictrioxide for relapsed AML in pediatric patients."],
        [1987, "Oral idarubicin was given as single-agent treatment of acute nonlymphocytic leukemia in 18 poor-risk patients."],
        [2022, "vincristine (vincristine) is one of the most common chemotherapy agents used in pediatric oncology."],
        [2017, "cytarabine (cytarabine) remains the backbone of most treatment regimens for AML (AML)."],
        [1992, "These observations suggest that low-dose cytarabine is effective in treating elderly patients with hypocellular acute leukemia."],
        [1988, "Cyclophosphamide is an effective antitumor agent with considerable side effects such as urotoxicity and carcinogenicity."],
        [2005, "The nucleoside analogue arabinofuranosylcytosine (cytarabine) has been used for many years in the treatment of acute leukemia."],
        [2019, "One patient with a unifocal mastoid lesion was treated with chemotherapy alone (vinblastine and prednisone)."],
        [2018, "Complete remission was attained following a course of chemotherapy with ATRA and arsenictrioxide."],
        [2020, "The patient received intensive chemotherapy plus midostaurin, followed by midostaurin maintenance."],
        [2001, "These results were not different from previous published reports using cytarabine-based chemotherapy regimens to treat CML-MBC."],
        [2022, "Idarubicin 12 mg/m2 has been recommended as a standard induction therapy for AML (AML)."],
        [2021, "The combination of chloroquine with low-dose cytarabine had an additive inhibitory effect on AML cell proliferation."],
        [1989, "Augmented induction of antitumor cells in vivo by cyclophosphamide fails to benefit antitumor resistance of the host."],
        [1987, "Potentiation of antitumor activity of vincristine by the biscoclaurine alkaloid cepharanthine."],
        [2014, "An autologous leukemia cell vaccine prevents murine acute leukemia relapse after cytarabine treatment."],
        [1982, "Relapses in nine patients with AML were treated with a combination of aclarubicin (ACR) and cytarabine (cytarabine)."],
        [2019, "To investigate the effect of apatinib combined with cytarabine on AML (AML) HL60 cells and its relevant mechanisms."],
        [1995, "Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to cytarabine."],
        [2008, "A novel arsenical has antitumor activity toward arsenictrioxide-resistant and MRP1/ABCC1-overexpressing cell lines."],
        [1990, "Fatal pulmonary failure complicating high-dose cytarabine therapy in acute leukemia."],
        [1994, "Plasma and leukemic cell pharmacokinetics of high-dose N4-behenoyl-cytarabine in acute leukemia patients."],
        [1996, "4-Hydroperoxycyclophosphamide is an effective antitumor agent worthy of further investigation."],
        [1981, "vincristine and 6alpha-methylprednisone combination chemotherapy in 325 adults with acute leukemia."],
        [2011, "In cytarabine-sensitive HL60 cells, the conjugates 6, 12, and 16 retained potent antitumor activities."],
        [2001, "The standard chemotherapy combination, CMF (cyclophosphamide, methotrexate, 5-fluorouracil), was administered to 77 women."],
        [1999, "dexamethasone does not counteract the response of AML cells to all-trans retinoic acid."],
        [1998, "Triple intrathecal chemotherapy (cytarabine, MTX, and hydrocortisone) was administered for central nervous system prophylaxis."],
        [1981, "Combination chemotherapy with an anthracycline, doxorubicin or zorubicin, cytarabine."],
        [2017, "Efficacy and toxicity of carboplatin and cytarabine chemotherapy for dogs with relapsed or refractory lymphoma (2000-2013)."],
        [2007, "Induction of complete remission in a patient with AML refractory to high-dose chemotherapy through treatment with azacitidine."],
        [2018, "The patient received vyxeos for relapsed AML via a left chest wall port-a-catheter."],
        [1995, "mitoxantrone and cytarabine as treatment for AML in older patients."],
        [2018, "Immunosuppressive agents like cyclophosphamide have been used in adults with fulminant acute disseminated encephalomyelitis."],
        [2022, "Based on the results of various clinical trials, ivosidenib was approved for AML harboring the IDH1 mutation."],
        [2013, "Adoptive transfer of pT(H)17 cells partially restored the antitumor efficacy of cyclophosphamide."],
        [1996, "thioguanine, a thioderivative of the nucleic acid base guanine, is a metabolic inhibitor and possesses antitumor activity."],
        [2004, "mitoxantrone (MTZ) has been shown to be effective in the treatment of newly diagnosed AML (AML)."],
        [2018, "MTT assay was used to investigate the cytotoxicity of carriers and the antitumor effect of arsenictrioxide formulation."],
        [2006, "He received multiagent chemotherapy with vincristine, carboplatin, and etoposide along with intrathecal methotrexate."],
        [2014, "Treatment of an AML relapse using arsenictrioxide and all-trans-retinoic in a 6-year-old child."],
        [2020, "The AML model reasonably predicted the observed ivosidenib concentration-time profiles across all dose levels in patients."],
        [2021, "We also report for the first time that FOXM1 inactivation can overcome AML venetoclax resistance."],
        [1981, "Improved antitumor activity of basic amino acid and dipeptide derivatives of daunorubicin on EL4 leukemia cells in mice."],
        [2010, "Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer."],
        [2009, "Blockade of MEK signaling potentiates azacitidine-2'-deoxycytidine-induced apoptosis and upregulation of p21(waf1) in AML cells."],
        [2003, "dexamethasone suppresses peripheral prostanoid levels without analgesia in a clinical model of acute inflammation."],
        [2009, "tropisetron) combined with dexamethasone are effective for the acute phase of cisplatin (CIS)-induced emesis."],
        [2012, "Intrathecal chemotherapy with MTX, cytarabine, and predonisolone was simultaneously performed."],
        [2011, "Anti-PD-1 synergizes with cyclophosphamide to induce potent anti-tumor vaccine effects through novel mechanisms."],
        [1989, "Treatment of acute nonlymphocytic leukemia in the elderly with intermediate high-dose cytarabine."],
        [2003, "A combination of an anthracycline and cytarabine (cytarabine) is the core of most AML induction regimens."],
        [2008, "Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients."],
        [2011, "Consolidation included modified chemotherapy or arsenictrioxide."],
        [1998, "To date, the prognostic impact of cytarabine dose escalation within various cytogenetic groups of AML has not been assessed."],
        [2018, "The application of the high-dose cytarabine in induction chemotherapy of ETP-ALL can bring better outcome."],
        [2014, "Maturation stage of T-cell acute lymphoblastic leukemia determines BCL-2 versus BCL-XL dependence and sensitivity to venetoclax."],
        [2004, "Morphoproteomics and bortezomib/dexamethasone-induced response in relapsed acute lymphoblastic leukemia."],
        [1999, "We report the case of a 5-year-old patient with leukemia who developed an acute polyneuropathy after treatment with vincristine."],
        [2015, "The drug-resistant AML cell line HL-60R was significantly less sensitive to cytarabine and daunorubicin than HL-60 cells."],
        [2021, "However, often there is also a small population of AML cells refractory to venetoclax treatment."],
        [2016, "Phase I study of azacitidine following donor lymphocyte infusion for relapsed AML post allogeneic stem cell transplantation."],
        [2009, "Patients diagnosed with AML (AML) often receive cytarabine-based chemotherapy as standard treatment."],
        [2021, "All eyes received conventional chemotherapy (carboplatin, vincristine, etoposide) and focal laser therapy."],
        [2019, "These results suggest that gilteritinib has therapeutic potential in FLT3-mutated AML patients with FL overexpression."],
        [2010, "This study aimed to investigate the effects of arsenictrioxide (As(2)O(3)) on the mitochondrial DNA (mtDNA) of AML (APL) cells."],
        [2001, "Chemotherapy for AML in the elderly with cytarabine, mitoxantrone, and granulocyte-macrophage colony-stimulating factor."],
        [1987, "Fifteen patients with AML were given a total of 17 courses of high-dose cytarabine (cytarabine)."],
        [2019, "Evaluation of gilteritinib in combination with chemotherapy in preclinical models of FLT3-ITD+ AML."],
        [2016, "Three patients with high-grade myelodysplastic syndrome or AML who received azacitidine."],
        [2009, "To report a case of isolated hyperbilirubinemia in a patient treated with cytarabine-based chemotherapy for AML."],
        [2020, "We found that metformin could synergistically sensitize AML cells to cytarabine via inhibiting mTORC1/P70S6K pathway."],
        [2013, "The use of rituximab together with intensive chemotherapy in Burkitt's lymphoma or leukemia (BL) has been scarcely explored."],
        [1989, "High-dose cytarabine may benefit patients with refractory acute leukemia."],
        [2021, "Three relapses were observed and these patients were further treated with chemotherapy and rituximab."],
        [1987, "The most effective chemotherapy is carmustine or a combination of lomustine, procarbazine, and vincristine (PCV)."],
        [2019, "Gilteritinib combined with chemotherapy reduced tumor volume to a greater extent than either gilteritinib or chemotherapy alone."],
        [2014, "Efficacy and safety of an increased-dose of dexamethasone in patients receiving fosaprepitant chemotherapy in Japan."],
        [2010, "Low-dose cyclophosphamide synergizes with dendritic cell-based immunotherapy in antitumor activity."],
        [2017, "Few studies have investigated the effects of preoperative dexamethasone in acute surgical patients."],
        [1998, "Frequency of prolonged remission duration after high-dose cytarabine intensification in AML varies by cytogenetic subtype."],
        [2002, "Pharmacokinetics of vincristine monotherapy in childhood acute lymphoblastic leukemia."],
        [2004, "Methotrexate, vincristine, doxorubicin and cisplatin (M-VAC) chemotherapy has been the standard of therapy for over a decade."],
        [2020, "Disrupting the LC3 Interaction Region (LIR) Binding of Selective Autophagy Receptors Sensitizes AML Cell Lines to Cytarabine."],
        [2007, "The response rate of cyclophosphamide/Platinum chemotherapy in this group with epithelial cell type was relatively low."],
        [2008, "arsenictrioxide (arsenictrioxide) is used clinically to treat AML but is less successful in other malignancies."],
        [2020, "In summary, we demonstrate that venetoclax is an effective and well-tolerated salvage option for R/R AML patients."],
        [2013, "Phase II trial of clofarabine and daunorubicin as induction therapy for AML patients greater than or equal to 60 years of age."],
        [2018, "Twenty patients with primary AML had been randomized into busulfan/fludarabine and modified busulfan/cyclophosphamide groups."],
        [1986, "We report here a model system for the study of acute effects of cyclophosphamide on pulmonary immune cells in rats."],
        [1991, "Following radiotherapy patients were to receive chemotherapy with procarbazine, lomustine, and vincristine for 1 year."],
        [2020, "Cytogenetics and mutations could predict outcome in relapsed and refractory AML patients receiving BCL-2 inhibitor venetoclax."],
        [2004, "Low-energy red light radiation improves antitumor activity of cyclophosphamide."],
        [1989, "The patient had previously been given chemotherapy including daunorubicin for treatment of her leukemia."],
        [2017, "Increased non-relapse mortality due to high-dose cytarabine plus CY/TBI in BMT/PBSCT for acute lymphoblastic leukemia in adults."],
        [2020, "NK cell alloreactivity in AML in the post-transplant cyclophosphamide era."],
        [2015, "arsenictrioxide (arsenictrioxide) is an approved treatment for AML (APL)."],
        [2007, "arsenictrioxide (arsenictrioxide) has demonstrated effectiveness in treating AML (APL)."],
        [2019, "arsenictrioxide and all-trans retinoic acid have become the frontline treatments for patients with AML (APL)."],
        [1986, "Idarubicin displayed no antitumor effect in 18 minimally pretreated cervical carcinoma patients."],
        [2020, "Furthermore, treatment of Cdx2 AML with azacitidine decreases leukemic burden."],
        [1999, "All chemotherapy regimens included cytarabine by continuous i.v."],
        [2021, "Currently, he is on cyclophosphamide and vincristine chemotherapy regime and his condition has improved much."],
        [2014, "arsenictrioxide (arsenictrioxide) is a highly effective agent for the treatment of AML (APL)."],
        [2017, "Our findings are consistent with clinical data, in which vyxeos activity is retained in high-risk AML patients."],
        [2011, "We reported here 4 patients treated with azacitidine for therapy related dysplasia after chemotherapy for non-Hodgkin lymphoma."],
        [2017, "arsenictrioxide (arsenictrioxide) has been verified as a breakthrough in the management of AML in recent decades."],
        [2018, "A 6-year-old girl was treated for AML with daunorubicin and mitoxantrone."],
        [2014, "Report of a rare and serious complication of chemotherapy with daunorubicin and cytarabine (DA regimen)."],
        [2011, "Anthracycline daunorubicin (daunorubicin) is one of the major antitumor agents widely used in the treatment of myeloid leukemia."],
        [2021, "These findings suggest a role for venetoclax-based regimens in R/R AML patients and support the design of prospective studies."],
        [2000, "Cyclophosphamide, cytarabine and topotecan (CAT) for patients with refractory or relapsed acute leukemia."],
        [2021, "We report a case of relapsed AML with FLT3-ITD that was treated with gilteritinib."],
        [1977, "Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytarabine."],
        [2016, "dexamethasone has a longer half-life and has been used safely in other acute pediatric conditions."],
        [2020, "Dendrogenin A synergizes with Cytarabine to Kill AML Cells In Vitro and In Vivo."],
        [1997, "Vincristine is a commonly used antitumor agent whose major dose-limiting side-effect is a mixed sensorimotor neuropathy."],
        [2009, "Daunorubicin (daunorubicin) is one of the most important antitumor agents belonging to the anthracycline group."],
        [2019, "Daunorubicin (Dnr) is at the forefront of AML (AML) therapy, but drug resistance poses a major threat to treatment success."],
        [2022, "dexamethasone abrogates the antitumor effects of checkpoint inhibitors on T lymphocytes in preclinical studies."],
        [2020, "Compared to CCR, decitabine and azacitidine can promote studied outcomes in elderly AML patients."],
        [2012, "Over 80% of AML patients express CD33, a target of gemtuzumab-ozogamicin (gemtuzumab-ozogamicin)."],
        [2017, "Seventy-five patients received docetaxel-based chemotherapy combined with dexamethasone."],
        [2020, "Efficacy of intermittent epidural dexamethasone bolus for zoster-associated pain beyond the acute phase."],
        [2012, "The azacitidine/ABT-737 combination synergistically induced apoptosis in AML cells in seven of eight patients."],
        [2013, "mitoxantrone (mitoxantrone) is an antitumor agent that causes cardiotoxicity in 18 % patients."],
        [2020, "The combination of radotinib and cytarabine was found to induce AML cell apoptosis, which involved the mitochondrial pathway."],
        [2008, "Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia."],
        [2015, "arsenictrioxide is an effective and potent antitumor agent used in patients with AML and produces dramatic remissions."],
        [2017, "Cyclophosphamide (CP) is a widely utilized chemotherapy drug."],
        [2021, "Rituximab combined with chemotherapy significantly improved PFS (p = 0.002) and OS (p = 0.006) in these patients."],
        [2022, "Treatment consisted of cyclophosphamide low-dose pre-phase chemotherapy before conventional-dose chemotherapy."],
        [2003, "midostaurin, a selective inhibitor of protein kinase C (PKC), is currently in clinical trials as an anti-tumor drug."],
        [1990, "Treatment of poor-prognosis, newly diagnosed AML with high-dose cytarabine (cytarabine) and rHUGM-CSF."],
        [1999, "Salvage therapy of refractory and relapsed acute leukemia with high dose mitoxantrone and high dose cytarabine."],
        [2000, "Respiratory failure during induction chemotherapy for AML (FAB M4Eo) with cytarabine and all-trans retinoic acid."],
        [2014, "Following post surgery, adjuvant chemotherapy of CAF regimens (cyclophosphamide+adriamycin+fluorouracil) was administered."],
        [2021, "Our model closely mirrors the timing and mutations of AML patients treated with gilteritinib."],
        [1997, "Natural resistance of AML cell lines to mitoxantrone is associated with lack of apoptosis."],
        [2005, "The efficacy of All-Trans Retinoic Acid (Atra) and arsenictrioxide (As(2)O(3)) in the treatment of AML (APL) is well known."],
        [2013, "Here, we investigated the antitumor effect of γ-PGA in combination with cyclophosphamide in a murine melanoma model."],
        [1983, "cytarabine conjugates of corticosteroids as potential antitumor agents."],
        [2016, "The efficacy of arsenictrioxide in AML (APL) was discovered in China."],
        [1999, "Subsequently, chemotherapy was to continue with CPM, vincristine, and carboplatin for 2 years."],
        [2020, "Cytarabine is the backbone of AML therapy, but the dose used during induction has remained controversial."],
        [2016, "He was treated with steroids, intravenous immunoglobulin, and cyclophosphamidemonohydrate and was sent to acute rehabilitation."],
        [1999, "Patients with poor risk factors also received adjuvant chemotherapy with lomustine, cisplatin, and vincristine."],
        [1992, "Low-dose cytarabine for treating hypocellular acute leukemia in the elderly."],
        [2013, "Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia."],
        [2020, "Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed AML Stem Cells."],
        [2011, "Before 2010, only docetaxel-based chemotherapy improved survival in patients with CRPC compared with mitoxantrone."],
        [2018, "At present, AML (APL) is the most curable form of AML and can be treated using all-trans retinoic acid and arsenictrioxide."],
        [1984, "daunorubicin (TAD) chemotherapy was 2.6 weeks and no patient reachieved the chronic phase of CML."],
        [2014, "CNS Involvement in AML Patient Treated with azacitidinecytidine."],
        [1996, "They received high-dose carmustine/cyclophosphamide/cisplatinum chemotherapy with autologous bone marrow rescue."],
        [1994, "There was a partial response to chemotherapy which included vincristine, doxorubicin, ifosfamide, carboplatinum and etoposide."],
        [2021, "Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma."],
        [2010, "It is revealed that arsenictrioxide aggravates mtDNA mutation in the D-loop region of AML cells both in vitro and in vivo."],
        [2008, "Inorganic arsenictrioxide (As(2)O(3)) is a highly effective treatment for AML (APL)."],
        [2017, "Novel Mitochondrial Mechanisms of Cytarabine Resistance in Primary AML Cells."],
        [2009, "The microtubule-active antitumor compound cevipabulin has both paclitaxel-like and vincristine-like properties."],
        [1990, "Schedule-dependent interaction of cytarabine plus doxorubicin or cytarabine plus mitoxantrone in AML cells in culture."],
        [1985, "Treatment of children with refractory acute lymphocytic leukemia with vincristine and diltiazem."],
        [2021, "Four cycles of rituximab plus CHOP chemotherapy is as effective as 6 cycles in low-risk diffuse large B-cell lymphoma (DLBCL)."],
        [2018, "We examined the role of TET-FOXP3 axis in the cytotoxic effects of arsenictrioxide on the human AML cell line, U937."],
        [2006, "Cyclophosphamide (CP), a potent antitumor drug, is known to cause severe cardiotoxicity."],
        [2021, "Cyclophosphamide (CTX) is a chemotherapy drug that suppresses the immune system."],
        [2021, "It is often overexpressed in AML (AML) and is associated with poor survival and reduced efficacy of cytarabine therapy."],
        [2021, "Eight of these 14 patients had R/R AML and had failed treatment with HMA (N=2) or venetoclax plus HMA (N=6)."],
        [2020, "Efficacy of additional dexamethasone administration for the attenuation of paclitaxel-associated acute pain syndrome."],
        [2003, "Cyclophosphamide is one of several cancer chemotherapy agents that can cause nail hyperpigmentation."],
        [2021, "The cyclophosphamide-free chemotherapy regimen might be associated with a higher probability of menses resumption."],
        [2020, "Inhibition of mTORC1/P70S6K pathway by Metformin synergistically sensitizes AML to cytarabine."],
        [1967, "Transport and phosphorylation as factors in the antitumor action of cytarabine."],
        [2018, "The ectopic expression of hTERT significantly attenuated the apoptotic effect of midostaurin on AML cells."],
        [2017, "Standard remission induction chemotherapy consisting of anthracycline plus cytarabine (3+7) is administered for adult AML (AML)."],
        [2016, "Successful use of high-dose cytarabine in a patient with AML and severe hepatic dysfunction."],
        [2019, "Increasingly, AML (APL) is treated with a combination of all-trans retinoic acid (ATRA) and arsenictrioxide (arsenictrioxide)."],
        [2021, "Our study details the stepwise evolution of gilteritinib resistance in FLT3-mutated AML (AML)."],
        [2019, "Unfortunately, similar to other agents used during antitumor therapy, vincristine might induce chemoresistance."],
        [2021, "Primary AML cells were also sensitive to KP772, whereas daunorubicin showed no significant effect."],
        [2019, "Bone Marrow Findings in Patients With AML Treated With arsenictrioxide."],
        [2019, "Apatinib enhances chemosensitivity of AML hl60 cells to cytarabine by inducing apoptosis."],
        [1994, "High-dose mercaptopurine followed by intermediate-dose cytarabine in relapsed acute leukemia."],
        [2017, "dexamethasone has been proposed as an alternative in the treatment of acute asthma exacerbation in children."],
        [2004, "Cyclophosphamide (CP) and thiotepa (TT) are frequently administered simultaneously in high-dose chemotherapy regimens."],
        [2011, "In addition the cytotoxicity of daunorubicin chemotherapy was assessed."],
        [1991, "He developed this eruption following chemotherapy with cytarabine and mitoxantrone."],
        [1985, "Misonidazole, a hypoxic cell sensitizer, enhances the antitumor effects of cyclophosphamide in preclinical studies."],
        [2006, "Cyclophosphamide therapy may abort progression and induce remission of this acute fulminant phase."],
        [2022, "Gilteritinib received approval for the treatment of FLT3-mutated relapsed or refractory AML in Japan in 2018."],
        [2020, "TUG1 weakens the sensitivity of AML cells to cytarabine by regulating miR-655-3p/CCND1 axis."],
        [2006, "Patients who received 30 mg of arsenictrioxide weekly showed non-serious acute toxicities."],
        [1976, "The synthesis of potentially specific antitumor peptide derivatives of daunorubicin is presented."],
        [1977, "The anti-tumor activity of cytarabine was markedly enhanced by encapsulation in liposomes when given in a single IP injection."],
        [2015, "Prognostic factors of patients with newly diagnosed AML treated with arsenictrioxide-based frontline therapy."],
        [2009, "The management of prolonged, isolated hyperbilirubinemia following cytarabine-based chemotherapy for AML."],
        [2019, "miR-9 Enhances the Chemosensitivity of AML Cells to Daunorubicin by Targeting the EIF5A2/MCL-1 Axis."],
        [1991, "mitoxantrone in combination with etoposide and cytarabine for treatment of poor prognosis acute non lymphoid leukemia patients."],
        [2005, "Finally, experiments indicated that ALC does not interfere with the antitumor effects of vincristine."],
        [2015, "High dose cytarabine, mitoxantrone and l-asparaginase (HAMA) salvage for relapsed or refractory AML (AML) in the elderly."],
        [1998, "Treatment of AML in the older patient with attenuated high-dose cytarabine."],
        [1977, "Sucessful treatment of severe bone pain and acute arthritis in chronic myelomonocytic leukemia by cytarabine."],
        [2008, "The value of oral cytarabine ocfosfate and etoposide in the treatment of refractory and elderly AML patients."],
        [2002, "CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytarabine."],
        [2012, "Arsenic in the form of arsenictrioxide (arsenictrioxide) is used as a therapeutic drug for treatment of AML (APL)."],
        [2006, "Hepatitis C virus acute quadriparetic vasculitic neuropathy responsive to cyclophosphamide."],
        [2007, "midostaurin (midostaurin) is a multitarget protein kinase inhibitor with anti-tumor activities."],
        [2010, "Daunorubicin (daunorubicin) is one of the anthracycline anti-tumor agents widely used in the treatment of AML."],
        [2012, "arsenictrioxide induces depolymerization of microtubules in an AML cell line."],
        [2021, "The AML microenvironment catalyzes a stepwise evolution to gilteritinib resistance."],
        [2017, "Enasidenib induces AML cell differentiation to promote clinical response."],
        [2016, "All patients received induction chemotherapy that consisted of pirarubicin, intermediate-dose cytarabine, and etoposide."],
        [2004, "LDL increments were not correlated with cholesterol increments in cytarabine-treated AML samples."],
        [1995, "She was treated with radical nephrectomy and adjuvant chemotherapy with actinomycind and vincristine."],
        [2022, "Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed AML Patients."],
        [2012, "BCL2L10 is a predictive factor for resistance to azacitidine in MDS and AML patients."],
        [2013, "vincristinesulfate liposomal injection for acute lymphoblastic leukemia."],
        [2017, "The combination of an anthracycline and cytarabine has been the standard induction therapy for AML for more than 3 decades."],
        [2011, "These liposomes were then evaluated as carriers of the chemotherapy agent vincristine (VIN)."],
        [2001, "Partial remission was obtained by chemotherapy with ifosfamide, dactinomycine, and vincristine."],
        [1985, "High field 1H-NMR analysis of the 1:1 intercalation complex of the antitumor agent mitoxantrone and the DNA duplex [d(CpGpCpG)]."],
        [2007, "arsenictrioxide (arsenictrioxide, arsenictrioxide) is used to treat patients with refractory or relapsed AML (APL)."],
        [2012, "In vivo, FdUMP[10] was active against a syngeneic AML model with a survival advantage equivalent to doxorubicin plus cytarabine."],
        [2009, "mitoxantrone is a potent antitumor drug, widely used in the treatment of various cancers."],
        [2003, "gemtuzumab-ozogamicin has moderate activity as a single agent in patients with CD33-positive refractory or relapsed AML (AML)."],
        [2017, "Induction treatment of AML in an elderly patient with intramarrow injection/administration of cytarabine."],
        [1985, "Six children with refractory acute lymphocytic leukemia were treated with vincristine combined with diltiazem."],
        [2021, "We present two patients with MC during treatment with idarubicin and all-trans-retinoic acid (ATRA) for AML (APL)."],
        [2017, "This study aimed to evaluate the effects of sodium sodiumvalproate and dexamethasone in the treatment of acute migraine."],
        [2013, "The synergistic antitumor effect with arsenictrioxide provides a novel implication in clinical treatment of UC."],
        [2009, "sirolimus, the mTOR kinase inhibitor, sensitizes AML cells, HL-60 cells, to the cytotoxic effect of arabinozide cytarabine."],
        [1987, "She underwent treatment with combined intra-arterial chemotherapy (carmustine) i.a., vincristine i.v., procarbazine orally)."],
        [2019, "Venetolax with azacitidine Drains Fuel from AML Stem Cells."],
        [1982, "Survival at 2 years was 61.9% for the combination chemotherapy group and 19.0% for those treated with cyclophosphamide alone."],
        [2019, "Apatinib combined with cytarabine resists AML through synergistically regulating cell cycle and promoting apoptosis."],
        [2018, "Then, he received 2 cycles of chemotherapy with IA (idarubicin 8 mg/m, day 1-3; cytarabine 100 mg/m, day 1-7) in August, 2016."],
        [2011, "Treatment of poor-risk myelodysplastic syndromes and AML with a combination of azacitidine and valproic acid."],
        [2011, "Adjuvant chemotherapy consisted of cisplatin, vincristine, and fluorouracil."],
        [2020, "We firstly found the synergistic anti-tumor effect of cytarabine/)metformin in AML through inhibiting mTORC1/P70S6K pathway."],
        [1985, "Low-dose cytarabine regimen induced a complete remission with normal karyotypes in a case with hypoplastic AML with No."],
        [2022, "Cyclophosphamide is a commonly used chemotherapy in the treatment of lymphoma."],
        [1982, "Treatment of relapsed AML with a combination of aclarubicin and cytarabine."],
        [2022, "Outcomes of antifungal prophylaxis for newly diagnosed AML patients treated with a hypomethylating agent and venetoclax."],
        [1985, "Treatment of acute leukemia with amsacrine and high-dose cytarabine."],
        [2009, "mitoxantrone-mediated apoptotic B16-F1 cells induce specific anti-tumor immune response."],
        [2013, "azacitidine (azacitidine) has changed the outcome of patients with MDS or AML (AML) unfit for intensive chemotherapy."],
        [2001, "Alternatively, arsenictrioxide or re-treatment with ATRA, followed by intensive chemotherapy may also be effective."],
        [2001, "Remission induction chemotherapy for AML typically combines cytarabine with an anthracycline or anthracycline derivative."],
        [2017, "Purpose gemtuzumab-ozogamicin (gemtuzumab-ozogamicin), a CD33-targeted immunoconjugate, is a re-emerging therapy for AML (AML)."],
        [2016, "Resistance to cytarabine remains a major challenge in the treatment of AML (AML)."],
        [2018, "Both cases accepted chemotherapy including cytarabine."],
        [2004, "The clinical efficacy of arsenictrioxide (As(2)O(3)) has been shown in patients with relapsed AML (APL)."],
        [2020, "Venetoclax in AML - current and future directions."],
        [2001, "These data suggest that cdk2 activity is likely to play a role in cytarabine-induced apoptosis in AML cells."],
        [2010, "Cytarabine is a chemotherapeutic agent predominately used for the treatment of AML and lymphoblastic leukemia."],
        [2014, "Prognostic factors for the outcomes of intratympanic dexamethasone in the treatment of acute subjective tinnitus."],
        [2016, "Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis."],
        [2011, "Intravenous dexamethasone versus morphine in relieving of acute migraine headache."],
        [2022, "Blockade of CD36 improved the effect of cytarabine, representing a promising strategy for AML therapy."],
        [2018, "We found that dexamethasone significantly reduced acute pain during mobilization."],
        [2020, "In vivo experiment also verified metformin in aid of cytarabine caused an obviously synergistic anti-tumor effect."],
        [2012, "Valproic acid combined with cytarabine in elderly patients with AML has in vitro but limited clinical activity."],
        [1999, "Recently, arsenictrioxide (As) was shown to be an effective treatment of AML (APL)."],
        [2001, "arsenictrioxide induces apoptosis of AML cells."],
        [2019, "Vincristine is an important drug of acute lymphoblastic leukemia (ALL) treatment protocols that can cause neurotoxicity."],
        [2014, "Limited data are available on azacitidine (azacitidine) treatment and its prognostic factors in AML (AML)."],
        [2020, "Radotinib enhances cytarabine (cytarabine)-induced AML cell death."],
        [2011, "A phase I/II study of combined chemotherapy with mitoxantrone and uracil/tegafur for advanced hepatocellular carcinoma."],
        [2008, "Prepubertal patients receiving chemotherapy are relatively resistant to cyclophosphamide-induced germinal cell alterations."],
        [2018, "In case 2, the patient received complete remission after the second circle of chemotherapy with high doses of cytarabine."],
        [2000, "A novel therapeutic potential for AML using arsenictrioxide (As(2) O(3) ) has been reported."],
        [2015, "We also tested whether exercise could improve chemotherapy (cyclophosphamide) efficacy."],
        [2006, "Cyclophosphamide is a potent alkylating agent used in cancer chemotherapy and immunosuppression."],
        [2018, "The 2 main formulations of anthracycline used for AML (AML) induction therapy are idarubicin (IDA) and daunorubicin."],
        [1981, "Synthesis of seleno- and thioguanine-platinum(II) complexes and their antitumor activity in mice."],
        [2021, "Efficacy and safety of consolidation therapy with intermediate and high dose cytarabine in AML patients."],
        [2008, "Peri-operative high-dose dexamethasone in cardiac transplants was associated with higher rates of acute cellular rejection."],
        [2022, 'Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax.']
    ]
    
    #df = pd.read_csv('https://docs.google.com/spreadsheets/d/' + '1A-O505D_vkOprtWKMyQ1hIgNlaLwwBZnIZukiiVTncQ' + '/export?gid=0&format=csv', sep=',', escapechar='\\')
    
    return pd.DataFrame(data, columns=['filename', 'sentences'])

def flat_list(composed_list):
    if any(isinstance(x, list) for x in composed_list):
        composed_list = [item for sublist in composed_list for item in sublist]

    return composed_list

# MAIN PROGRAM:
if __name__ == '__main__':
    if 'execution_counter' not in st.session_state:
        st.session_state['execution_counter'] = 0
        
    sentences_df = get_sentences_dataset()
        
    hide_streamlit_style = """
            <style>           
            footer {
                visibility: hidden;
            }
            
            footer:after {
                content:'Developed by Matheus Vargas Volpon Berto.'; 
                visibility: visible;
                display: block;
                position: relative;
                padding: 5px;
                top: 2px;
                color: black;
            }
            </style>
            """
    st.markdown(hide_streamlit_style, unsafe_allow_html=True)
    
    with st.sidebar.form('sidebar_form'):
        st.header('Models exploration settings')
        
        loaded_model = st.selectbox(
         'Choose one of the preloaded models:',
         ('19: 1921 - 2022',
          '18: 1921 - 2018',
          '17: 1921 - 2014',
          '16: 1921 - 2013',
          '15: 1921 - 2011',
          '14: 1921 - 2009',
          '13: 1921 - 2001',
          '12: 1921 - 1999',
          '11: 1921 - 1998',
          '10: 1921 - 1995',
          '09: 1921 - 1983',
          '08: 1921 - 1982',
          '07: 1921 - 1977',
          '06: 1921 - 1976',
          '05: 1921 - 1974',
          '04: 1921 - 1971',
          '03: 1921 - 1969',
          '02: 1921 - 1967',
          '01: 1921 - 1963'))
        
        top_n = st.slider('Select the neighborhood size',
            5, 20, (5), 5)
        
        input_sentence = st.text_input(label='Input sentence', max_chars=128, help='Type the sentence that you want to compare to the others.')
        
        submitted = st.form_submit_button('Apply settings')
    
    st.sidebar.header('GitHub Repository')
    st.sidebar.markdown("[![Foo](https://cdn-icons-png.flaticon.com/32/25/25231.png)](https://github.com/matheusvvb-19/WE4LKD-leukemia_w2v)")
        
    st.title('Sentence Viewer')
    st.header('Sentence Embedding Visualization Based on Cosine Similarity')
    with st.expander('How to use this app'):
        st.markdown('**Sidebar**')
        st.markdown('Select the BERT-based model that you want to explore. Then, define the number of most similar sentences from the dataset that you want to compare to your input sentence. Finally, type your input sentence in the text box and click on "Apply settings"')

        st.markdown('**Main window**')
        st.markdown('_Hint: To see this window content better, you can minimize the sidebar._')
        st.markdown('lalala')
        
    if submitted or st.session_state['execution_counter'] != 0:
        st.markdown('**Input**')
        st.markdown(input_sentence)
        
        st.session_state['execution_counter'] += 1

        aux_df = sentences_df[(sentences_df["filename"].values <= int(loaded_model[-4:]))]
        sentences = aux_df['sentences'].to_list()
        sentences.insert(0, input_sentence)

        tokenizer = AutoTokenizer.from_pretrained('microsoft/BiomedNLP-PubMedBERT-base-uncased-abstract-fulltext')
        model = AutoModel.from_pretrained('matheusvolpon/WE4LKD_AML_distilbert_1921_{}'.format(loaded_model[-4:]))

        # initialize dictionary that will contain tokenized sentences
        tokens = {'input_ids': [], 'attention_mask': []}

        for sentence in sentences:
            # tokenize sentence and append to dictionary lists
            new_tokens = tokenizer.encode_plus(sentence, max_length=128, truncation=True,
                                               padding='max_length', return_tensors='pt')
            tokens['input_ids'].append(new_tokens['input_ids'][0])
            tokens['attention_mask'].append(new_tokens['attention_mask'][0])

        # reformat list of tensors into single tensor
        tokens['input_ids'] = torch.stack(tokens['input_ids'])
        tokens['attention_mask'] = torch.stack(tokens['attention_mask'])

        outputs = model(**tokens)

        embeddings = outputs.last_hidden_state

        attention_mask = tokens['attention_mask']

        mask = attention_mask.unsqueeze(-1).expand(embeddings.size()).float()

        masked_embeddings = embeddings * mask
        summed = torch.sum(masked_embeddings, 1)
        summed_mask = torch.clamp(mask.sum(1), min=1e-9)
        mean_pooled = summed / summed_mask

        # convert from PyTorch tensor to numpy array
        mean_pooled = mean_pooled.detach().numpy()

        # calculate
        similarities = flat_list(cosine_similarity([mean_pooled[0]], mean_pooled[1:]).tolist())
        
        data = {
            'sentence': [],
            'similarity': [],
        }

        for s, si in zip(sentences[1:], similarities):
            data['sentence'].append(s)
            data['similarity'].append(si)

        df_similar_sentences = pd.DataFrame(data).sort_values(by=['similarity'], ascending=False)
        df_similar_sentences = df_similar_sentences.head(top_n)
        
        st.markdown('**Top {} similar sentences to the input**'.format(top_n))
        st.table(df_similar_sentences)
